<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">30589669</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>04</Month>
            <Day>18</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>04</Month>
            <Day>18</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1536-0229</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>44</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Apr</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical nuclear medicine</Title>
                <ISOAbbreviation>Clin Nucl Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Initial Versus Follow-up Sequential Myocardial 123I-MIBG Scintigraphy to Discriminate Parkinson Disease From Atypical Parkinsonian Syndromes.</ArticleTitle>
            <Pagination>
                <MedlinePgn>282-288</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/RLU.0000000000002424</ELocationID>
            <Abstract>
                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Previous single-center or meta-analysis studies analyzed myocardial I-metaiodobenzylguanidine (I-MIBG) scintigraphy in a single image session and demonstrated low sensitivity and high specificity for discriminating Parkinson disease (PD) from atypical Parkinsonian syndromes (APS). This study aimed to assess diagnostic ability of myocardial I-MIBG scintigraphy at 2 phases to discriminate PD from APS.</AbstractText>
                <AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">This hospital-based prospective study enrolled 162 PD and 26 APS patients who underwent 2 sequential I-MIBG scintigraphy evaluations. Patients were stratified into normal and decreased I-MIBG groups according to early and delayed heart-to-mediastinum (H/M) ratios. Patients with PD and normal I-MIBG uptake (initial delayed H/M ratio, ≥1.78) were considered scans without evidence of cardiac norepinephrine deficit (SWEND). Early and delayed H/M ratios on the initial and 2-year follow-up scintigraphs were studied. The diagnostic sensitivity and specificity were calculated from these confusion matrices and were analyzed according to receiver-operating characteristic curve analysis. A repeated-measures general linear model was used to investigate differences among groups over time in H/M ratio changes and washout rates.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Follow-up I-MIBG scintigraphy analysis had a higher diagnostic sensitivity (89.5%) than the initial imaging (72.2%). The improved sensitivity was associated with a steeper decrease in H/M ratio in the SWEND group than in the APS group.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Follow-up I-MIBG scintigraphy can identify cardiac sympathetic denervation and its progression in patients with PD and may be effective in discriminating PD from APS. A later decrease in myocardial I-MIBG uptake in the group with SWEND meets the Braak staging threshold hypothesis for synucleinopathy.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ryu</LastName>
                    <ForeName>Dong-Woo</ForeName>
                    <Initials>DW</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Neurology and.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Joong-Seok</ForeName>
                    <Initials>JS</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Neurology and.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Jee-Eun</ForeName>
                    <Initials>JE</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Neurology and.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oh</LastName>
                    <ForeName>Yoon-Sang</ForeName>
                    <Initials>YS</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Neurology and.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yoo</LastName>
                    <ForeName>Sang-Won</ForeName>
                    <Initials>SW</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Neurology and.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yoo</LastName>
                    <ForeName>Ie Ryung</ForeName>
                    <Initials>IR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nuclear Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Kwang-Soo</ForeName>
                    <Initials>KS</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Neurology and.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016430">Clinical Trial</PublicationType>
                <PublicationType UI="D003160">Comparative Study</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Clin Nucl Med</MedlineTA>
            <NlmUniqueID>7611109</NlmUniqueID>
            <ISSNLinking>0363-9762</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>35MRW7B4AD</RegistryNumber>
                <NameOfSubstance UI="D019797">3-Iodobenzylguanidine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D019797" MajorTopicYN="Y">3-Iodobenzylguanidine</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055414" MajorTopicYN="Y">Myocardial Perfusion Imaging</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020734" MajorTopicYN="N">Parkinsonian Disorders</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>4</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30589669</ArticleId>
            <ArticleId IdType="doi">10.1097/RLU.0000000000002424</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">30586953</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>09</Month>
            <Day>29</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1976-8710</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>12</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>May</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical and experimental otorhinolaryngology</Title>
                <ISOAbbreviation>Clin Exp Otorhinolaryngol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Characteristics of Smell Identification Test in Patients With Parkinson Disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>206-211</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.21053/ceo.2018.01116</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Parkinson disease (PD) is frequently associated with olfactory disorder at early stage, which is caused by deposition of Lewy bodies emerging from the olfactory bulb to higher olfactory centers. Early detection of olfactory disorder in the patients with PD may lead to the early diagnosis and treatment for this refractory disease.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Visual analog scale (VAS), Jet Stream Olfactometry, and Japanese smell identification test, Open Essence (OE), were carried out on 39 patients with PD. Thirty-one patients with postviral olfactory disorder (PVOD), which was caused by the olfactory mucosal dysfunction, were also enrolled in this study as control.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">There were no significant differences in detection thresholds (2.2 vs. 1.4, P=0.13), recognition thresholds (3.9 vs. 3.5, P=0.39) and OE (4.8 vs. 4.2, P=0.47) between PVOD and PD, while VAS scores of PVOD and PD were significantly different (2.0 and 6.2, P&lt;0.01). In OE, significant differences were observed in the accuracy rates of menthol (68% vs. 44%, P=0.04) and Indian ink (42% vs. 15%, P=0.01) between PVOD and PD. Of particular interest, patients with PVOD tended to select &quot;no detectable,&quot; while patients with PD tended to select wrong alternative other than &quot;no smell detected.&quot;</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Discrepancy between VAS and OE, and high selected rates of wrong alternative other than &quot;undetectable&quot; in OE might be significant signs of olfactory dysfunction associated with PD.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fujio</LastName>
                    <ForeName>Hisami</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Inokuchi</LastName>
                    <ForeName>Go</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tatehara</LastName>
                    <ForeName>Shun</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kuroki</LastName>
                    <ForeName>Shunsuke</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fukuda</LastName>
                    <ForeName>Yuriko</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kowa</LastName>
                    <ForeName>Hisamoto</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Rehabilitation Science, Kobe University Graduate School of Health Sciences, Kobe, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nibu</LastName>
                    <ForeName>Ken-Ichi</ForeName>
                    <Initials>KI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>27</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Korea (South)</Country>
            <MedlineTA>Clin Exp Otorhinolaryngol</MedlineTA>
            <NlmUniqueID>101474010</NlmUniqueID>
            <ISSNLinking>1976-8710</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Open Essence</Keyword>
            <Keyword MajorTopicYN="N">Parkinson Disease</Keyword>
            <Keyword MajorTopicYN="N">Postviral Olfactory Disorder</Keyword>
            <Keyword MajorTopicYN="N">Smell Identification Test</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30586953</ArticleId>
            <ArticleId IdType="pii">ceo.2018.01116</ArticleId>
            <ArticleId IdType="doi">10.21053/ceo.2018.01116</ArticleId>
            <ArticleId IdType="pmc">PMC6453781</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Auris Nasus Larynx. 1999 Oct;26(4):435-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10530739</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Chronic Dis. 1975 Oct;28(9):493-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1176578</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Otol Rhinol Laryngol. 1975 Sep-Oct;84(5 Pt 1):672-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1190677</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Aging. 2003 Mar-Apr;24(2):197-211</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12498954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Otorhinolaryngol. 2006;63:125-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16733337</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2008 Feb;63(2):167-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18067173</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsonism Relat Disord. 2007;13 Suppl 3:S225-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18267240</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain. 2012 Jan;135(Pt 1):161-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22287381</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Otol Rhinol Laryngol. 2012 Jun;121(6):413-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22737965</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Parkinsons Dis. 2014;4(2):181-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24625830</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intern Med. 2017 Nov 1;56(21):2871-2878</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28943542</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Psychol Med. 1988 Nov;18(4):1007-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3078045</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1984 Dec 21;226(4681):1441-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6505700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Laryngoscope. 1984 Feb;94(2 Pt 1):176-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6694486</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Laryngoscope. 1996 Mar;106(3 Pt 1):353-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8614203</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rhinology. 1996 Dec;34(4):222-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9050101</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol Neurosurg Psychiatry. 1997 May;62(5):436-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9153598</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Neurol. 1998 Jan;55(1):84-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9443714</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">30586057</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>20</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1538-8689</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>49</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Nursing</Title>
                <ISOAbbreviation>Nursing</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Drugs for Parkinson disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>70</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/01.NURSE.0000549729.45434.8e</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bridgeman</LastName>
                    <ForeName>Mary Barna</ForeName>
                    <Initials>MB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Mary Barna Bridgeman is a clinical associate professor at Rutgers University Ernest Mario School of Pharmacy in Piscataway, N.J. Kavitha S. Dalal is a critical care pharmacist at Virtua in Marlton, N.J.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dalal</LastName>
                    <ForeName>Kavitha S</ForeName>
                    <Initials>KS</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Nursing</MedlineTA>
            <NlmUniqueID>7600137</NlmUniqueID>
            <ISSNLinking>0360-4039</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>N</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30586057</ArticleId>
            <ArticleId IdType="doi">10.1097/01.NURSE.0000549729.45434.8e</ArticleId>
            <ArticleId IdType="pii">00152193-201901000-00021</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30585570</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>28</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1467-1107</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>29</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Feb</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Cardiology in the young</Title>
                <ISOAbbreviation>Cardiol Young</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Aborted sudden cardiac death in a young soldier with concomitant hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome.</ArticleTitle>
            <Pagination>
                <MedlinePgn>252-255</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1017/S1047951118002123</ELocationID>
            <Abstract>
                <AbstractText>We present a young soldier presenting with aborted sudden cardiac death, who was found to have concomitant hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome. Along with pathological haemodynamic features of hypertrophic cardiomyopathy, an easily-inducible re-entrant tachycardia was clearly documented in our patient. Given the fatal potential of supraventricular tachycardia in hypertrophic cardiomyopathy, we postulated that his tachyarrhythmia could potentially trigger the event. Upon his refusal to receive implantable cardioverter/defibrillator therapy, we ablated anatomical arrhythmogenic substrate instead, and he remained uneventfully over 3 years on β-blocker.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Sunwon</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-7735-1763</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, Korea University Ansan Hospital, Ansan, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Song</LastName>
                    <ForeName>Woo Hyuk</ForeName>
                    <Initials>WH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, Korea University Ansan Hospital, Ansan, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Sung Soon</ForeName>
                    <Initials>SS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cardiology, Department of Internal Medicine, The Armed Forces Capital Hospital, Seongnam, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>26</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Cardiol Young</MedlineTA>
            <NlmUniqueID>9200019</NlmUniqueID>
            <ISSNLinking>1047-9511</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000319" MajorTopicYN="N">Adrenergic beta-Antagonists</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002312" MajorTopicYN="N">Cardiomyopathy, Hypertrophic</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016757" MajorTopicYN="N">Death, Sudden, Cardiac</DescriptorName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008889" MajorTopicYN="N">Military Personnel</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014927" MajorTopicYN="N">Wolff-Parkinson-White Syndrome</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Sudden cardiac death</Keyword>
            <Keyword MajorTopicYN="N">Wolff–Parkinson–White syndrome</Keyword>
            <Keyword MajorTopicYN="N">hypertrophic cardiomyopathy</Keyword>
            <Keyword MajorTopicYN="N">implantable cardioverter defibrillator</Keyword>
            <Keyword MajorTopicYN="N">ventricular fibrillation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>5</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30585570</ArticleId>
            <ArticleId IdType="pii">S1047951118002123</ArticleId>
            <ArticleId IdType="doi">10.1017/S1047951118002123</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30579934</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>07</Month>
            <Day>29</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>07</Month>
            <Day>29</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-0712</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>845</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Feb</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>European journal of pharmacology</Title>
                <ISOAbbreviation>Eur J Pharmacol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Aldehyde adducts inhibit 3,4-dihydroxyphenylacetaldehyde-induced α-synuclein aggregation and toxicity: Implication for Parkinson neuroprotective therapy.</ArticleTitle>
            <Pagination>
                <MedlinePgn>65-73</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0014-2999(18)30736-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejphar.2018.12.027</ELocationID>
            <Abstract>
                <AbstractText>3,4-Dihydroxyphenylacetaldehyde (DOPAL), the monoamine oxidase (MAO) metabolite of dopamine, plays a role in pathogenesis of Parkinson disease, inducing α-synuclein aggregation. DOPAL generates discrete α-synuclein aggregates. Inhibiting this aggregation could provide therapy for slowing Parkinson disease progression. Primary and secondary amines form adducts with aldehydes. Rasagiline and aminoindan contain these amine groups. DOPAL-induced α-synuclein aggregates were resolved in the presence and absence of rasagiline or aminoindan using quantitative Western blotting. DOPAL levels in incubation mixtures, containing increased rasagiline or aminoindan concentrations, were determined by high pressure liquid chromatography (HPLC). Schiff base adducts between DOPAL and rasagiline or aminoindan were determined using mass spectrometry. A neuroprotective effect of rasagiline and aminoindan against DOPAL-induced toxicity was demonstrated using PC-12 cells. Rasagiline and aminoindan significantly reduced aggregation of α-synuclein of all sizes in test tube and PC-12 cells experiments. Dimethylaminoindan did not reduce aggregation. DOPAL levels in incubation mixtures were reduced with increasing rasagiline or aminoindan concentrations but not with dimethylaminoindan. Schiff base adducts between DOPAL and either rasagiline or aminoindan were demonstrated by mass spectrometry. A neuroprotective effect against DOPAL-induced toxicity in PC-12 cells was demonstrated for both rasagiline and aminoindan. Inhibiting DOPAL-induced α-synuclein aggregation through amine adducts provides a therapeutic approach for slowing Parkinson disease progression.</AbstractText>
                <CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kumar</LastName>
                    <ForeName>Vijaya B</ForeName>
                    <Initials>VB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Saint Louis Veterans Affairs Medical Center, Saint Louis, MO 63125, USA; Departments of Medicine, School of Medicine, Saint Louis University Medical Center, 3635 Vista at Grand, Saint Louis, MO 63110, USA; Department of Geriatric Research, 3635 Vista at Grand, Saint Louis, MI 63110, USA. Electronic address: vkbuddhiraju@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hsu</LastName>
                    <ForeName>Fong-Fu</ForeName>
                    <Initials>FF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Biomedical and Bioorganic Mass Spectrometry, Washington University School of Medicine, 660S. Euclid, Saint Louis, MO 63110, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lakshmi</LastName>
                    <ForeName>Vijaya M</ForeName>
                    <Initials>VM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Saint Louis Veterans Affairs Medical Center, Saint Louis, MO 63125, USA; Departments of Medicine, School of Medicine, Saint Louis University Medical Center, 3635 Vista at Grand, Saint Louis, MO 63110, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gillespie</LastName>
                    <ForeName>Kathleen N</ForeName>
                    <Initials>KN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Management &amp; Policy, College for Public Health and Social Justice, Saint Louis University Health Sciences Center, 3635 Vista at Grand, Saint Louis, MO 63110, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Burke</LastName>
                    <ForeName>William J</ForeName>
                    <Initials>WJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Neurology, School of Medicine, Saint Louis University Medical Center, 3635 Vista at Grand, Saint Louis, MO 63110, USA; Departments of Medicine, School of Medicine, Saint Louis University Medical Center, 3635 Vista at Grand, Saint Louis, MO 63110, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Eur J Pharmacol</MedlineTA>
            <NlmUniqueID>1254354</NlmUniqueID>
            <ISSNLinking>0014-2999</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000447">Aldehydes</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007189">Indans</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>003N66TS6T</RegistryNumber>
                <NameOfSubstance UI="C031967">rasagiline</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>102-32-9</RegistryNumber>
                <NameOfSubstance UI="D015102">3,4-Dihydroxyphenylacetic Acid</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>5707-55-1</RegistryNumber>
                <NameOfSubstance UI="C007430">3,4-dihydroxyphenylacetaldehyde</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>H9SCX043IG</RegistryNumber>
                <NameOfSubstance UI="C093582">indan</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D015102" MajorTopicYN="N">3,4-Dihydroxyphenylacetic Acid</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000447" MajorTopicYN="N">Aldehydes</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007189" MajorTopicYN="N">Indans</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016716" MajorTopicYN="N">PC12 Cells</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">3,4-Dihydroxyphenylacetaldehyde</Keyword>
            <Keyword MajorTopicYN="N">Schiff base adducts</Keyword>
            <Keyword MajorTopicYN="N">α-Synuclein aggregation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>05</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>7</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30579934</ArticleId>
            <ArticleId IdType="pii">S0014-2999(18)30736-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ejphar.2018.12.027</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30576816</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>04</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>04</Month>
            <Day>04</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-8769</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>123</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Mar</Month>
                    </PubDate>
                </JournalIssue>
                <Title>World neurosurgery</Title>
                <ISOAbbreviation>World Neurosurg</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A Review of Biomarkers Use in Parkinson with Deep Brain Stimulation: A Successful Past Promising a Bright Future.</ArticleTitle>
            <Pagination>
                <MedlinePgn>197-207</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1878-8750(18)32814-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2018.11.247</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Parkinson disease (PD) remains a common neurodegenerative disorder. Functional neurosurgery largely arose with the introduction of deep brain stimulation (DBS) as a potential option for PD unresponsive to medical management. Biomarkers are clinical and laboratory indicators of therapeutic success or failure.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine the current and published literature relating to the development and use of biomarkers in monitoring and determining the efficacy of DBS in PD.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">The PubMed database was systematically searched using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines for systemic reviews. Studies that examined current or potential biomarkers measurable after DBS were included. Articles from 1952 to date were examined.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The initial search identified 49 articles. Thirty articles met the inclusion criteria. Articles were subdivided into those addressing biomarkers with proven clinical usefulness and potential biomarkers that have future application.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Biomarkers have been identified that can help to determine the effect of DBS on patients with PD. Current studies show that there are measured differences in electrophysiologic oscillations, gene expression, neuropeptide levels, metabolic function, inflammatory activity, and others in the central nervous system after DBS in PD. Local field potential and β-band analysis stand as the clinically proven biomarkers of choice for DBS in PD. Many of the identified changes noted could be implemented as clinically useful biomarkers through which DBS may be monitored. Future studies are needed to determine which noted physiologic changes are most appropriately used as biomarkers and in which contexts they are most helpful.</AbstractText>
                <CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mugge</LastName>
                    <ForeName>Luke</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, The University of Toledo Medical Center, Toledo, Ohio, USA. Electronic address: luke.mugge@rockets.utoledo.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krafcik</LastName>
                    <ForeName>Brianna</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, The University of Toledo Medical Center, Toledo, Ohio, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pontasch</LastName>
                    <ForeName>Gregory</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, The University of Toledo Medical Center, Toledo, Ohio, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alnemari</LastName>
                    <ForeName>Ahmed</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, The University of Toledo Medical Center, Toledo, Ohio, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Neimat</LastName>
                    <ForeName>Joseph</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, The University of Louisville Hospital, Louisville, Kentucky, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gaudin</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, The University of Toledo Medical Center, Toledo, Ohio, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>World Neurosurg</MedlineTA>
            <NlmUniqueID>101528275</NlmUniqueID>
            <ISSNLinking>1878-8750</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D046690" MajorTopicYN="Y">Deep Brain Stimulation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Biomarkers</Keyword>
            <Keyword MajorTopicYN="N">Deep brain stimulation</Keyword>
            <Keyword MajorTopicYN="N">Parkinson disease</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>04</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>4</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30576816</ArticleId>
            <ArticleId IdType="pii">S1878-8750(18)32814-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.wneu.2018.11.247</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30572013</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>03</Month>
            <Day>03</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>03</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-260X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>1865</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>08</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biochimica et biophysica acta. Molecular basis of disease</Title>
                <ISOAbbreviation>Biochim Biophys Acta Mol Basis Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2008-2023</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0925-4439(18)30475-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbadis.2018.11.014</ELocationID>
            <Abstract>
                <AbstractText>Protein post-translational modifications (PTMs) that potentiate protein aggregation have been implicated in several neurological disorders, including Alzheimer's (AD) and Parkinson's disease (PD). In fact, Tau and alpha-synuclein (ASYN) undergo several PTMs potentiating their aggregation and neurotoxicity. Recent data posits a role for acetylation in Tau and ASYN aggregation. Herein we aimed to clarify the role of Sirtuin-2 (SIRT2) and HDAC6 tubulin deacetylases as well as p300 acetyltransferase in AD and PD neurodegeneration. We used transmitochondrial cybrids that recapitulate pathogenic alterations observed in sporadic PD and AD patient brains and ASYN and Tau cellular models. We confirmed that Tau protein and ASYN are microtubules (MTs)-associated proteins (MAPs). Moreover, our results suggest that α-tubulin acetylation induced by SIRT2 inhibition is functionally associated with the improvement of MT dynamic determined by decreased Tau phosphorylation and by increased Tau/tubulin and ASYN/tubulin binding. Our data provide a strong evidence for a functional role of tubulin and MAPs acetylation on autophagic vesicular traffic and cargo clearance. Additionally, we showed that an accumulation of ASYN oligomers imbalance mitochondrial dynamics, which further compromise autophagy. We also demonstrated that an increase in Tau acetylation is associated with Tau phosphorylation. We found that p300, HDAC6 and SIRT2 influences Tau phosphorylation and autophagic flux in AD. In addition, we demonstrated that p300 and HDAC6 modulate Tau and Tubulin acetylation. Overall, our data disclose the role of Tau and ASYN modifications through acetylation in AD and PD pathology, respectively. Moreover, this study indicates that MTs can be a promising therapeutic target in the field of neurodegenerative disorders in which intracellular transport is altered.</AbstractText>
                <CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Esteves</LastName>
                    <ForeName>A R</ForeName>
                    <Initials>AR</Initials>
                    <AffiliationInfo>
                        <Affiliation>CNC - Centro de Neurociências e Biologia Celular, Universidade de Coimbra, Coimbra, Portugal. Electronic address: esteves.raquel@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Palma</LastName>
                    <ForeName>A M</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>CNC - Centro de Neurociências e Biologia Celular, Universidade de Coimbra, Coimbra, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gomes</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>CNC - Centro de Neurociências e Biologia Celular, Universidade de Coimbra, Coimbra, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Santos</LastName>
                    <ForeName>D</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>CNC - Centro de Neurociências e Biologia Celular, Universidade de Coimbra, Coimbra, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Silva</LastName>
                    <ForeName>D F</ForeName>
                    <Initials>DF</Initials>
                    <AffiliationInfo>
                        <Affiliation>CNC - Centro de Neurociências e Biologia Celular, Universidade de Coimbra, Coimbra, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cardoso</LastName>
                    <ForeName>S M</ForeName>
                    <Initials>SM</Initials>
                    <AffiliationInfo>
                        <Affiliation>CNC - Centro de Neurociências e Biologia Celular, Universidade de Coimbra, Coimbra, Portugal; Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Biochim Biophys Acta Mol Basis Dis</MedlineTA>
            <NlmUniqueID>101731730</NlmUniqueID>
            <ISSNLinking>0925-4439</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014404">Tubulin</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.5.1.98</RegistryNumber>
                <NameOfSubstance UI="C433811">HDAC6 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.5.1.98</RegistryNumber>
                <NameOfSubstance UI="D000073864">Histone Deacetylase 6</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000107" MajorTopicYN="N">Acetylation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001343" MajorTopicYN="Y">Autophagy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000073864" MajorTopicYN="N">Histone Deacetylase 6</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008870" MajorTopicYN="N">Microtubules</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014404" MajorTopicYN="N">Tubulin</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Alpha-synuclein</Keyword>
            <Keyword MajorTopicYN="Y">Alzheimer's disease</Keyword>
            <Keyword MajorTopicYN="Y">Autophagy</Keyword>
            <Keyword MajorTopicYN="Y">Microtubules acetylation</Keyword>
            <Keyword MajorTopicYN="Y">Parkinson's disease</Keyword>
            <Keyword MajorTopicYN="Y">Tau</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>08</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>3</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30572013</ArticleId>
            <ArticleId IdType="pii">S0925-4439(18)30475-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbadis.2018.11.014</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30571663</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1473-558X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>30</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neuroreport</Title>
                <ISOAbbreviation>Neuroreport</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effects and mechanism of epigallocatechin-3-gallate on apoptosis and mTOR/AKT/GSK-3β pathway in substantia nigra neurons in Parkinson rats.</ArticleTitle>
            <Pagination>
                <MedlinePgn>60-65</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/WNR.0000000000001149</ELocationID>
            <Abstract>
                <AbstractText>The aim of this study is to investigate the protective effect of epigallocatechin-3-gallate (EGCG) on apoptosis and mTOR/AKT/GSK-3β pathway in substantia nigra neurons in 6-dopamine-induced Parkinson rats. A total of 30 healthy male SD rats were randomly divided into control group, the Parkinson model group, and Parkinson model+EGCG treatment group. The model and EGCG groups were injected into the right striatum with 6-OHDA to establish the Parkinson model, and the control group was injected with saline only. The EGCG group was intragastrically administered with EGCG 50 mg/kg daily for 4 weeks. The rats' turns, speed, and left forelimb usage; neuron apoptosis by TUNEL; and the α-synuclein protein expression in substantia nigra by immunohistochemical staining were studied. Western blotting was used to detect the relative protein (mTOR, AKT and GSK-3β) expressions. Compared with the model group, the EGCG group significantly reduced the rotation speed; increased the left forelimb usage (P&lt;0.01); reduced the neuron apoptosis (P&lt;0.01); decreased α-synuclein expression (P&lt;0.01); and decreased the mTOR, AKT, and GSK-3β protein expressions (P&lt;0.01). EGCG can reduce neuron cell apoptosis in substantia nigra neurons in 6-OHDA-induced Parkinson rats. The mechanism might be related to mTOR/AKT/GSK-3β activation.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Tianjin United Medical Centre.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Lei</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Tianjin Huanhu Hospital, Tianjin, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Xiqing</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Tianjin United Medical Centre.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cao</LastName>
                    <ForeName>Shanshan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Tianjin University of Traditional Chinese Medicine.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Junxiu</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Tianjin University of Traditional Chinese Medicine.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Neuroreport</MedlineTA>
            <NlmUniqueID>9100935</NlmUniqueID>
            <ISSNLinking>0959-4965</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>8R1V1STN48</RegistryNumber>
                <NameOfSubstance UI="D002392">Catechin</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>BQM438CTEL</RegistryNumber>
                <NameOfSubstance UI="C045651">epigallocatechin gallate</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.1.1</RegistryNumber>
                <NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.1.1</RegistryNumber>
                <NameOfSubstance UI="C546845">mTOR protein, rat</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.11.1</RegistryNumber>
                <NameOfSubstance UI="D000071679">Glycogen Synthase Kinase 3 beta</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.11.1</RegistryNumber>
                <NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002392" MajorTopicYN="N">Catechin</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000071679" MajorTopicYN="N">Glycogen Synthase Kinase 3 beta</DescriptorName>
                <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020734" MajorTopicYN="N">Parkinsonian Disorders</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
                <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013378" MajorTopicYN="N">Substantia Nigra</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName>
                <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName>
                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>2</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30571663</ArticleId>
            <ArticleId IdType="doi">10.1097/WNR.0000000000001149</ArticleId>
            <ArticleId IdType="pii">00001756-201901020-00002</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">30570519</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>07</Month>
            <Day>24</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>07</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1473-5660</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>42</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jun</Month>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation</Title>
                <ISOAbbreviation>Int J Rehabil Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Speed and temporal adaptations during nonmotorized treadmill walking in Parkinson disease and nondisabled individuals.</ArticleTitle>
            <Pagination>
                <MedlinePgn>126-132</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/MRR.0000000000000334</ELocationID>
            <Abstract>
                <AbstractText>Few studies have explored the potential of gait analysis and training in nonmotorized treadmill (NMT) in Parkinson's disease (PD) patients. We investigated (a) the walking strategy adopted by patients with PD on NMT and (b) how balance may influence spatiotemporal gait parameters. We enrolled 12 patients with PD of modified Hoehn and Yahr stage 2-3 and 13 nondisabled individuals as controls. All participants were evaluated using Tinetti's performance oriented mobility assessment scale, freezing of gait questionnaire, modified falls efficacy scale, and the timed up and go test. They were asked to ambulate with comfortable and maximal speeds on the NMT. The gait parameters acquired on the NMT included walking speed, cadence (CAD), step length, and vertical ground reaction force, which were calculated for intragroup and intergroup comparisons. The PD group took on with higher contribution of CAD and less contribution of step length to increase walking speed as compared with control group. The postural stability is correlated significantly positively to the CAD at the setting of maximal speed in the PD group. Moreover, a significantly lower ratio of vertical ground reaction force/body weight was noted in the PD group during both comfortable and maximal walking speeds compared with the nondisabled controls. Our study outcomes clearly support the perceived benefits of NMT to differentiate spatiotemporal gait parameters between PD and controls. NMT may potentially be useful to evaluate the recovery of physical activities in PD receiving medications and/or rehabilitation.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Penn</LastName>
                    <ForeName>I-Wen</ForeName>
                    <Initials>IW</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Physical Medicine and Rehabilitation, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sung</LastName>
                    <ForeName>Wen-Hsu</ForeName>
                    <Initials>WH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physical Therapy and Assistive Technology, National Yang-Ming University.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Pei-Hsin</ForeName>
                    <Initials>PH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rehabilitation and Technical Aid Center.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Jia-Chi</ForeName>
                    <Initials>JC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physical Medicine and Rehabilitation, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chuang</LastName>
                    <ForeName>Eric</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Integrative Biology Alumnus, University of California, Berkeley, California, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chuang</LastName>
                    <ForeName>Tien-Yow</ForeName>
                    <Initials>TY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physical Medicine and Rehabilitation, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Physical Medicine and Rehabilitation, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kuo</LastName>
                    <ForeName>Chia-Yu</ForeName>
                    <Initials>CY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physical Medicine and Rehabilitation, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Int J Rehabil Res</MedlineTA>
            <NlmUniqueID>7805421</NlmUniqueID>
            <ISSNLinking>0342-5282</ISSNLinking>
        </MedlineJournalInfo>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000222" MajorTopicYN="Y">Adaptation, Physiological</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020233" MajorTopicYN="N">Gait Disorders, Neurologic</DescriptorName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004856" MajorTopicYN="N">Postural Balance</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000072797" MajorTopicYN="Y">Walking Speed</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>7</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30570519</ArticleId>
            <ArticleId IdType="doi">10.1097/MRR.0000000000000334</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">30558462</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>26</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>26</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">0891-9887</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>32</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of geriatric psychiatry and neurology</Title>
                <ISOAbbreviation>J Geriatr Psychiatry Neurol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Music Therapy and Dance as Gait Rehabilitation in Patients With Parkinson Disease: A Review of Evidence.</ArticleTitle>
            <Pagination>
                <MedlinePgn>49-56</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1177/0891988718819858</ELocationID>
            <Abstract>
                <AbstractText Label="AIM">This review aims to demonstrate the efficiency of music and dance for gait improvement and symptom alleviation in Parkinson disease.</AbstractText>
                <AbstractText Label="METHODOLOGY">Studies that analyzed sound stimuli and dance in gait improvement in Parkinson disease were searched through PubMed, Scopus, Doaj, MEDLINE, and ScienceDirect databases from November 2017 to April 2018 and repeated in September 2018.</AbstractText>
                <AbstractText Label="RESULTS AND DISCUSSION">Forty-five studies met the inclusion criteria to synthesize the findings on dance and music performance as a treatment for classical symptoms of Parkinson disease. Five reviews and 40 experimental papers have shown that rhythmic stimulation and dance provide the motor, cognitive, and quality of life benefits for participants with Parkinson disease. Thus, sound stimuli and dance offer satisfactory effects for gait, improving cognitive abilities such as motor control and adjustment and spatial memory. In addition, these new treatment modalities stimulate the elderly population to practice physical exercise, generating well-being and helping self-esteem.</AbstractText>
                <AbstractText Label="CONCLUSION">Dance and music therapy interventions are noninvasive, simple treatment options, which promote gait and cognition.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pereira</LastName>
                    <ForeName>Ana Paula S</ForeName>
                    <Initials>APS</Initials>
                    <AffiliationInfo>
                        <Affiliation>1 Department of Physical Therapy, Federal University of Piauí, Parnaíba, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marinho</LastName>
                    <ForeName>Victor</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>2 Neuro-innovation Technology &amp; Brain Mapping Laboratory, Federal University of Piauí, Parnaíba, Brazil.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>3 The Northeast Biotechnology Network, Federal University of Piauí, Teresina, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gupta</LastName>
                    <ForeName>Daya</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>4 Department of Biology, Camden County College, Blackwood, NJ, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Magalhães</LastName>
                    <ForeName>Francisco</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>2 Neuro-innovation Technology &amp; Brain Mapping Laboratory, Federal University of Piauí, Parnaíba, Brazil.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>3 The Northeast Biotechnology Network, Federal University of Piauí, Teresina, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ayres</LastName>
                    <ForeName>Carla</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>2 Neuro-innovation Technology &amp; Brain Mapping Laboratory, Federal University of Piauí, Parnaíba, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Teixeira</LastName>
                    <ForeName>Silmar</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>1 Department of Physical Therapy, Federal University of Piauí, Parnaíba, Brazil.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>2 Neuro-innovation Technology &amp; Brain Mapping Laboratory, Federal University of Piauí, Parnaíba, Brazil.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>3 The Northeast Biotechnology Network, Federal University of Piauí, Teresina, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Geriatr Psychiatry Neurol</MedlineTA>
            <NlmUniqueID>8805645</NlmUniqueID>
            <ISSNLinking>0891-9887</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003614" MajorTopicYN="N">Dance Therapy</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003615" MajorTopicYN="Y">Dancing</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005081" MajorTopicYN="N">Exercise Therapy</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005684" MajorTopicYN="N">Gait</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009147" MajorTopicYN="Y">Music Therapy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
                <QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004856" MajorTopicYN="N">Postural Balance</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Parkinson disease</Keyword>
            <Keyword MajorTopicYN="Y">dance</Keyword>
            <Keyword MajorTopicYN="Y">gait</Keyword>
            <Keyword MajorTopicYN="Y">music therapy</Keyword>
            <Keyword MajorTopicYN="Y">rehabilitation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30558462</ArticleId>
            <ArticleId IdType="doi">10.1177/0891988718819858</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30557688</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>29</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>29</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-8421</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>328</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>03</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neuroimmunology</Title>
                <ISOAbbreviation>J Neuroimmunol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>NMDAR encephalitis presenting as akinesia in a patient with Parkinson disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>35-37</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0165-5728(18)30530-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jneuroim.2018.12.002</ELocationID>
            <Abstract>
                <AbstractText>We describe the case of a woman with Parkinson disease who developed an N-methyl-d-aspartate receptor antibody-mediated encephalitis. As a novelty, the encephalitis presentation mimicked a worsening of the pre-existing extrapyramidal syndrome, manifesting mainly as severe bradykinesia and, eventually, akinesia. Brain MRI was normal, whereas cerebrospinal fluid (CSF) analysis disclosed unique-to-CSF oligoclonal bands. Prompt identification and timely immunotherapy led to a complete recovery.</AbstractText>
                <CopyrightInformation>Copyright © 2018. Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gastaldi</LastName>
                    <ForeName>Matteo</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neuroimmunology Laboratory, IRCCS Mondino Foundation, Pavia, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arbasino</LastName>
                    <ForeName>Carla</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neurology Unit, ASST Pavia-Ospedale Civile di Voghera, Voghera, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dallocchio</LastName>
                    <ForeName>Carlo</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neurology Unit, ASST Pavia-Ospedale Civile di Voghera, Voghera, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Diamanti</LastName>
                    <ForeName>Luca</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neuroncology and Neuroinflammation Unit, IRCCS Mondino Foundation, Pavia, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bini</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neuroncology and Neuroinflammation Unit, IRCCS Mondino Foundation, Pavia, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marchioni</LastName>
                    <ForeName>Enrico</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neuroncology and Neuroinflammation Unit, IRCCS Mondino Foundation, Pavia, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Franciotta</LastName>
                    <ForeName>Diego</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neuroimmunology Laboratory, IRCCS Mondino Foundation, Pavia, Italy. Electronic address: diego.franciotta@mondino.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>J Neuroimmunol</MedlineTA>
            <NlmUniqueID>8109498</NlmUniqueID>
            <ISSNLinking>0165-5728</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D060426" MajorTopicYN="N">Anti-N-Methyl-D-Aspartate Receptor Encephalitis</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Akinesia</Keyword>
            <Keyword MajorTopicYN="Y">Autoantibodies</Keyword>
            <Keyword MajorTopicYN="Y">Autoimmune encephalitis</Keyword>
            <Keyword MajorTopicYN="Y">NMDAR encephalitis</Keyword>
            <Keyword MajorTopicYN="Y">Parkinson disease</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30557688</ArticleId>
            <ArticleId IdType="pii">S0165-5728(18)30530-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2018.12.002</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">30555879</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>09</Month>
            <Day>29</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2352-5126</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>5</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>JAAD case reports</Title>
                <ISOAbbreviation>JAAD Case Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Eruptive melanocytic nevi in a patient with Parkinson disease treated by carbidopa-levodopa.</ArticleTitle>
            <Pagination>
                <MedlinePgn>21-23</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jdcr.2018.10.005</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Haraszti</LastName>
                    <ForeName>Samantha</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ezaldein</LastName>
                    <ForeName>Harib</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Delost</LastName>
                    <ForeName>Gregory R</ForeName>
                    <Initials>GR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>JAAD Case Rep</MedlineTA>
            <NlmUniqueID>101665210</NlmUniqueID>
            <ISSNLinking>2352-5126</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">6-MP, 6-mercaptupurine</Keyword>
            <Keyword MajorTopicYN="N">CMM, cutaneous malignant melanoma</Keyword>
            <Keyword MajorTopicYN="N">ENAMS, eruptive nevi associated with medications</Keyword>
            <Keyword MajorTopicYN="N">ENM, eruptive melanocytic nevi</Keyword>
            <Keyword MajorTopicYN="N">L-DOPA, levodopa</Keyword>
            <Keyword MajorTopicYN="N">PD, Parkinson disease</Keyword>
            <Keyword MajorTopicYN="N">Parkinson disease</Keyword>
            <Keyword MajorTopicYN="N">carbidopa-levodopa</Keyword>
            <Keyword MajorTopicYN="N">eruptive melanocytic nevi</Keyword>
            <Keyword MajorTopicYN="N">eruptive nevi associated with medications</Keyword>
            <Keyword MajorTopicYN="N">melanoma</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30555879</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jdcr.2018.10.005</ArticleId>
            <ArticleId IdType="pii">S2352-5126(18)30295-9</ArticleId>
            <ArticleId IdType="pmc">PMC6280631</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Dtsch Dermatol Ges. 2006 Jun;4(6):486-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16734838</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Anticancer Ther. 2011 May;11(5):711-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21554046</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Dermatol. 2015 May;42(5):547-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25766430</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Acad Dermatol. 2016 Nov;75(5):1045-1052</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27241804</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Drug Metab Toxicol. 2017 Mar;13(3):293-300</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27759434</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2016 Dec;80(6):811-820</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27761938</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ther Adv Neurol Disord. 2017 Oct 30;11:1756285617737728</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29399046</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30551452</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>03</Month>
            <Day>27</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>03</Month>
            <Day>27</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>109</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed Pharmacother</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Anti-Parkinson activity of bioactive substances extracted from Holothuria leucospilota.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1967-1977</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(18)36392-3</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2018.11.063</ELocationID>
            <Abstract>
                <AbstractText>Parkinson's disease (PD) is a well-known neurodegenerative disorder characterized by dopaminergic (DA) neuron loss and α-synuclein aggregation. Recent study revealed that the extracts from sea cucumber, Holothuroidea spp., exhibited neuroprotective and lifespan extension effects in Caenorhabditis elegans model. Interestingly, the black sea cucumber, Holothuria leucospilota, possesses body wall and a specialized organ called cuvierian tubules containing high amount of bioactive compounds. In this study, the neuroprotective effects of the body wall (BW) and cuvierian tubules (CT) from this sea cucumber against PD were evaluated using C. elegans as a model. H. leucospilota were extracted using ethanol (ET), ethyl acetate (EA), butanol (BU) and aqueous (AQ) fractions. Extracts from these fractions were used to treat the 6-OHDA-induced BZ555 and α-synuclein expressing NL5901 strains of C. elegans. Treatment with ET, EA, BU and AQ fractions of H. leucospilota extracts could significantly prevent degeneration of DA neurons in 6-OHDA-induced worms, improve food-sensing behavior mediated by DA neurons, and up-regulate cat-2 and sod-3 gene expressions. These results indicate the neuroprotective activity of the extracts which may be attributed to the anti-oxidant activity of the bioactive compounds. Moreover, α-synuclein aggregation was significantly reduced together with the recovery of lipid deposition upon the treatment with H. leucospilota extracts. In addition, treatment with H. leucospilota extracts was able to increase the lifespan of 6-OHDA-induced N2. NMR analysis revealed the major chemical components in the effective EA fractions were terpenoids, steroids, saponins, and glycosides. In summary, H. leucospilota extracts exhibited anti-Parkinson effect in both toxin-induced and transgenic C. elegans models of PD. Further study will be performed to elucidate the most effective anti-PD molecules which will lead to the development of anti-PD drug.</AbstractText>
                <CopyrightInformation>Copyright © 2018 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Malaiwong</LastName>
                    <ForeName>Nawaphat</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomy, Faculty of Science, Mahidol University, Ratchathewi, Bangkok, 10400, Thailand.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chalorak</LastName>
                    <ForeName>Pawanrat</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomy, Faculty of Science, Mahidol University, Ratchathewi, Bangkok, 10400, Thailand.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jattujan</LastName>
                    <ForeName>Prapaporn</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomy, Faculty of Science, Mahidol University, Ratchathewi, Bangkok, 10400, Thailand; Chulabhorn International College of Medicine, Thammasat University, Pathumthani, 12121, Thailand.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Manohong</LastName>
                    <ForeName>Preeyanuch</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemistry, Faculty of Science, King Mongkut's University of Technology Thonburi, Bang Mod, Bangkok, 10140, Thailand.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Niamnont</LastName>
                    <ForeName>Nakorn</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemistry, Faculty of Science, King Mongkut's University of Technology Thonburi, Bang Mod, Bangkok, 10140, Thailand.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Suphamungmee</LastName>
                    <ForeName>Worawit</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomy, Faculty of Science, Mahidol University, Ratchathewi, Bangkok, 10400, Thailand.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sobhon</LastName>
                    <ForeName>Prasert</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomy, Faculty of Science, Mahidol University, Ratchathewi, Bangkok, 10400, Thailand; Faculty of Allied Health Sciences, Burapha University, Chonburi 20131, Thailand.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meemon</LastName>
                    <ForeName>Krai</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomy, Faculty of Science, Mahidol University, Ratchathewi, Bangkok, 10400, Thailand. Electronic address: krai.mee@mahidol.ac.th.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>26</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>VTD58H1Z2X</RegistryNumber>
                <NameOfSubstance UI="D004298">Dopamine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D030801" MajorTopicYN="N">Animals, Genetically Modified</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000978" MajorTopicYN="N">Antiparkinson Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059290" MajorTopicYN="N">Dopaminergic Neurons</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D047332" MajorTopicYN="N">Holothuria</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Caenorhabditis elegans</Keyword>
            <Keyword MajorTopicYN="N">Dopaminergic neuron</Keyword>
            <Keyword MajorTopicYN="N">Holothuria leucospilota</Keyword>
            <Keyword MajorTopicYN="N">Neurodegeneration</Keyword>
            <Keyword MajorTopicYN="N">Neuroprotective</Keyword>
            <Keyword MajorTopicYN="N">Parkinson’s disease</Keyword>
            <Keyword MajorTopicYN="N">α-synuclein</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>3</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30551452</ArticleId>
            <ArticleId IdType="pii">S0753-3322(18)36392-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2018.11.063</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30545438</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>06</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1976-670X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>52</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Apr</Month>
                    </PubDate>
                </JournalIssue>
                <Title>BMB reports</Title>
                <ISOAbbreviation>BMB Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Disease model organism for Parkinson disease: Drosophila melanogaster.</ArticleTitle>
            <Pagination>
                <MedlinePgn>250-258</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>Parkinson's disease (PD) is a common neurodegenerative disorder characterized by selective and progressive loss of dopaminergic neurons. Genetic and environmental risk factors are associated with this disease. The genetic factors are composed of approximately 20 genes, such as SNCA, parkin, PTEN-induced kinase1 (pink1), leucine-rich repeat kinase 2 (LRRK2), ATP13A2, MAPT, VPS35, and DJ-1, whereas the environmental factors consist of oxidative stress-induced toxins such as 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP), rotenone, and paraquat. The analyses of their functions and mechanisms have provided important insights into the disease process, which has demonstrated that these factors cause oxidative damage and mitochondrial dysfunction. The most invaluable studies have been performed using disease model organisms, such as mice, fruit flies, and worms. Among them, Drosophila melanogaster has emerged as an excellent model organism to study both environmental and genetic factors and provide insights to the pathways relevant for PD pathogenesis, facilitating development of therapeutic strategies. In this review, we have focused on the fly model organism to summarize recent progress, including pathogenesis, neuroprotective compounds, and newer approaches. [BMB Reports 2019; 52(4): 250-258].</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Aryal</LastName>
                    <ForeName>Binod</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Bio and Fermentation Convergence Technology, Kookmin University, BK21 PLUS Project, Seoul 02707, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Youngseok</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Bio and Fermentation Convergence Technology, Kookmin University, BK21 PLUS Project, Seoul 02707, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Korea (South)</Country>
            <MedlineTA>BMB Rep</MedlineTA>
            <NlmUniqueID>101465334</NlmUniqueID>
            <ISSNLinking>1976-6696</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015386">Hazardous Substances</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D033921">Vesicular Transport Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.3.2.27</RegistryNumber>
                <NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.3.2.27</RegistryNumber>
                <NameOfSubstance UI="C111567">parkin protein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.11.1</RegistryNumber>
                <NameOfSubstance UI="D000071158">Leucine-Rich Repeat Serine-Threonine Protein Kinase-2</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.11.1</RegistryNumber>
                <NameOfSubstance UI="C534484">PINK1 protein, Drosophila</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.11.1</RegistryNumber>
                <NameOfSubstance UI="D017346">Protein-Serine-Threonine Kinases</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.1.2.-</RegistryNumber>
                <NameOfSubstance UI="D000071617">Protein Deglycase DJ-1</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.6.1.-</RegistryNumber>
                <NameOfSubstance UI="D000251">Adenosine Triphosphatases</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000251" MajorTopicYN="N">Adenosine Triphosphatases</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059290" MajorTopicYN="N">Dopaminergic Neurons</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D029721" MajorTopicYN="N">Drosophila Proteins</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015386" MajorTopicYN="N">Hazardous Substances</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000071158" MajorTopicYN="N">Leucine-Rich Repeat Serine-Threonine Protein Kinase-2</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000071617" MajorTopicYN="N">Protein Deglycase DJ-1</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017346" MajorTopicYN="N">Protein-Serine-Threonine Kinases</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D033921" MajorTopicYN="N">Vesicular Transport Proteins</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30545438</ArticleId>
            <ArticleId IdType="pii">4331</ArticleId>
            <ArticleId IdType="pmc">PMC6507844</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2000 Mar 23;404(6776):394-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10746727</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Neurosci. 2000 Dec;3(12):1301-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11100151</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prog Neurobiol. 2001 Oct;65(2):135-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11403877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol. 2001 Oct;248(10):833-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11697518</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8968-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12084935</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4078-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12642658</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2003 Oct 31;302(5646):841</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14593171</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurol Sci. 2003 Oct;24(3):159-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14598065</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2003 Nov 26;23(34):10756-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14645467</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2004 May 21;304(5674):1158-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15087508</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuropathol Exp Neurol. 2004 Apr;63(4):302-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15099020</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2004 May 21;304(5674):1120-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15155938</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Tissue Res. 2004 Oct;318(1):215-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15503155</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Biol. 2004 Nov;24(22):9848-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15509788</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2004 Nov 18;44(4):601-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15541309</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2005 Jul 15;14(14):2063-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15944198</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10345-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16002472</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Biol. 2005 Sep 6;15(17):1572-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16139213</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Biol. 2005 Sep 6;15(17):1578-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16139214</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gene. 2005 Nov 21;361:133-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16203113</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Genet. 2005;39:153-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16285856</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Neurosci. 2006 Mar;7(3):207-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16495942</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2006 Jun 29;441(7097):1157-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16672980</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2006 Jun 29;441(7097):1162-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16672981</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10793-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16818890</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12517-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16894167</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Genet. 2006 Oct;38(10):1184-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16964263</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Cell Physiol. 2007 Feb;292(2):C641-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17092996</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Biol Evol. 2007 Feb;24(2):551-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17138626</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Physiol Rev. 2007 Jan;87(1):99-163</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17237344</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroscience. 2007 Apr 14;145(4):1233-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17303344</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Pharmacol. 2007 Apr;150(8):963-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17339843</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2007 May 8;104(19):8161-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17483459</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS J. 2007 Sep;274(18):4788-801</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17697112</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Nerve. 2007 Aug;59(8):851-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17713121</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2008 Apr 4;283(14):9089-100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18245082</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2693-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18258746</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2008 Dec 19;377(3):975-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18957282</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Biol. 2008 Dec 1;183(5):795-803</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19029340</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2009 Feb 18;29(7):1962-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19228951</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Death Differ. 2009 Aug;16(8):1118-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19282869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2009 Apr 30;62(2):218-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19409267</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Neurosci. 2009 Jul;12(7):826-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19503083</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2009 Dec 1;18(23):4629-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19744960</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Top Med Chem. 2009;9(10):880-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19754400</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2009 Dec 18;390(3):667-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19822128</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4412-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20160091</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biol Chem. 2010 May;391(5):513-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20302514</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2010 Apr 21;30(16):5525-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20410106</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2010 Oct 1;19(19):3734-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20639397</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Hum Genet. 2011 Jul 15;89(1):168-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21763483</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Hum Genet. 2011 Sep 9;89(3):398-406</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21907011</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cold Spring Harb Perspect Med. 2011 Sep;1(1):a009316</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22229125</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS J. 2012 Apr;279(7):1156-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22251459</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(3):e32629</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22403686</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2012 Mar 21;32(12):4240-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22442086</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2012 Jun 8;336(6086):1306-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22582012</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15918-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23019375</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsonism Relat Disord. 2013 Mar;19(3):320-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23211418</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2013 Feb 6;77(3):425-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23395371</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mutat. 2013 Sep;34(9):1208-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23804577</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Neurosci. 2013 Sep;16(9):1257-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23933751</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuropharmacology. 2014 Feb;77:350-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24161480</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurotherapeutics. 2014 Jan;11(1):111-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24258196</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2014 May 30;9(5):e97758</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24879013</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Dis. 2014 Nov;71:1-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25107340</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Neuroanat. 2014 Dec 15;8:155</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25565980</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2015 May 29;290(22):13862-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25861987</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS J. 2015 Aug;282(15):2806-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25899482</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Neurol. 2015 Aug;14(8):855-866</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26050140</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Autophagy. 2015;11(8):1358-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26086452</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2015 Sep 8;12(10):1631-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26321632</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2015 Dec 1;24(23):6675-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26362253</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2016 Jan 12;7:10332</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26755131</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Chem Neuroanat. 2016 Oct;76(Pt B):90-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26808467</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Genet. 2016 Mar 28;12(3):e1005944</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27019408</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 2016 Sep 15;35(18):2008-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27497298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2017 Jan 31;18(5):1132-1143</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28147270</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2017 Mar 16;7:44558</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28300150</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2017 Nov 22;37(47):11366-11376</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29054882</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncotarget. 2017 Sep 15;8(45):79046-79060</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29108286</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Res. 2018 Feb 1;1680:1-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29229503</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Cell Biol. 2018 Aug;96(4):441-449</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29268033</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Neurodegener. 2018 Jan 30;13(1):4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29378605</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Death Dis. 2018 Feb 21;9(3):304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29467464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Neurosci. 2018 Feb 16;12:81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29503608</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2018 Mar 13;8(1):4468</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29535397</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Elife. 2018 May 29;7:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29809156</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2018 Jun 12;9(1):2293</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29895861</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2018 Sep 5;503(2):1042-1048</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29935183</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cells. 2018 Jul 31;41(7):646-652</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29936793</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):E8844-E8853</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30185553</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurochem. 1987 Jun;48(6):1787-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3106573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 1995 Jan 27;80(2):311-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7834751</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuropathol Exp Neurol. 1996 Mar;55(3):259-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8786384</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1997 Jun 27;276(5321):2045-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9197268</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1998 Apr 9;392(6676):605-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9560156</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">30542071</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>04</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1759-4766</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>15</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Nature reviews. Neurology</Title>
                <ISOAbbreviation>Nat Rev Neurol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Parkinson disease gene therapy rewires brain circuits to improve motor function.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41582-018-0120-x</ELocationID>
            <Abstract>
                <AbstractText/>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ridler</LastName>
                    <ForeName>Charlotte</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nature Reviews Neurology, . nrneuro@nature.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016420">Comment</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Rev Neurol</MedlineTA>
            <NlmUniqueID>101500072</NlmUniqueID>
            <ISSNLinking>1759-4758</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentOn">
                <RefSource>Sci Transl Med. 2018 Nov 28;10(469):</RefSource>
                <PMID Version="1">30487248</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D046690" MajorTopicYN="Y">Deep Brain Stimulation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015316" MajorTopicYN="N">Genetic Therapy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30542071</ArticleId>
            <ArticleId IdType="doi">10.1038/s41582-018-0120-x</ArticleId>
            <ArticleId IdType="pii">10.1038/s41582-018-0120-x</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30541866</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>16</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>16</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1526-632X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>92</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neurology</Title>
                <ISOAbbreviation>Neurology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Age and time course of long-term motor and nonmotor complications in Parkinson disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e148-e160</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000006737</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE">To determine the time course of hazard for motor and nonmotor milestones of Parkinson disease (PD) in the long term and to investigate whether risk scales nonlinearly with time is instrumental in identifying changes in pathological processes and evaluating disease-modifying therapies in PD.</AbstractText>
                <AbstractText Label="METHODS">Outpatients with PD at the Lyon University Movement Disorders Center were evaluated for 7 clinical milestones in this retrospective cohort study, encompassing 4 domains of PD progression: (1) motor (motor fluctuations, dyskinesias); (2) axial (postural instability and falls, freezing of gait); (3) neuropsychiatric (impulse control disorders, hallucinations); and (4) cognitive (dementia) complications. For each complication, we estimated the outcome-specific hazard using parsimonious smooth parametric Poisson regression models allowing for nonlinear scaling over disease duration, age at diagnosis, current age, and their interaction.</AbstractText>
                <AbstractText Label="RESULTS">A total of 1,232 patients with PD experienced 1,527 disease-related complications in up to 12 years of follow-up. Specific to each complication, hazard rates increased dramatically starting from diagnosis and were highest for motor fluctuations and lowest for dementia up to 6 years after diagnosis in patients aged 65 years at diagnosis. Nonlinear patterns indicated dramatic changes in the course of PD after 5 years and predicted more severe axial prognosis after 70 years and for motor fluctuations, dyskinesias, and impulse control disorders before 60 years at diagnosis.</AbstractText>
                <AbstractText Label="CONCLUSION">Time course of motor and nonmotor milestones in PD is determined by disease duration and age at diagnosis in nonlinear patterns and their interaction. This indicates disease- and age-specific thresholds across the multiple neurodegenerative processes accumulating in PD at different paces.</AbstractText>
                <CopyrightInformation>© 2018 American Academy of Neurology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Prange</LastName>
                    <ForeName>Stéphane</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>From Université Lyon (S.P., T.D., C.L., E.M., E.B., S.T.), Institut des Sciences Cognitives-Marc Jeannerod, CNRS, UMR 5229, Bron; Hospices Civils de Lyon (S.P., T.D., C.C., C.L., E.M., H.M., E.B., S.T.), Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, Centre Expert Parkinson, Bron; Université Lyon (C.L., E.B., D.M.-B., S.T.), Faculté de Médecine Lyon Sud Charles Mérieux, Oullins; Hospices Civils de Lyon (D.M.-B.), Service de Biostatistique, Lyon; and Université Lyon (D.M.-B.), Laboratoire de Biométrie et Biologie Évolutive, CNRS, UMR 5558, Pierre Benite, France. stephane.prange@isc.cnrs.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Danaila</LastName>
                    <ForeName>Teodor</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>From Université Lyon (S.P., T.D., C.L., E.M., E.B., S.T.), Institut des Sciences Cognitives-Marc Jeannerod, CNRS, UMR 5229, Bron; Hospices Civils de Lyon (S.P., T.D., C.C., C.L., E.M., H.M., E.B., S.T.), Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, Centre Expert Parkinson, Bron; Université Lyon (C.L., E.B., D.M.-B., S.T.), Faculté de Médecine Lyon Sud Charles Mérieux, Oullins; Hospices Civils de Lyon (D.M.-B.), Service de Biostatistique, Lyon; and Université Lyon (D.M.-B.), Laboratoire de Biométrie et Biologie Évolutive, CNRS, UMR 5558, Pierre Benite, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Laurencin</LastName>
                    <ForeName>Chloé</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>From Université Lyon (S.P., T.D., C.L., E.M., E.B., S.T.), Institut des Sciences Cognitives-Marc Jeannerod, CNRS, UMR 5229, Bron; Hospices Civils de Lyon (S.P., T.D., C.C., C.L., E.M., H.M., E.B., S.T.), Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, Centre Expert Parkinson, Bron; Université Lyon (C.L., E.B., D.M.-B., S.T.), Faculté de Médecine Lyon Sud Charles Mérieux, Oullins; Hospices Civils de Lyon (D.M.-B.), Service de Biostatistique, Lyon; and Université Lyon (D.M.-B.), Laboratoire de Biométrie et Biologie Évolutive, CNRS, UMR 5558, Pierre Benite, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Caire</LastName>
                    <ForeName>Catherine</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>From Université Lyon (S.P., T.D., C.L., E.M., E.B., S.T.), Institut des Sciences Cognitives-Marc Jeannerod, CNRS, UMR 5229, Bron; Hospices Civils de Lyon (S.P., T.D., C.C., C.L., E.M., H.M., E.B., S.T.), Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, Centre Expert Parkinson, Bron; Université Lyon (C.L., E.B., D.M.-B., S.T.), Faculté de Médecine Lyon Sud Charles Mérieux, Oullins; Hospices Civils de Lyon (D.M.-B.), Service de Biostatistique, Lyon; and Université Lyon (D.M.-B.), Laboratoire de Biométrie et Biologie Évolutive, CNRS, UMR 5558, Pierre Benite, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Metereau</LastName>
                    <ForeName>Elise</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>From Université Lyon (S.P., T.D., C.L., E.M., E.B., S.T.), Institut des Sciences Cognitives-Marc Jeannerod, CNRS, UMR 5229, Bron; Hospices Civils de Lyon (S.P., T.D., C.C., C.L., E.M., H.M., E.B., S.T.), Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, Centre Expert Parkinson, Bron; Université Lyon (C.L., E.B., D.M.-B., S.T.), Faculté de Médecine Lyon Sud Charles Mérieux, Oullins; Hospices Civils de Lyon (D.M.-B.), Service de Biostatistique, Lyon; and Université Lyon (D.M.-B.), Laboratoire de Biométrie et Biologie Évolutive, CNRS, UMR 5558, Pierre Benite, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Merle</LastName>
                    <ForeName>Hélène</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>From Université Lyon (S.P., T.D., C.L., E.M., E.B., S.T.), Institut des Sciences Cognitives-Marc Jeannerod, CNRS, UMR 5229, Bron; Hospices Civils de Lyon (S.P., T.D., C.C., C.L., E.M., H.M., E.B., S.T.), Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, Centre Expert Parkinson, Bron; Université Lyon (C.L., E.B., D.M.-B., S.T.), Faculté de Médecine Lyon Sud Charles Mérieux, Oullins; Hospices Civils de Lyon (D.M.-B.), Service de Biostatistique, Lyon; and Université Lyon (D.M.-B.), Laboratoire de Biométrie et Biologie Évolutive, CNRS, UMR 5558, Pierre Benite, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Broussolle</LastName>
                    <ForeName>Emmanuel</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>From Université Lyon (S.P., T.D., C.L., E.M., E.B., S.T.), Institut des Sciences Cognitives-Marc Jeannerod, CNRS, UMR 5229, Bron; Hospices Civils de Lyon (S.P., T.D., C.C., C.L., E.M., H.M., E.B., S.T.), Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, Centre Expert Parkinson, Bron; Université Lyon (C.L., E.B., D.M.-B., S.T.), Faculté de Médecine Lyon Sud Charles Mérieux, Oullins; Hospices Civils de Lyon (D.M.-B.), Service de Biostatistique, Lyon; and Université Lyon (D.M.-B.), Laboratoire de Biométrie et Biologie Évolutive, CNRS, UMR 5558, Pierre Benite, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maucort-Boulch</LastName>
                    <ForeName>Delphine</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>From Université Lyon (S.P., T.D., C.L., E.M., E.B., S.T.), Institut des Sciences Cognitives-Marc Jeannerod, CNRS, UMR 5229, Bron; Hospices Civils de Lyon (S.P., T.D., C.C., C.L., E.M., H.M., E.B., S.T.), Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, Centre Expert Parkinson, Bron; Université Lyon (C.L., E.B., D.M.-B., S.T.), Faculté de Médecine Lyon Sud Charles Mérieux, Oullins; Hospices Civils de Lyon (D.M.-B.), Service de Biostatistique, Lyon; and Université Lyon (D.M.-B.), Laboratoire de Biométrie et Biologie Évolutive, CNRS, UMR 5558, Pierre Benite, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thobois</LastName>
                    <ForeName>Stéphane</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>From Université Lyon (S.P., T.D., C.L., E.M., E.B., S.T.), Institut des Sciences Cognitives-Marc Jeannerod, CNRS, UMR 5229, Bron; Hospices Civils de Lyon (S.P., T.D., C.C., C.L., E.M., H.M., E.B., S.T.), Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, Centre Expert Parkinson, Bron; Université Lyon (C.L., E.B., D.M.-B., S.T.), Faculté de Médecine Lyon Sud Charles Mérieux, Oullins; Hospices Civils de Lyon (D.M.-B.), Service de Biostatistique, Lyon; and Université Lyon (D.M.-B.), Laboratoire de Biométrie et Biologie Évolutive, CNRS, UMR 5558, Pierre Benite, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016448">Multicenter Study</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Neurology</MedlineTA>
            <NlmUniqueID>0401060</NlmUniqueID>
            <ISSNLinking>0028-3878</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015259">Dopamine Agents</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000375" MajorTopicYN="Y">Aging</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName>
                <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007174" MajorTopicYN="N">Disruptive, Impulse Control, and Conduct Disorders</DescriptorName>
                <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015259" MajorTopicYN="N">Dopamine Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020820" MajorTopicYN="N">Dyskinesias</DescriptorName>
                <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020233" MajorTopicYN="N">Gait Disorders, Neurologic</DescriptorName>
                <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>05</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30541866</ArticleId>
            <ArticleId IdType="pii">WNL.0000000000006737</ArticleId>
            <ArticleId IdType="doi">10.1212/WNL.0000000000006737</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">30539376</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>09</Month>
            <Day>30</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">2193-8253</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>8</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jun</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Neurology and therapy</Title>
                <ISOAbbreviation>Neurol Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Emerging Immunotherapies for Parkinson Disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>29-44</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s40120-018-0122-z</ELocationID>
            <Abstract>
                <AbstractText>Symptomatic treatment options for Parkinson disease have steadily improved, and individualized therapeutic approaches are becoming established for every stage of the disease. However, disease-modifying therapy with a causal approach is still unavailable. The central causative role of alpha-synuclein pathology, including its progressive spread to most areas of the CNS, has been widely recognized, and a strong involvement of immune responses has recently been discovered. New immunologic technologies have been shown to effectively prevent the progression of alpha-synuclein pathology in animal models. These approaches have recently been translated into the first human clinical trials, representing a novel starting point for the causal therapy of Parkinson disease. In this review, the pathomechanistic role of alpha-synuclein and its influence on the surrounding cellular environment are analyzed with a strong focus on immune responses and neuroinflammation. The potential of novel immunotherapeutic approaches that reduce the burden of alpha-synuclein pathology in the CNS is critically evaluated, and currently ongoing human clinical trials are presented. The clinical development of these new immunotherapies is progressing rapidly and gives reason to hope that a causal therapy of Parkinson disease could be possible in the foreseeable future.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zella</LastName>
                    <ForeName>Samis M A</ForeName>
                    <Initials>SMA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neurologische Klinik der Ruhr-Universität Bochum, St. Josef-Hospital, Bochum, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Metzdorf</LastName>
                    <ForeName>Judith</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neurologische Klinik der Ruhr-Universität Bochum, St. Josef-Hospital, Bochum, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ciftci</LastName>
                    <ForeName>Emine</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neurologische Klinik der Ruhr-Universität Bochum, St. Josef-Hospital, Bochum, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ostendorf</LastName>
                    <ForeName>Friederike</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neurologische Klinik der Ruhr-Universität Bochum, St. Josef-Hospital, Bochum, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Muhlack</LastName>
                    <ForeName>Siegfried</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neurologische Klinik der Ruhr-Universität Bochum, St. Josef-Hospital, Bochum, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gold</LastName>
                    <ForeName>Ralf</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neurologische Klinik der Ruhr-Universität Bochum, St. Josef-Hospital, Bochum, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Neurodegeneration Research, Protein Research Unit Ruhr (PURE), Ruhr University Bochum, Bochum, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tönges</LastName>
                    <ForeName>Lars</ForeName>
                    <Initials>L</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6621-144X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Neurologische Klinik der Ruhr-Universität Bochum, St. Josef-Hospital, Bochum, Germany. lars.toenges@rub.de.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Neurodegeneration Research, Protein Research Unit Ruhr (PURE), Ruhr University Bochum, Bochum, Germany. lars.toenges@rub.de.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>New Zealand</Country>
            <MedlineTA>Neurol Ther</MedlineTA>
            <NlmUniqueID>101637818</NlmUniqueID>
            <ISSNLinking>2193-6536</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Alpha-synuclein</Keyword>
            <Keyword MajorTopicYN="N">Antibody-based therapy</Keyword>
            <Keyword MajorTopicYN="N">Immunotherapy</Keyword>
            <Keyword MajorTopicYN="N">Neuroinflammation</Keyword>
            <Keyword MajorTopicYN="N">Parkinson disease</Keyword>
            <Keyword MajorTopicYN="N">Vaccination</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30539376</ArticleId>
            <ArticleId IdType="doi">10.1007/s40120-018-0122-z</ArticleId>
            <ArticleId IdType="pii">10.1007/s40120-018-0122-z</ArticleId>
            <ArticleId IdType="pmc">PMC6534677</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Neurosci. 2000 Sep 1;20(17):6365-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10964942</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci Res. 2002 Jun 1;68(5):568-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12111846</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Aging. 2003 Mar-Apr;24(2):197-211</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12498954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2003 Sep 11;39(6):889-909</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12971891</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2004 Oct 20;24(42):9434-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15496679</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochemistry. 2005 May 31;44(21):7818-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15909996</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2005 Jun 16;46(6):857-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15953415</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2006 Apr 12;26(15):3942-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16611810</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Microbiol. 2007 Jul;5(7):505-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17558426</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurodegener Dis. 2008;5(2):55-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18182779</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Biol. 2008 Jun 24;18(12):R506-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18579087</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Hum Neurosci. 2009 Nov 09;3:31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19915731</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Neuropathol. 2010 Jan;119(1):7-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20012068</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tohoku J Exp Med. 2010 Feb;220(2):95-106</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20139660</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2010 Sep 24;329(5999):1663-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20798282</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2011 Apr 29;6(4):e19338</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21559417</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2011 Oct 6;72(1):57-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21982369</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Alzheimers Dis. 2012;2012:628070</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22292124</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2012 Jul 12;75(1):11-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22794257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Death Dis. 2012 Jul 19;3:e350</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22825468</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2012 Aug 22;32(34):11750-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22915117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2012 Sep 26;32(39):13454-69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23015436</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2012 Nov 16;338(6109):949-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23161999</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Neurosci. 2013 Jan;14(1):38-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23254192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Free Radic Biol Med. 2013 Sep;62:132-144</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23380027</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Ther. 2013 Jun;138(3):311-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23384597</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2013;4:1562</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23463005</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Neurol. 2013 Aug;9(8):445-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23857047</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2013 Sep 18;79(6):1044-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24050397</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2013 Oct;19(10):1227-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24100992</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurosci Lett. 2014 Feb 7;560:86-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24361548</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Neuropathol. 2014;127(6):861-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24525765</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Dis. 2014 Sep;69:134-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24851801</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2014 Jun 26;7(6):2054-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24931606</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2014 Jul 9;34(28):9441-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25009275</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Protoc. 2014 Sep;9(9):2135-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25122523</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2014 Sep 3;34(36):11929-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25186741</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Aging Neurosci. 2014 Sep 10;6:239</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25309425</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2015 Feb 06;10(2):e0116841</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25658425</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Dis. 2016 Jan;85:262-274</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25766679</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2015 Mar 18;85(6):1162-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25789753</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2015 Apr 1;35(13):5221-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25834048</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Neurodegener. 2015 Mar 19;10:10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25886309</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2015 Jun 18;522(7556):340-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26061766</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Neurol. 2015 Nov;11(11):625-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26503923</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2016 Feb;31(2):203-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26704735</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Neuropathol. 2016 Apr;131(4):539-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26820848</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Mol Neurobiol. 2017 Jan;37(1):121-131</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26961542</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Neurosci. 2016 Apr;17(4):251-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26988744</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods Mol Biol. 2016;1403:57-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27076125</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2016 Sep 13;11(9):e0162717</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27622765</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2016 Oct 28;479(4):881-886</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27666480</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2016 Sep 30;353(6307):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27708076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2017 Feb;32(2):211-218</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27886407</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Physiol. 2017 Feb 10;79:619-643</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27959620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroimmune Pharmacol. 2017 Mar;12(1):194-203</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28025724</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2017 Feb 7;23(2):1-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28170377</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Neuropathol. 2017 Apr;133(4):535-545</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28180961</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Parkinsons Dis. 2017;7(s1):S71-S85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28282810</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Dis Primers. 2017 Mar 23;3:17013</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28332488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Dis. 2017 Aug;104:85-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28476636</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2017 May 31;16(6):371-373</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28559555</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2017 Oct 2;127(10):3577-3587</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28872464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Glia. 2018 Jan;66(1):191-205</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29024008</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2017 Dec 6;37(49):11835-11853</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29089438</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuroinflammation. 2017 Dec 11;14(1):241</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29228971</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Neurol. 2018 Apr;302:155-168</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29339052</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Neurosci. 2018 Feb 19;12:80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29515354</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2018 May;33(5):684-696</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29704272</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Neurol. 2018 Oct 1;75(10):1206-1214</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29913017</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Fortschr Neurol Psychiatr. 2018 Sep;86(S 01):S10-S20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30016808</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Pathol. 1998 Apr;152(4):879-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9546347</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">30531387</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1557-0584</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>43</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neurologic physical therapy : JNPT</Title>
                <ISOAbbreviation>J Neurol Phys Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Lower Extremity Muscle Strength and Force Variability in Persons With Parkinson Disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>56-62</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/NPT.0000000000000244</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND AND PURPOSE">Adequate lower limb strength and motor control are essential for mobility and quality of life. People with Parkinson disease (PD) experience a significant and progressive decline in motor capabilities as part of this neurodegenerative disease. The primary objective of this study was to examine the effect of PD on (1) muscular strength and (2) force steadiness in muscles that are primarily responsible for locomotion and stability.</AbstractText>
                <AbstractText Label="METHODS">Thirteen persons with PD and 13 healthy age-matched controls participated. Participants performed maximal and submaximal (5%, 10%, and 20% maximum voluntary contractions) isometric force tasks with the limb stabilized in a customized device. Strength of the hip extensors and flexors, hip abductors and adductors, and ankle plantar flexors and dorsiflexors was quantified based on data obtained from force transducers, with the relevant joint stabilized in standardized positions.</AbstractText>
                <AbstractText Label="RESULTS">Individuals with PD were weaker and exhibited higher amounts of force variability than controls across the lower extremity. Reduced strength was greatest in the hip flexors (2.0 N/kg vs 2.6 N/kg) and ankle plantar flexors (1.74 N/kg vs 2.64 N/kg) and dorsiflexors (1.9 N/kg vs 2.3 N/kg). Force steadiness was impaired in the hip flexors, ankle plantar flexors, and dorsiflexors.</AbstractText>
                <AbstractText Label="DISCUSSION AND CONCLUSIONS">Reduced maximal force production was concomitant with impaired force control within the muscles that are critical for effective ambulation (hip flexion, ankle dorsiflexion, and ankle plantar flexion). These features should be evaluated when considering contributors to reduced mobility and quality of life.Video Abstract available for more insights from the authors (see Video, Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A241).</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Skinner</LastName>
                    <ForeName>Jared W</ForeName>
                    <Initials>JW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Geriatric Research Education and Clinical Centers, Malcom Randall VA Medical Center, Gainesville, Florida (J.W.S.); and Department of Applied Physiology and Kinesiology, University of Florida, Gainesville (E.A.C., C.J.H.).</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Christou</LastName>
                    <ForeName>Evangelos A</ForeName>
                    <Initials>EA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hass</LastName>
                    <ForeName>Chris J</ForeName>
                    <Initials>CJ</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Neurol Phys Ther</MedlineTA>
            <NlmUniqueID>101193365</NlmUniqueID>
            <ISSNLinking>1557-0576</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001696" MajorTopicYN="N">Biomechanical Phenomena</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007537" MajorTopicYN="N">Isometric Contraction</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>5</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30531387</ArticleId>
            <ArticleId IdType="doi">10.1097/NPT.0000000000000244</ArticleId>
            <ArticleId IdType="pii">01253086-201901000-00008</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">30531386</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1557-0584</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>43</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neurologic physical therapy : JNPT</Title>
                <ISOAbbreviation>J Neurol Phys Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Auditory Cueing for Gait Impairment in Persons With Parkinson Disease: A Pilot Study of Changes in Response With Disease Progression.</ArticleTitle>
            <Pagination>
                <MedlinePgn>50-55</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/NPT.0000000000000250</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND AND PURPOSE">Gait impairments in persons with Parkinson disease (PD) are difficult to manage. Auditory cueing has been shown to be an effective therapy. However, the optimal time to introduce cues with respect to disease stage has not yet been established. This longitudinal study examines the effect of auditory cues on gait characteristics in people with early PD at 2 time points, 3 years apart.</AbstractText>
                <AbstractText Label="METHODS">We assessed 25 people with PD from the Incidence of Cognitive Impairment in Cohorts with Longitudinal Evaluation-Parkinson's disease (ICICLE-PD) study. Participants walked with and without an auditory cue set at individual cadence. Characteristics of step velocity, step length, step time, step length variability, and step time variability were collected using an instrumented walkway. In a subset of 9 participants with PD, all assessments were repeated 3 years later. Twenty-nine healthy older adults were assessed at 1 time point to provide comparison data.</AbstractText>
                <AbstractText Label="RESULTS">At baseline, independent of group, step velocity, step length, and step time improved with auditory cue; however, there was an increase in step time variability, indicating a worsening of gait with the cue. Three years later, in the smaller subset the response to cue was improved, demonstrated by increased step velocity and length but step time variability was no longer increased.</AbstractText>
                <AbstractText Label="DISCUSSION AND CONCLUSIONS">This pilot study indicates that people with early PD have small benefits from auditory cues and the benefit increases as disease progresses. Early in disease the benefit of cue may come at the cost of increased variability. Therefore, the time to introduce an auditory cue in PD rehabilitation may be important to optimize therapeutic effect.Video Abstract available for more insights from the authors (see Video, Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A243).</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lirani-Silva</LastName>
                    <ForeName>Ellen</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Neuroscience/Newcastle University Institute of Ageing, Clinical Ageing Research Unit, Campus for Ageing and Vitality Newcastle University, Newcastle upon Tyne, United Kingdom (E.L.S., S.L., D.M., L.R., R.M.); Institute of Biosciences, São Paulo State University (UNESP), Rio Claro, Brazil (E.L.S.); School of Clinical Sciences, Auckland University of Technology, New Zealand (S.L.); John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle upon Tyne, United Kingdom (D.M.); The Newcastle upon Tyne Hospitals, NHS Foundation Trust, United Kingdom (L.R.); and Department of Neurology, Oregon Health &amp; Science University, Portland (R.M.).</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lord</LastName>
                    <ForeName>Sue</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moat</LastName>
                    <ForeName>Dionne</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rochester</LastName>
                    <ForeName>Lynn</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morris</LastName>
                    <ForeName>Rosie</ForeName>
                    <Initials>R</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Neurol Phys Ther</MedlineTA>
            <NlmUniqueID>101193365</NlmUniqueID>
            <ISSNLinking>1557-0576</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003463" MajorTopicYN="Y">Cues</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005081" MajorTopicYN="N">Exercise Therapy</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020233" MajorTopicYN="N">Gait Disorders, Neurologic</DescriptorName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
                <QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000066530" MajorTopicYN="N">Neurological Rehabilitation</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010043" MajorTopicYN="Y">Outcome and Process Assessment, Health Care</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
                <QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016138" MajorTopicYN="Y">Walking</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>5</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30531386</ArticleId>
            <ArticleId IdType="doi">10.1097/NPT.0000000000000250</ArticleId>
            <ArticleId IdType="pii">01253086-201901000-00007</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">30531385</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>04</Month>
            <Day>27</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>04</Month>
            <Day>27</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1557-0584</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>43</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neurologic physical therapy : JNPT</Title>
                <ISOAbbreviation>J Neurol Phys Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Factors Associated With Responsiveness to Gait and Balance Training in People With Parkinson Disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>42-49</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/NPT.0000000000000246</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND AND PURPOSE">Although increasing evidence supports the benefit- of exercise among people with Parkinson disease (PwPD), it is unclear whether a given exercise modality suits all PwPD, given the heterogeneity of the disease. The purpose of this study was to explore factors associated with responsiveness to a highly challenging training intervention that incorporated dual-task exercises.</AbstractText>
                <AbstractText Label="METHODS">Forty-seven PwPD (mean age: 73 years; 19 females, Hoehn and Yahr stages 2-3) who had participated in 10 weeks of highly challenging gait and balance training were included. Baseline demographics, disease-related factors, physical and cognitive ability, and perceived health were used for the prediction of percent change in balance performance (the Mini-BESTest) and comfortable gait speed between the pre- and postassessments, using multiple linear regression analyses.</AbstractText>
                <AbstractText Label="RESULTS">Thirty-five percent of the variance of change in balance performance was explained by General Health Perceptions (β = -0.36), the Timed Up and Go test (β = -0.33), and the single-task performance of a cognitive task (β = -0.24). Forty-nine percent of change in gait speed was explained by gait speed while performing a dual task (β = -0.46), dual-task interference while walking (β = 0.43), time to complete the Timed Up and Go test (β = -0.29), and percent error on a cognitive task (β = -0.25).</AbstractText>
                <AbstractText Label="DISCUSSION AND CONCLUSIONS">The results may suggest that the PwPD with overall lower perceived health, functional mobility, and cognitive functions are the ones most likely to benefit from highly challenging and attention-demanding gait and balance training.Video Abstract available for more insights from the authors (see Video, Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A240).</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Löfgren</LastName>
                    <ForeName>Niklas</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Stockholm, Sweden (N.L., D.C., C.J., B.L., M.H., E.F.); Function Area Occupational Therapy and Physiotherapy, Allied Health Professionals Function, Karolinska University Hospital, Stockholm, Sweden (N.L., D.C., B.L., M.H., E.F.); Community Health Sciences Faculty, Physiotherapy Department, University of the Western Cape, Bellville, South Africa (C.J.); and Stockholms Sjukhem, R&amp;D Unit, Stockholm, Sweden (E.F., B.L.).</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Conradsson</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Joseph</LastName>
                    <ForeName>Conran</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Leavy</LastName>
                    <ForeName>Breiffni</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hagströmer</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Franzén</LastName>
                    <ForeName>Erika</ForeName>
                    <Initials>E</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>ClinicalTrials.gov</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>NCT01417598</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Neurol Phys Ther</MedlineTA>
            <NlmUniqueID>101193365</NlmUniqueID>
            <ISSNLinking>1557-0576</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
                <QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D056344" MajorTopicYN="N">Executive Function</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005081" MajorTopicYN="N">Exercise Therapy</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005684" MajorTopicYN="N">Gait</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
                <QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004856" MajorTopicYN="N">Postural Balance</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011597" MajorTopicYN="N">Psychomotor Performance</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>4</Month>
                <Day>28</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30531385</ArticleId>
            <ArticleId IdType="doi">10.1097/NPT.0000000000000246</ArticleId>
            <ArticleId IdType="pii">01253086-201901000-00006</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">30531384</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1557-0584</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>43</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neurologic physical therapy : JNPT</Title>
                <ISOAbbreviation>J Neurol Phys Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Predicting Motor Sequence Learning in People With Parkinson Disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>33-41</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/NPT.0000000000000251</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND AND PURPOSE">Skill acquisition (ie, performance changes during practice) occurs in a nonlinear fashion. Despite this, motor learning is typically measured by comparing discrete timepoints. Thus, typical measures of motor learning do not detect skill acquisition characteristics that may be clinically meaningful. Reliable prediction of motor skill learning in people with Parkinson disease (PD) would allow therapists to more effectively individualize practice doses to fit specific patients' needs. The purposes of this study were to (a) characterize postural skill acquisition in people with PD, and identify factors (such as acquisition rate and practice dose to plateau) that predict learning, and (b) investigate whether levodopa medication (L-dopa) status during practice impacted learning.</AbstractText>
                <AbstractText Label="METHODS">Twenty-seven adults with PD practiced a postural motor task over 3 days, followed by 2 retention tests. Participants were randomized to practice either ON or OFF L-dopa. Data for repeating and random sequences were each analyzed using nonlinear curve-fitting and mixed-effects regressions. Learning was defined as pretest minus retention test performance.</AbstractText>
                <AbstractText Label="RESULTS">Participants with less physical impairment demonstrated less learning on the repeating and random sequence tasks compared with participants with more impairment. Participants who improved faster during practice demonstrated less learning on the repeating sequence task compared with participants who improved more slowly. Reaching plateau during practice was not related to learning. L-dopa did not impair learning.</AbstractText>
                <AbstractText Label="DISCUSSION AND CONCLUSIONS">Participants' skill acquisition characteristics were related to learning a postural motor task. Patient-specific factors, such as the rate of skill acquisition, level of physical function, and medication status, may influence how postural motor practice is delivered during balance rehabilitation.Video Abstract available for more insights from the authors (see the Video, Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A250).</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Olivier</LastName>
                    <ForeName>Geneviève N</ForeName>
                    <Initials>GN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Physical Therapy and Athletic Training (G.N.O., S.S.P., K.R.L., C.S.W., S.Y.S., L.E.D.), Health, Kinesiology, and Recreation (K.R.L., L.E.D.), University of Utah, Salt Lake City; Faculty of Health Sciences, the University of Sydney, Australia (S.S.P.); Physical Therapy, University of Arkansas for Medical Sciences, Fayetteville (C.S.W.); and Biological and Health Systems Engineering, Arizona State University, Phoenix (S.Y.S.).</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paul</LastName>
                    <ForeName>Serene S</ForeName>
                    <Initials>SS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lohse</LastName>
                    <ForeName>Keith R</ForeName>
                    <Initials>KR</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Walter</LastName>
                    <ForeName>Christopher S</ForeName>
                    <Initials>CS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schaefer</LastName>
                    <ForeName>Sydney Y</ForeName>
                    <Initials>SY</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dibble</LastName>
                    <ForeName>Leland E</ForeName>
                    <Initials>LE</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Neurol Phys Ther</MedlineTA>
            <NlmUniqueID>101193365</NlmUniqueID>
            <ISSNLinking>1557-0576</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015259">Dopamine Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>46627O600J</RegistryNumber>
                <NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015259" MajorTopicYN="N">Dopamine Agents</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007980" MajorTopicYN="N">Levodopa</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009048" MajorTopicYN="N">Motor Skills</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000066530" MajorTopicYN="Y">Neurological Rehabilitation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004856" MajorTopicYN="N">Postural Balance</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011214" MajorTopicYN="Y">Practice, Psychological</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012691" MajorTopicYN="N">Serial Learning</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>5</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30531384</ArticleId>
            <ArticleId IdType="doi">10.1097/NPT.0000000000000251</ArticleId>
            <ArticleId IdType="pii">01253086-201901000-00005</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">30531383</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1557-0584</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>43</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neurologic physical therapy : JNPT</Title>
                <ISOAbbreviation>J Neurol Phys Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Exercise and Parkinson Disease: Comparing Tango, Treadmill, and Stretching.</ArticleTitle>
            <Pagination>
                <MedlinePgn>26-32</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/NPT.0000000000000245</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND AND PURPOSE">Impaired gait, balance, and motor function are common in Parkinson disease (PD) and may lead to falls and injuries. Different forms of exercise improve motor function in persons with PD, but determining which form of exercise is most effective requires a direct comparison of various approaches. In this prospective, controlled trial, we evaluated the impact of tango, treadmill walking, and stretching on gait, balance, motor function, and quality of life. We hypothesized tango and treadmill would improve forward walking and motor symptom severity, and tango would also improve backward walking, balance, and quality of life.</AbstractText>
                <AbstractText Label="METHODS">Ninety-six participants (age: 67.2 ± 8.9 years, 42% female) with mild to moderate idiopathic PD were serially assigned to tango, treadmill walking, or stretching (active control group) and attended 1-hour classes twice weekly for 12 weeks. Assessments occurred OFF anti-PD medication before and after the intervention and at follow-up 12 weeks after the intervention.</AbstractText>
                <AbstractText Label="RESULTS">Forward velocity and backward velocity improved for the treadmill group from baseline to posttest and improvements persisted at follow-up. Backward velocity and motor functioning improved for the stretching group from baseline to posttest, but results did not persist at follow-up. There were no significant changes in the tango group across time points.</AbstractText>
                <AbstractText Label="DISCUSSION AND CONCLUSIONS">Contrary to our hypotheses, only treadmill improved forward walking, while backward walking improved with treadmill and stretching. Future research should examine combinations of exercises with a focus on optimizing dosing and examining whether specific characteristics of people with PD correlate with different types of exercise.Video Abstract available for more insights from the authors (see Video, Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A237).</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rawson</LastName>
                    <ForeName>Kerri S</ForeName>
                    <Initials>KS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Program in Physical Therapy (K.S.R., M.E.M., R.P.D., J.S.P., G.M.E.), Department of Neurology (M.E.M., R.P.D., J.S.P., G.M.E.), Department of Neuroscience (J.S.P., G.M.E.), Department of Radiology (J.S.P.), and Program in Occupational Therapy (J.S.P.), Washington University School of Medicine in Saint Louis, Missouri; and Department of Kinesiology and Occupational Therapy Program, University of Wisconsin-Madison (K.A.P.).</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McNeely</LastName>
                    <ForeName>Marie E</ForeName>
                    <Initials>ME</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Duncan</LastName>
                    <ForeName>Ryan P</ForeName>
                    <Initials>RP</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pickett</LastName>
                    <ForeName>Kristen A</ForeName>
                    <Initials>KA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Perlmutter</LastName>
                    <ForeName>Joel S</ForeName>
                    <Initials>JS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Earhart</LastName>
                    <ForeName>Gammon M</ForeName>
                    <Initials>GM</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>ClinicalTrials.gov</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>NCT01768832</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>K12 HD055931</GrantID>
                    <Acronym>HD</Acronym>
                    <Agency>NICHD NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 NS075321</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 NS077959</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>T32 HD007434</GrantID>
                    <Acronym>HD</Acronym>
                    <Agency>NICHD NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D003160">Comparative Study</PublicationType>
                <PublicationType UI="D018848">Controlled Clinical Trial</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Neurol Phys Ther</MedlineTA>
            <NlmUniqueID>101193365</NlmUniqueID>
            <ISSNLinking>1557-0576</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>J Neurol Phys Ther. 2019 Jan;43(1):1-2</RefSource>
                <PMID Version="1">30531380</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003614" MajorTopicYN="N">Dance Therapy</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005081" MajorTopicYN="N">Exercise Therapy</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020233" MajorTopicYN="N">Gait Disorders, Neurologic</DescriptorName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D052580" MajorTopicYN="N">Muscle Stretching Exercises</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010043" MajorTopicYN="Y">Outcome and Process Assessment, Health Care</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004856" MajorTopicYN="Y">Postural Balance</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016138" MajorTopicYN="Y">Walking</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>5</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30531383</ArticleId>
            <ArticleId IdType="doi">10.1097/NPT.0000000000000245</ArticleId>
            <ArticleId IdType="pii">01253086-201901000-00004</ArticleId>
            <ArticleId IdType="pmc">PMC6294320</ArticleId>
            <ArticleId IdType="mid">NIHMS1509141</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Med Genet. 1999 Oct 15;88(5):539-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10490713</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Sports Med Phys Fitness. 1999 Dec;39(4):336-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10726435</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann N Y Acad Sci. 2003 Jun;991:1-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12846969</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2008 Apr 30;23(6):790-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18361474</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2008 Nov 15;23(15):2129-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19025984</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Complement Ther Med. 2009 Aug;17(4):203-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19632547</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Rehabil Med. 2010 Apr;42(4):323-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20461334</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2010 Nov 15;25(15):2649-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21069833</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurorehabil Neural Repair. 2012 Feb;26(2):132-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21959675</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gait Posture. 2012 May;36(1):144-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22418585</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Neurol. 2013 Feb;70(2):183-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23128427</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2013 Aug;28(9):1230-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23536417</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Yoga. 2015 Jan;8(1):74-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25558138</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol Phys Ther. 2015 Oct;39(4):204-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26308937</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2015 Sep 13;(9):CD007830</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26363646</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurorehabil Neural Repair. 2016 Jul;30(6):512-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26493731</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Neurol. 2015 Nov 05;15:226</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26542475</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Neurol. 2018 Feb 1;75(2):219-226</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29228079</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Psychopharmacol Bull. 1988;24(4):689-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3249771</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gerontol A Biol Sci Med Sci. 1995 Jan;50A(1):M28-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7814786</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Age Ageing. 1997 Sep;26(5):353-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9351479</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Geriatr Soc. 1998 Oct;46(10):1207-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9777901</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">30531382</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1557-0584</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>43</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neurologic physical therapy : JNPT</Title>
                <ISOAbbreviation>J Neurol Phys Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A High-Intensity Exercise Boot Camp for Persons With Parkinson Disease: A Phase II, Pragmatic, Randomized Clinical Trial of Feasibility, Safety, Signal of Efficacy, and Disease Mechanisms.</ArticleTitle>
            <Pagination>
                <MedlinePgn>12-25</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/NPT.0000000000000249</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND AND PURPOSE">The feasibility, safety, and efficacy of a high-intensity multimodal exercise program (aerobic, strengthening, and balance training) have not been well vetted in persons with Parkinson disease (PD). Thus, the primary aim was to determine whether a high-intensity multimodal exercise boot camp (HIBC) was both feasible and safe in persons with PD. The secondary aim was to determine whether the program would produce greater benefit than a usual care, low-intensity exercise program (UC). An exploratory aim was to determine whether these programs affected putative disease-modifying mechanisms.</AbstractText>
                <AbstractText Label="METHODS">Twenty-seven participants (19 men and 8 women) were randomized into 8 weeks of either the HIBC or UC supervised by physical therapists. For feasibility, participation, and meeting, Centers for Disease Control and Prevention (CDC) exercise guidelines were assessed. For safety, adverse events were monitored. For efficacy, the following outcome domains were assessed before and after participation: balance, motor activity, endurance and fatigue, strength, mental health, and quality of life. For disease-modifying mechanisms, circulating brain-derived neurotrophic factor (BDNF) and its genotype, superoxide dismutase, and cytokines (tumor necrosis factor-α, interleukin-6, and interleukin-10) were monitored.</AbstractText>
                <AbstractText Label="RESULTS">The HIBC was better at attaining CDC guidelines (P = 0.013) and spent more minutes in higher-intensity exercise per week (P &lt; 0.001). There were no differences in adverse events (P = 0.419). The HIBC experienced significant improvements in 7/31 outcomes versus 3/31 in the UC arm. BDNF improved significantly for both groups from pre- to posttests (Ps ≤ 0.041) and an improved anti-inflammatory was observed for both groups.</AbstractText>
                <AbstractText Label="DISCUSSION AND CONCLUSIONS">A high-intensity multimodal exercise boot camp was feasible and safe in persons with PD. Compared with usual care, there were no differences in adverse events. Moreover, the high-intensity multimodal exercise program produced more improvement across more domains than usual care. Our results also suggest a possible link between improvement in outcomes and an improved anti-inflammatory milieu.Video Abstract available for more insights from the authors (see Video, Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A244).</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Landers</LastName>
                    <ForeName>Merrill R</ForeName>
                    <Initials>MR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Physical Therapy (M.R.L.), Kinesiology and Nutritional Sciences (J.W.N.), and Psychology (J.W.K.), University of Nevada, Las Vegas; Alzheimer's Association, Chicago, Illinois (A.S.M.); and Department of Neurology, University of New Mexico and New Mexico VA Healthcare System, Albuquerque, New Mexico (S.P.R.).</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Navalta</LastName>
                    <ForeName>James W</ForeName>
                    <Initials>JW</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murtishaw</LastName>
                    <ForeName>Andrew S</ForeName>
                    <Initials>AS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kinney</LastName>
                    <ForeName>Jefferson W</ForeName>
                    <Initials>JW</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pirio Richardson</LastName>
                    <ForeName>Sarah</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>U54 GM104944</GrantID>
                    <Acronym>GM</Acronym>
                    <Agency>NIGMS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D065007">Pragmatic Clinical Trial</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Neurol Phys Ther</MedlineTA>
            <NlmUniqueID>101193365</NlmUniqueID>
            <ISSNLinking>1557-0576</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>7171WSG8A2</RegistryNumber>
                <NameOfSubstance UI="C579455">BDNF protein, human</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019208" MajorTopicYN="N">Brain-Derived Neurotrophic Factor</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005081" MajorTopicYN="N">Exercise Therapy</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010043" MajorTopicYN="Y">Outcome and Process Assessment, Health Care</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>5</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30531382</ArticleId>
            <ArticleId IdType="doi">10.1097/NPT.0000000000000249</ArticleId>
            <ArticleId IdType="pii">01253086-201901000-00003</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">30531381</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1557-0584</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>43</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neurologic physical therapy : JNPT</Title>
                <ISOAbbreviation>J Neurol Phys Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Determinants of Dual-Task Training Effect Size in Parkinson Disease: Who Will Benefit Most?</ArticleTitle>
            <Pagination>
                <MedlinePgn>3-11</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/NPT.0000000000000247</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND AND PURPOSE">Dual-task interventions show positive effects in people with Parkinson disease (PD), but it remains unclear which factors determine the size of these benefits. As a secondary analysis of the DUALITY trial, the aim of this study was to assess the determinants of the effect size after 2 types of dual-task practice.</AbstractText>
                <AbstractText Label="METHODS">We randomly allocated 121 participants with PD to receive either integrated or consecutive dual-task training. Dual-task walking performance was assessed during (i) a backward digit span task (digit), (ii) an auditory Stroop task (Stroop), and (iii) a functional mobile phone task. Baseline descriptive, motor, and cognitive variables were correlated with the change in dual-task gait velocity after the intervention. Factors correlated with the change in dual-task gait velocity postintervention (P &lt; 0.20) were entered into a stepwise forward multiple linear regression model.</AbstractText>
                <AbstractText Label="RESULTS">Lower dual-task gait velocity and higher cognitive capacity (Scales for Outcomes in Parkinson's Disease-Cognition [ScopaCog]) at baseline were related to larger improvements in dual-task gait velocity after both integrated and consecutive dual-task training for all 3 tasks (β[gait] = -0.45, β[ScopaCog] = 0.34, R = 0.23, P &lt; 0.001, for digit; β[gait] = -0.52, β[ScopaCog] = 0.29, R = 0.26, P &lt; 0.001, for Stroop; and β[gait] = -0.40, β[ScopaCog] = 0.30, R = 0.18, P &lt; 0.001, for mobile phone task).</AbstractText>
                <AbstractText Label="DISCUSSION AND CONCLUSIONS">Participants with PD who showed a slow dual-task gait velocity and good cognitive functioning at baseline benefited most from the dual-task training, irrespective of the type of training and type of dual-task outcome.Video Abstract available for more insights from the authors (see Video, Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A242).</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Strouwen</LastName>
                    <ForeName>Carolien</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neuromotor Rehabilitation Research Group, Department of Rehabilitation Sciences, KU Leuven, Belgium (C.S., L.M., S.B., P.G., A.N., E.H.); and Department of Neurology, Nijmegen Centre for Evidence Based Practice (E.A.M.) and Department of Neurology, Donders Institute for Brain, Cognition and Behaviour (B.R.B.), Radboud University Medical Center, Nijmegen, the Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Molenaar</LastName>
                    <ForeName>Esther A L M</ForeName>
                    <Initials>EALM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Münks</LastName>
                    <ForeName>Liesbeth</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Broeder</LastName>
                    <ForeName>Sanne</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ginis</LastName>
                    <ForeName>Pieter</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bloem</LastName>
                    <ForeName>Bastiaan R</ForeName>
                    <Initials>BR</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nieuwboer</LastName>
                    <ForeName>Alice</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Heremans</LastName>
                    <ForeName>Elke</ForeName>
                    <Initials>E</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016448">Multicenter Study</PublicationType>
                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Neurol Phys Ther</MedlineTA>
            <NlmUniqueID>101193365</NlmUniqueID>
            <ISSNLinking>1557-0576</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000072466" MajorTopicYN="N">Cognitive Remediation</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D056344" MajorTopicYN="N">Executive Function</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005081" MajorTopicYN="N">Exercise Therapy</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017063" MajorTopicYN="Y">Outcome Assessment, Health Care</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011597" MajorTopicYN="N">Psychomotor Performance</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016138" MajorTopicYN="N">Walking</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>5</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30531381</ArticleId>
            <ArticleId IdType="doi">10.1097/NPT.0000000000000247</ArticleId>
            <ArticleId IdType="pii">01253086-201901000-00002</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30527540</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>06</Month>
            <Day>24</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>04</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-4164</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>73</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>03</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular cell</Title>
                <ISOAbbreviation>Mol Cell</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1001-1014.e8</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1097-2765(18)30998-5</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.molcel.2018.11.028</ELocationID>
            <Abstract>
                <AbstractText>In Parkinson's disease (PD), α-synuclein (αS) pathologically impacts the brain, a highly lipid-rich organ. We investigated how alterations in αS or lipid/fatty acid homeostasis affect each other. Lipidomic profiling of human αS-expressing yeast revealed increases in oleic acid (OA, 18:1), diglycerides, and triglycerides. These findings were recapitulated in rodent and human neuronal models of αS dyshomeostasis (overexpression; patient-derived triplication or E46K mutation; E46K mice). Preventing lipid droplet formation or augmenting OA increased αS yeast toxicity; suppressing the OA-generating enzyme stearoyl-CoA-desaturase (SCD) was protective. Genetic or pharmacological SCD inhibition ameliorated toxicity in αS-overexpressing rat neurons. In a C. elegans model, SCD knockout prevented αS-induced dopaminergic degeneration. Conversely, we observed detrimental effects of OA on αS homeostasis: in human neural cells, excess OA caused αS inclusion formation, which was reversed by SCD inhibition. Thus, monounsaturated fatty acid metabolism is pivotal for αS-induced neurotoxicity, and inhibiting SCD represents a novel PD therapeutic approach.</AbstractText>
                <CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fanning</LastName>
                    <ForeName>Saranna</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haque</LastName>
                    <ForeName>Aftabul</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Imberdis</LastName>
                    <ForeName>Thibaut</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baru</LastName>
                    <ForeName>Valeriya</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barrasa</LastName>
                    <ForeName>M Inmaculada</ForeName>
                    <Initials>MI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nuber</LastName>
                    <ForeName>Silke</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Termine</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ramalingam</LastName>
                    <ForeName>Nagendran</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ho</LastName>
                    <ForeName>Gary P H</ForeName>
                    <Initials>GPH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Noble</LastName>
                    <ForeName>Tallie</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Mira Costa College, 1 Barnard Drive, Oceanside, CA 92056, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sandoe</LastName>
                    <ForeName>Jackson</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lou</LastName>
                    <ForeName>Yali</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Landgraf</LastName>
                    <ForeName>Dirk</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Freyzon</LastName>
                    <ForeName>Yelena</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Newby</LastName>
                    <ForeName>Gregory</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, MIT, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soldner</LastName>
                    <ForeName>Frank</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Terry-Kantor</LastName>
                    <ForeName>Elizabeth</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Tae-Eun</ForeName>
                    <Initials>TE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hofbauer</LastName>
                    <ForeName>Harald F</ForeName>
                    <Initials>HF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Molecular Biosciences, BioTechMed-Graz, University of Graz, 8010 Graz, Austria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Becuwe</LastName>
                    <ForeName>Michel</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Complex Diseases, Harvard T.H. Chan School of Public Health, 655 Huntington Avenue, Boston, MA 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jaenisch</LastName>
                    <ForeName>Rudolf</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, MIT, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pincus</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Clish</LastName>
                    <ForeName>Clary B</ForeName>
                    <Initials>CB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Walther</LastName>
                    <ForeName>Tobias C</ForeName>
                    <Initials>TC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Complex Diseases, Harvard T.H. Chan School of Public Health, 655 Huntington Avenue, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA; Department of Genetics, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA; HHMI, Department of Genetics and Complex Diseases, Harvard T.H. Chan School of Public Health, 655 Huntington Avenue, Boston, MA 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Farese</LastName>
                    <ForeName>Robert V</ForeName>
                    <Initials>RV</Initials>
                    <Suffix>Jr</Suffix>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Complex Diseases, Harvard T.H. Chan School of Public Health, 655 Huntington Avenue, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA; Department of Genetics, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Srinivasan</LastName>
                    <ForeName>Supriya</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemical Physiology and The Dorris Neuroscience Center, 1 Barnard Drive, Oceanside, CA 92056, USA; The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Welte</LastName>
                    <ForeName>Michael A</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biology, University of Rochester, Rochester, NY 14627, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kohlwein</LastName>
                    <ForeName>Sepp D</ForeName>
                    <Initials>SD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Molecular Biosciences, BioTechMed-Graz, University of Graz, 8010 Graz, Austria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dettmer</LastName>
                    <ForeName>Ulf</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: udettmer@bwh.harvard.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lindquist</LastName>
                    <ForeName>Susan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, MIT, Cambridge, MA 02139, USA; HHMI, Department of Biology, MIT, Cambridge, MA 02139, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Selkoe</LastName>
                    <ForeName>Dennis</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: dselkoe@bwh.harvard.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R25 NS065743</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 GM102155</GrantID>
                    <Acronym>GM</Acronym>
                    <Agency>NIGMS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>RF1 NS083845</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 NS099328</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 NS083845</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>DP5 OD017941</GrantID>
                    <Acronym>OD</Acronym>
                    <Agency>NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R21 NS103123</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mol Cell</MedlineTA>
            <NlmUniqueID>9802571</NlmUniqueID>
            <ISSNLinking>1097-2765</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004075">Diglycerides</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014280">Triglycerides</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>2UMI9U37CP</RegistryNumber>
                <NameOfSubstance UI="D019301">Oleic Acid</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.14.19.1</RegistryNumber>
                <NameOfSubstance UI="D013230">Stearoyl-CoA Desaturase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000978" MajorTopicYN="N">Antiparkinson Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017173" MajorTopicYN="N">Caenorhabditis elegans</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004075" MajorTopicYN="N">Diglycerides</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059290" MajorTopicYN="N">Dopaminergic Neurons</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D066292" MajorTopicYN="N">Lipid Droplets</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058990" MajorTopicYN="N">Molecular Targeted Therapy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058953" MajorTopicYN="N">Neural Stem Cells</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019301" MajorTopicYN="N">Oleic Acid</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013230" MajorTopicYN="N">Stearoyl-CoA Desaturase</DescriptorName>
                <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014280" MajorTopicYN="N">Triglycerides</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Parkinson’s disease</Keyword>
            <Keyword MajorTopicYN="Y">alpha-synuclein</Keyword>
            <Keyword MajorTopicYN="Y">diglyceride</Keyword>
            <Keyword MajorTopicYN="Y">inclusions</Keyword>
            <Keyword MajorTopicYN="Y">lipid droplets</Keyword>
            <Keyword MajorTopicYN="Y">oleic acid</Keyword>
            <Keyword MajorTopicYN="Y">stearoyl-CoA-desaturase</Keyword>
            <Keyword MajorTopicYN="Y">synucleinopathy</Keyword>
            <Keyword MajorTopicYN="Y">tetramer</Keyword>
            <Keyword MajorTopicYN="Y">triglyceride</Keyword>
            <Keyword MajorTopicYN="Y">unsaturated fatty acid</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>01</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pmc-release">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30527540</ArticleId>
            <ArticleId IdType="pii">S1097-2765(18)30998-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.molcel.2018.11.028</ArticleId>
            <ArticleId IdType="pmc">PMC6408259</ArticleId>
            <ArticleId IdType="mid">NIHMS1514256</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Neurochem Res. 1998 Feb;23(2):227-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9475518</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Dis. 2017 Oct;106:191-204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28711409</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS Lett. 2004 Oct 22;576(3):363-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15498564</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Neurobiol. 2014 Dec;23(4):292-313</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25548530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2011 Aug 14;477(7362):107-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21841800</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Biol Cell. 2012 Apr;23(7):1146-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22323296</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Microbiol Mol Biol Rev. 2003 Sep;67(3):454-72, table of contents</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12966144</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2003 Dec 5;302(5651):1772-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14657500</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prog Lipid Res. 1985;24(2):69-176</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3916238</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Neurosci. 2013 Jun;20(6):880-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23618683</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>NPJ Parkinsons Dis. 2017 Apr 10;3:14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28649614</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods Enzymol. 2003;365:303-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14696355</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2017 Sep 15;26(18):3466-3481</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28911198</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cold Spring Harb Perspect Med. 2012 Aug 01;2(8):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22908195</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2003 Oct 31;302(5646):841</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14593171</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2005 Nov 4;123(3):383-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16269331</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Oct;1862(10 Pt B):1205-1211</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28711458</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Biol. 2015 Nov 23;211(4):829-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26572621</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Neurol. 2013 Feb;240:190-204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23201181</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3077-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12629214</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci Res. 2007 Jun;85(8):1819-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17465029</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2006 Jan 6;281(1):491-500</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16267052</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Neurol. 2008 Apr;210(2):409-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18164295</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2011 Sep 2;286(35):30670-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21768100</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Soc Trans. 2005 Nov;33(Pt 5):1174-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16246075</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2015 Jun 16;6:7314</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26076669</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurosci Lett. 2003 Oct 2;349(2):133-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12946570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochimie. 2009 Jun;91(6):796-803</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19278620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(10):e45049</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23071506</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2008 Mar 5;28(10):2471-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18322092</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Sci. 2014 Mar 15;127(Pt 6):1214-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24434579</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2003 Jul 2;23(13):5928-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12843297</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2016 Nov 1;17(6):1546-1559</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27806294</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2013 Jun 5;78(5):785-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23764284</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2016 May 5;533(7601):95-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27096366</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2013 Mar 1;288(9):6371-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23319586</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Biol Cell. 2015 Feb 15;26(4):726-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25540432</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2011 May 26;476(7359):220-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21617644</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2011 Aug 23;2:440</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21863007</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Cell Dev Biol. 2016 Oct 18;4:112</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27803897</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Chem Soc. 2013 Mar 13;135(10):3865-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23398399</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2013 Jan 18;288(3):1829-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23184946</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ACS Synth Biol. 2017 Mar 17;6(3):545-554</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27930885</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Cell Dev Biol. 2017 Oct 6;33:491-510</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28793795</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Elife. 2016 Aug 26;5:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27564575</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Lipid Res. 2011 Dec;52(12):2136-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21957196</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Biol. 2002 Jan 25;315(4):799-807</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11812148</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS Lett. 2009 Dec 17;583(24):3905-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19854183</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9110-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11481478</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2014 Mar 14;289(11):7929-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24474688</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2016 Jun 28;16(1):9-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27320911</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell. 2016 Jul 7;63(1):49-59</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27320200</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2011 Jul 22;146(2):318-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21757228</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Biol. 2014 Oct 6;24(19):2319-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25264250</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2013 Dec 27;288(52):37216-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24240094</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochim Biophys Acta. 2010 Aug;1801(8):750-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20471492</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Pathol. 2012 Jul;22(4):485-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21988495</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Future Lipidol. 2007 Aug;2(4):403-422</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18176634</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2003 Feb 20;37(4):583-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12597857</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Cell Neurosci. 2014 Feb 20;8:25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24600344</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Alzheimers Dis. 2006;9(3 Suppl):35-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16914843</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Biol Cell. 2008 Mar;19(3):1093-103</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18172022</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9596-601</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26153422</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci Res. 1987;18(4):551-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3481403</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):E4274-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25246573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochim Biophys Acta Biomembr. 2017 Sep;1859(9 Pt B):1583-1595</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28411173</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS Lett. 2018 Apr;592(8):1256-1272</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29178478</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Biol. 2007 Mar 9;366(5):1510-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17222866</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dev Cell. 2014 Jun 23;29(6):729-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24960695</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Parkinsons Dis. 2017;7(3):433-450</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28671142</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroscience. 2009 Jun 30;161(2):441-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19318117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2013 Apr;73(4):459-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23526723</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Biol. 2008 Feb 1;375(5):1394-404</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18082181</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2002 Aug 23;277(34):31062-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12052836</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Neurosci. 2004;23(1-2):23-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15126689</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2009 Nov 6;284(45):30981-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19608739</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Genet. 2017 Oct;49(10):1511-1516</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28892059</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20890-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18093937</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 1998 Apr 17;273(16):9443-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9545270</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Biol. 2011 Jul 11;194(1):89-103</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21746853</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochim Biophys Acta. 2007 Mar;1771(3):286-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16798075</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2013 Nov 22;342(6161):979-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24158909</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proteomics. 2014 Mar;14(6):784-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24449343</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Lipid Res. 2006 Aug;47(8):1714-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16687662</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17797-802</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22006323</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Neurosci. 2004 Nov;27(3):236-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15519239</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2009 Sep 18;138(6):1222-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19766573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroscience. 2009 Jun 2;160(4):796-804</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19272424</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Biol. 2009 Jul 24;390(4):775-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19481095</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Oct;1862(10 Pt B):1273-1283</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28668300</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods Mol Biol. 2011;793:129-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21913098</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2006 Oct 6;281(40):29739-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16847063</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
        <PMID Version="1">30526202</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>26</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>26</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">0891-9887</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>32</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of geriatric psychiatry and neurology</Title>
                <ISOAbbreviation>J Geriatr Psychiatry Neurol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Apolipoprotein E Polymorphisms and Parkinson Disease With or Without Dementia: A Meta-Analysis Including 6453 Participants.</ArticleTitle>
            <Pagination>
                <MedlinePgn>3-15</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1177/0891988718813675</ELocationID>
            <Abstract>
                <AbstractText>A large number of case-control studies have investigated the association of apolipoprotein E ( APOE) polymorphisms with Parkinson disease (PD) and Parkinson disease dementia (PDD), with inconsistent results. This meta-analysis aimed to evaluate the relationship between APOE polymorphisms and PD/PDD risk. We searched for published studies in PubMed, Web of Science, WanFang Data (in Chinese), and CNKI (in Chinese) from inception to June 2017. Case-control studies reporting part or complete APOE genotype and allele frequency data were included. Pooled odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated using RevMan 5.3 software. A total of 39 studies involving 6453 cases with PD, with 461 cases with PDD, and 6855 controls were included in this meta-analysis. The results showed that the APOE ε3 allele was a protective factor for PD (OR = 0.90, 95% CI: 0.81-0.99; P = .04), whereas no significant differences in PD risk among all cases compared to controls were found for APOE ε2 and ε4. In Asian subgroups, the APOE ε4 allele was shown to be a risk factor for PD (OR = 1.22, 95% CI: 1.01-1.46; P = .04). Additionally, APOE polymorphisms were significantly associated with PDD risk in the entire case group (ε3: OR = 0.72, 95% CI: 0.58-0.89, P = .003; ε4: OR = 1.46, 95% CI: 1.12-1.88, P = .004) and in Asian subgroups.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Ruoyi</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>1 Department of General Practitioner, Jiang Chuan Community Health Service Center, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Simin</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>2 Department of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zheng</LastName>
                    <ForeName>Bing</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>3 Department of Clinical Laboratory, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Jianping</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>4 Department of Geriatrics, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Xiaowei</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>3 Department of Clinical Laboratory, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D017418">Meta-Analysis</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Geriatr Psychiatry Neurol</MedlineTA>
            <NlmUniqueID>8805645</NlmUniqueID>
            <ISSNLinking>0891-9887</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D053329">Apolipoprotein E2</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D053327">Apolipoprotein E4</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D053329" MajorTopicYN="N">Apolipoprotein E2</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D053327" MajorTopicYN="N">Apolipoprotein E4</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D044466" MajorTopicYN="N">Asian Continental Ancestry Group</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003704" MajorTopicYN="N">Dementia</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Parkinson disease</Keyword>
            <Keyword MajorTopicYN="Y">Parkinson disease dementia</Keyword>
            <Keyword MajorTopicYN="Y">apolipoprotein E</Keyword>
            <Keyword MajorTopicYN="Y">meta-analysis</Keyword>
            <Keyword MajorTopicYN="Y">polymorphisms</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30526202</ArticleId>
            <ArticleId IdType="doi">10.1177/0891988718813675</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30520758</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>04</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>11</Month>
            <Day>17</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1537-162X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>42</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <MedlineDate>2019 Jan/Feb</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical neuropharmacology</Title>
                <ISOAbbreviation>Clin Neuropharmacol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Single-Dose Pharmacokinetics and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson Disease: A Comparison With Immediate-Release Carbidopa-Levodopa and With Extended-Release Carbidopa-Levodopa Capsules.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4-8</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/WNF.0000000000000314</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">IPX203 is an investigational oral extended-release capsule formulation of carbidopa-levodopa (CD-LD). The aim of this study was to characterize the single-dose pharmacodynamics, pharmacokinetics, and safety of IPX203 in subjects with advanced Parkinson disease compared with immediate-release (IR) CD-LD and extended-release CD-LD (Rytary).</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">This was a randomized, open-label, rater-blinded, multicenter, single-dose crossover study. Blinded clinicians assessed subject's motor state and Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III scores for up to 10 hours postdose. Duration of effect was determined using improvement thresholds in the MDS-UPDRS part III.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Levodopa concentrations increased rapidly and similarly across all 3 treatments and were sustained for a longer duration after IPX203 dosing. All treatments exhibited a rapid onset of pharmacodynamic effect, whereas IPX203 had a significantly longer duration of effect based on MDS-UPDRS part III scores compared with IR CD-LD (P &lt; 0.0001) and Rytary (P ≤ 0.0290). IPX203 had a 2.7-hour advantage over IR CD-LD (P &lt; 0.0001) and a 0.9-hour advantage over Rytary in &quot;off&quot; time (P = 0.023) and in &quot;good on&quot; time (2.6 hours more than IR CD-LD, P &lt; 0.0001; 0.9 hours more than Rytary, P = 0.0259) as measured by the Investigator Assessment of Subject's Motor State. Subjects were 77% more likely to require rescue following IR CD-LD treatment compared with IPX203 (hazard ratio, 0.23; P &lt; 0.0001). More subjects reported treatment-emergent adverse effects during IR CD-LD (28.0%) and IPX203 (19.2%) than during Rytary (8.0%) treatment.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Compared with Rytary and IR CD-LD, IPX203 had a longer pharmacodynamic effect consistent with LD pharmacokinetics for the 3 treatments. The safety and tolerability of IPX203 were similar to those of IR CD-LD and Rytary.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Modi</LastName>
                    <ForeName>Nishit B</ForeName>
                    <Initials>NB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Impax Laboratories, LLC, Hayward, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mittur</LastName>
                    <ForeName>Aravind</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rubens</LastName>
                    <ForeName>Robert</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Khanna</LastName>
                    <ForeName>Sarita</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gupta</LastName>
                    <ForeName>Suneel</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016448">Multicenter Study</PublicationType>
                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Clin Neuropharmacol</MedlineTA>
            <NlmUniqueID>7607910</NlmUniqueID>
            <ISSNLinking>0362-5664</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D002214">Capsules</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D003692">Delayed-Action Preparations</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C009265">carbidopa, levodopa drug combination</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>46627O600J</RegistryNumber>
                <NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>MNX7R8C5VO</RegistryNumber>
                <NameOfSubstance UI="D002230">Carbidopa</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000978" MajorTopicYN="N">Antiparkinson Agents</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002214" MajorTopicYN="N">Capsules</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002230" MajorTopicYN="N">Carbidopa</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003692" MajorTopicYN="N">Delayed-Action Preparations</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007980" MajorTopicYN="N">Levodopa</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000073216" MajorTopicYN="N">Mental Status and Dementia Tests</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>4</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30520758</ArticleId>
            <ArticleId IdType="doi">10.1097/WNF.0000000000000314</ArticleId>
            <ArticleId IdType="pmc">PMC7654938</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2008 Dec 4;359(23):2468-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19052127</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2011 Oct;26(12):2246-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21755537</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Neuropharmacol. 2003 May-Jun;26(3):156-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12782919</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 1967 May;17(5):427-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6067254</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2004 Dec;19(12):1409-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15390057</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2008 Nov 15;23(15):2129-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19025984</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1564476</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Geriatr Soc. 2005 Apr;53(4):695-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15817019</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Neurol Scand. 2001 Dec;104(6):343-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11903087</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Neuropharmacol. 2004 Sep-Oct;27(5):245-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15602106</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 1988 Jun;23(6):589-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3408240</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Neurol. 2009 Sep;16(9):982-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19538218</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Neuropharmacol. 2000 Mar-Apr;23(2):75-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10803796</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2015 Jan;30(1):80-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25488260</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2015 Aug;30(9):1222-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25847690</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30519817</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>01</Month>
            <Day>14</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1559-1182</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>56</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular neurobiology</Title>
                <ISOAbbreviation>Mol Neurobiol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Conditional Haploinsufficiency of β-Catenin Aggravates Neuronal Damage in a Paraquat-Based Mouse Model of Parkinson Disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>5157-5166</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-018-1431-z</ELocationID>
            <Abstract>
                <AbstractText>The canonical Wnt pathway is critical for both the development and adulthood survival and homeostatic maintenance of the midbrain dopaminergic (DA) neurons. Expanding evidence has demonstrated that genetic factors associated with familial Parkinson disease (PD) deregulate this important pathway, suggesting that a disturbed canonical Wnt pathway is likely involved in PD pathogenesis; yet, the specific role of this pathway in sporadic PD remains unclear. In this study, we aimed to determine the effects of specific inhibition of the canonical pathway by hemizygous knockout of β-catenin, the obligatory component of the canonical Wnt pathway, on paraquat (PQ)-induced DA neuronal degeneration in the substantia nigra in vivo. We found that while hemizygous conditional knockout of β-catenin in DA neurons did not cause any significant TH+ neuronal loss in the substantia nigra at basal level, it triggered elevated oxidative stress at basal level and further enhanced PQ-induced oxidative damage and loss of TH+ neurons in the substantia nigra and axonal termini in the striatum that manifested as exacerbated motor deficits. These data support the notion that reduced Wnt/β-catenin signaling in sporadic PD likely contributes to DA neuronal loss through an enhanced oxidative stress-response pathway.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Fanpeng</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, OH, 44106, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Siedlak</LastName>
                    <ForeName>Sandra L</ForeName>
                    <Initials>SL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, OH, 44106, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Torres</LastName>
                    <ForeName>Sandy L</ForeName>
                    <Initials>SL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, OH, 44106, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Qian</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya road, Changsha, 410008, Hunan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tang</LastName>
                    <ForeName>Beisha</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Xiangya Hospital, Central South University, 87 Xiangya road, Changsha, 410008, Hunan, People's Republic of China. bstang7398@163.com.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Clinical Research Center for Geriatric Medicine, Changsha, Hunan, People's Republic of China. bstang7398@163.com.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, Hunan, People's Republic of China. bstang7398@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Xiongwei</ForeName>
                    <Initials>X</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-2092-6508</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, OH, 44106, USA. xiongwei.zhu@case.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>NS083498</GrantID>
                    <Acronym>NH</Acronym>
                    <Agency>NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>81361120404</GrantID>
                    <Agency>NSFC-NIH joint programme</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>81430023</GrantID>
                    <Agency>National Natural Science Foundation of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>R01 NS083498</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>2016YFC1306000</GrantID>
                    <Agency>National Key Plan for Scientific Research and Development of China</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mol Neurobiol</MedlineTA>
            <NlmUniqueID>8900963</NlmUniqueID>
            <ISSNLinking>0893-7648</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C495267">CTNNB1 protein, mouse</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D051176">beta Catenin</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>PLG39H7695</RegistryNumber>
                <NameOfSubstance UI="D010269">Paraquat</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059290" MajorTopicYN="N">Dopaminergic Neurons</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057895" MajorTopicYN="N">Haploinsufficiency</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010269" MajorTopicYN="N">Paraquat</DescriptorName>
                <QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020734" MajorTopicYN="N">Parkinsonian Disorders</DescriptorName>
                <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051176" MajorTopicYN="N">beta Catenin</DescriptorName>
                <QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Canonical Wnt pathway</Keyword>
            <Keyword MajorTopicYN="N">Neurodegeneration</Keyword>
            <Keyword MajorTopicYN="N">Oxidative stress</Keyword>
            <Keyword MajorTopicYN="N">Parkinson disease</Keyword>
            <Keyword MajorTopicYN="N">β-Catenin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>1</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30519817</ArticleId>
            <ArticleId IdType="doi">10.1007/s12035-018-1431-z</ArticleId>
            <ArticleId IdType="pii">10.1007/s12035-018-1431-z</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Brain Res. 1999 Mar 27;823(1-2):1-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10095006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurotoxicology. 2000 Aug;21(4):435-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11022853</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Development. 2001 Apr;128(8):1253-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11262227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2003 Sep 11;39(6):889-909</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12971891</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12747-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14557550</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):665-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14704277</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurochem. 2005 May;93(4):1030-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15857406</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2005 May 20;308(5725):1181-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15905404</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Development. 2006 Jan;133(1):89-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16339193</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dev Cell. 2008 Jan;14(1):4-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18194646</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18344392</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2009 Oct 23;388(3):473-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19591802</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dev Cell. 2009 Jul;17(1):9-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19619488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2009 Sep 30;4(9):e7247</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19789628</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neuropathol Exp Neurol. 2010 May;69(5):511-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20418776</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Dis. 2011 Feb;41(2):508-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21056667</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Neurodegener. 2011 Jul 13;6:49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21752258</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(5):e36191</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22563483</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurotoxicology. 2012 Oct;33(5):947-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22627180</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Int. 2012 Oct 1;46:30-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22698719</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2012 Nov 15;21(22):4966-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22899650</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurosci Lett. 2012 Sep 13;525(2):83-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22902902</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Neurosci. 2013 Jan;49(1):105-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23065334</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Free Radic Biol Med. 2013 Sep;62:90-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23200807</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2013 May 28;80(22):2035-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23713084</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Cell Biol. 2014 Feb;6(1):27-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24287202</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Age (Dordr). 2014 Jun;36(3):9618</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24488586</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genes Dev. 2014 May 1;28(9):995-1004</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24788518</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Ther Med. 2014 Aug;8(2):384-390</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25009587</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Aging. 2015 Feb;36(2):720-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25443287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Transl Neurodegener. 2015 Jun 16;4:11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26085927</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Biol. 2015 Sep 21;25(18):2349-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26320949</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2015 Sep 30;35(39):13385-401</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26424886</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2016 Jan;22(1):54-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26618722</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Genet Genomics. 2016 Oct 20;43(10):587-592</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27692691</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Neurodegener. 2017 Jan 19;12(1):9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28103901</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1359-1370</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28215578</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ageing Res Rev. 2017 Aug;37:135-145</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28624530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Neurodegener. 2017 Jul 11;12(1):54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28697798</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2017 Dec 2;493(4):1573-1580</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28989026</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Handb Clin Neurol. 2018;147:211-227</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29325612</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Neurodegener. 2018 Feb 1;13(1):5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29391029</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 1997 Jun;48(6):1583-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9191770</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Baillieres Clin Neurol. 1997 Apr;6(1):15-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9426866</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Free Radic Biol Med. 1998 Jul 15;25(2):169-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9667492</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">30508157</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>15</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">2168-6157</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>76</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>JAMA neurology</Title>
                <ISOAbbreviation>JAMA Neurol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Neuropathology of Circadian Alterations in Parkinson Disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>115</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamaneurol.2018.3755</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fifel</LastName>
                    <ForeName>Karim</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016420">Comment</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>JAMA Neurol</MedlineTA>
            <NlmUniqueID>101589536</NlmUniqueID>
            <ISSNLinking>2168-6149</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentOn">
                <RefSource>JAMA Neurol. 2018 Aug 1;75(8):1008-1012</RefSource>
                <PMID Version="1">29710120</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>JAMA Neurol. 2019 Jan 1;76(1):115-116</RefSource>
                <PMID Version="1">30508142</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019578" MajorTopicYN="Y">Multiple System Atrophy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000069338" MajorTopicYN="N">Neuropathology</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013494" MajorTopicYN="Y">Supranuclear Palsy, Progressive</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30508157</ArticleId>
            <ArticleId IdType="pii">2716830</ArticleId>
            <ArticleId IdType="doi">10.1001/jamaneurol.2018.3755</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">30508142</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>15</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>02</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">2168-6157</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>76</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>JAMA neurology</Title>
                <ISOAbbreviation>JAMA Neurol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Neuropathology of Circadian Alterations in Parkinson Disease-Reply.</ArticleTitle>
            <Pagination>
                <MedlinePgn>115-116</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamaneurol.2018.3758</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>De Pablo-Fernández</LastName>
                    <ForeName>Eduardo</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Queen Square Brain Bank for Neurological Disorders, University College London Institute of Neurology, London, England.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Reta Lila Weston Institute, University College London Institute of Neurology, London, England.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Warner</LastName>
                    <ForeName>Thomas T</ForeName>
                    <Initials>TT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Queen Square Brain Bank for Neurological Disorders, University College London Institute of Neurology, London, England.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Reta Lila Weston Institute, University College London Institute of Neurology, London, England.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Holton</LastName>
                    <ForeName>Janice L</ForeName>
                    <Initials>JL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Queen Square Brain Bank for Neurological Disorders, University College London Institute of Neurology, London, England.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>MR/L023784/1</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MR/L023784/2</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016420">Comment</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>JAMA Neurol</MedlineTA>
            <NlmUniqueID>101589536</NlmUniqueID>
            <ISSNLinking>2168-6149</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentOn">
                <RefSource>JAMA Neurol. 2018 Aug 1;75(8):1008-1012</RefSource>
                <PMID Version="1">29710120</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="CommentOn">
                <RefSource>JAMA Neurol. 2019 Jan 1;76(1):115</RefSource>
                <PMID Version="1">30508157</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D002940" MajorTopicYN="N">Circadian Rhythm</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019578" MajorTopicYN="Y">Multiple System Atrophy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000069338" MajorTopicYN="N">Neuropathology</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013494" MajorTopicYN="Y">Supranuclear Palsy, Progressive</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30508142</ArticleId>
            <ArticleId IdType="pii">2716832</ArticleId>
            <ArticleId IdType="doi">10.1001/jamaneurol.2018.3758</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30504432</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>14</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>04</Month>
            <Day>16</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1526-632X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>92</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neurology</Title>
                <ISOAbbreviation>Neurology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>White matter differences between essential tremor and Parkinson disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e30-e39</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000006694</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE">To assess white matter integrity in patients with essential tremor (ET) and Parkinson disease (PD) with moderate to severe motor impairment.</AbstractText>
                <AbstractText Label="METHODS">Sedated participants with ET (n = 57) or PD (n = 99) underwent diffusion tensor imaging (DTI) and fractional anisotropy, mean diffusivity, axial diffusivity, and radial diffusivity values were computed. White matter tracts were defined using 3 well-described atlases. To determine candidate white matter regions that differ between ET and PD groups, a bootstrapping analysis was applied using the least absolute shrinkage and selection operator. Linear regression was applied to assess magnitude and direction of differences in DTI metrics between ET and PD populations in the candidate regions.</AbstractText>
                <AbstractText Label="RESULTS">Fractional anisotropy values that differentiate ET from PD localize primarily to thalamic and visual-related pathways, while diffusivity differences localized to the cerebellar peduncles. Patients with ET exhibited lower fractional anisotropy values than patients with PD in the lateral geniculate body (<i>p</i> &lt; 0.01), sagittal stratum (<i>p</i> = 0.01), forceps major (<i>p</i> = 0.02), pontine crossing tract (<i>p</i> = 0.03), and retrolenticular internal capsule (<i>p</i> = 0.04). Patients with ET exhibited greater radial diffusivity values than patients with PD in the superior cerebellar peduncle (<i>p</i> &lt; 0.01), middle cerebellar peduncle (<i>p</i> = 0.05), and inferior cerebellar peduncle (<i>p</i> = 0.05).</AbstractText>
                <AbstractText Label="CONCLUSIONS">Regionally, distinctive white matter microstructural values in patients with ET localize to the cerebellar peduncles and thalamo-cortical visual pathways. These findings complement recent functional imaging studies in ET but also extend our understanding of putative physiologic features that account for distinctions between ET and PD.</AbstractText>
                <CopyrightInformation>© 2018 American Academy of Neurology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Juttukonda</LastName>
                    <ForeName>Meher R</ForeName>
                    <Initials>MR</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Radiology and Radiological Sciences (M.R.J., M.J.D.), Neurological Surgery (D.J.E., P.E.K.), Biostatistics (Y.-C.L., H.K.), Neurology (P.T., P.H., M.J.D.), and Psychiatry (M.J.D.), Vanderbilt University Medical Center, Nashville, TN; Department of Pathophysiology and Transplantation (G.F.) University of Milan, Italy; and Chemical and Physical Biology Program (K.J.P.) and Departments of Electrical Engineering (B.A.L., B.M.D.), Computer Engineering (B.A.L., B.M.D.), Computer Science and Biomedical Engineering (B.A.L., B.M.D.), and Neurology (D.O.C.), Vanderbilt University, Nashville, TN.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Franco</LastName>
                    <ForeName>Giulia</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Radiology and Radiological Sciences (M.R.J., M.J.D.), Neurological Surgery (D.J.E., P.E.K.), Biostatistics (Y.-C.L., H.K.), Neurology (P.T., P.H., M.J.D.), and Psychiatry (M.J.D.), Vanderbilt University Medical Center, Nashville, TN; Department of Pathophysiology and Transplantation (G.F.) University of Milan, Italy; and Chemical and Physical Biology Program (K.J.P.) and Departments of Electrical Engineering (B.A.L., B.M.D.), Computer Engineering (B.A.L., B.M.D.), Computer Science and Biomedical Engineering (B.A.L., B.M.D.), and Neurology (D.O.C.), Vanderbilt University, Nashville, TN.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Englot</LastName>
                    <ForeName>Dario J</ForeName>
                    <Initials>DJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Radiology and Radiological Sciences (M.R.J., M.J.D.), Neurological Surgery (D.J.E., P.E.K.), Biostatistics (Y.-C.L., H.K.), Neurology (P.T., P.H., M.J.D.), and Psychiatry (M.J.D.), Vanderbilt University Medical Center, Nashville, TN; Department of Pathophysiology and Transplantation (G.F.) University of Milan, Italy; and Chemical and Physical Biology Program (K.J.P.) and Departments of Electrical Engineering (B.A.L., B.M.D.), Computer Engineering (B.A.L., B.M.D.), Computer Science and Biomedical Engineering (B.A.L., B.M.D.), and Neurology (D.O.C.), Vanderbilt University, Nashville, TN.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Ya-Chen</ForeName>
                    <Initials>YC</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Radiology and Radiological Sciences (M.R.J., M.J.D.), Neurological Surgery (D.J.E., P.E.K.), Biostatistics (Y.-C.L., H.K.), Neurology (P.T., P.H., M.J.D.), and Psychiatry (M.J.D.), Vanderbilt University Medical Center, Nashville, TN; Department of Pathophysiology and Transplantation (G.F.) University of Milan, Italy; and Chemical and Physical Biology Program (K.J.P.) and Departments of Electrical Engineering (B.A.L., B.M.D.), Computer Engineering (B.A.L., B.M.D.), Computer Science and Biomedical Engineering (B.A.L., B.M.D.), and Neurology (D.O.C.), Vanderbilt University, Nashville, TN.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Petersen</LastName>
                    <ForeName>Kalen J</ForeName>
                    <Initials>KJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Radiology and Radiological Sciences (M.R.J., M.J.D.), Neurological Surgery (D.J.E., P.E.K.), Biostatistics (Y.-C.L., H.K.), Neurology (P.T., P.H., M.J.D.), and Psychiatry (M.J.D.), Vanderbilt University Medical Center, Nashville, TN; Department of Pathophysiology and Transplantation (G.F.) University of Milan, Italy; and Chemical and Physical Biology Program (K.J.P.) and Departments of Electrical Engineering (B.A.L., B.M.D.), Computer Engineering (B.A.L., B.M.D.), Computer Science and Biomedical Engineering (B.A.L., B.M.D.), and Neurology (D.O.C.), Vanderbilt University, Nashville, TN.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Trujillo</LastName>
                    <ForeName>Paula</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Radiology and Radiological Sciences (M.R.J., M.J.D.), Neurological Surgery (D.J.E., P.E.K.), Biostatistics (Y.-C.L., H.K.), Neurology (P.T., P.H., M.J.D.), and Psychiatry (M.J.D.), Vanderbilt University Medical Center, Nashville, TN; Department of Pathophysiology and Transplantation (G.F.) University of Milan, Italy; and Chemical and Physical Biology Program (K.J.P.) and Departments of Electrical Engineering (B.A.L., B.M.D.), Computer Engineering (B.A.L., B.M.D.), Computer Science and Biomedical Engineering (B.A.L., B.M.D.), and Neurology (D.O.C.), Vanderbilt University, Nashville, TN.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hedera</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Radiology and Radiological Sciences (M.R.J., M.J.D.), Neurological Surgery (D.J.E., P.E.K.), Biostatistics (Y.-C.L., H.K.), Neurology (P.T., P.H., M.J.D.), and Psychiatry (M.J.D.), Vanderbilt University Medical Center, Nashville, TN; Department of Pathophysiology and Transplantation (G.F.) University of Milan, Italy; and Chemical and Physical Biology Program (K.J.P.) and Departments of Electrical Engineering (B.A.L., B.M.D.), Computer Engineering (B.A.L., B.M.D.), Computer Science and Biomedical Engineering (B.A.L., B.M.D.), and Neurology (D.O.C.), Vanderbilt University, Nashville, TN.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Landman</LastName>
                    <ForeName>Bennett A</ForeName>
                    <Initials>BA</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Radiology and Radiological Sciences (M.R.J., M.J.D.), Neurological Surgery (D.J.E., P.E.K.), Biostatistics (Y.-C.L., H.K.), Neurology (P.T., P.H., M.J.D.), and Psychiatry (M.J.D.), Vanderbilt University Medical Center, Nashville, TN; Department of Pathophysiology and Transplantation (G.F.) University of Milan, Italy; and Chemical and Physical Biology Program (K.J.P.) and Departments of Electrical Engineering (B.A.L., B.M.D.), Computer Engineering (B.A.L., B.M.D.), Computer Science and Biomedical Engineering (B.A.L., B.M.D.), and Neurology (D.O.C.), Vanderbilt University, Nashville, TN.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kang</LastName>
                    <ForeName>Hakmook</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Radiology and Radiological Sciences (M.R.J., M.J.D.), Neurological Surgery (D.J.E., P.E.K.), Biostatistics (Y.-C.L., H.K.), Neurology (P.T., P.H., M.J.D.), and Psychiatry (M.J.D.), Vanderbilt University Medical Center, Nashville, TN; Department of Pathophysiology and Transplantation (G.F.) University of Milan, Italy; and Chemical and Physical Biology Program (K.J.P.) and Departments of Electrical Engineering (B.A.L., B.M.D.), Computer Engineering (B.A.L., B.M.D.), Computer Science and Biomedical Engineering (B.A.L., B.M.D.), and Neurology (D.O.C.), Vanderbilt University, Nashville, TN.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Donahue</LastName>
                    <ForeName>Manus J</ForeName>
                    <Initials>MJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Radiology and Radiological Sciences (M.R.J., M.J.D.), Neurological Surgery (D.J.E., P.E.K.), Biostatistics (Y.-C.L., H.K.), Neurology (P.T., P.H., M.J.D.), and Psychiatry (M.J.D.), Vanderbilt University Medical Center, Nashville, TN; Department of Pathophysiology and Transplantation (G.F.) University of Milan, Italy; and Chemical and Physical Biology Program (K.J.P.) and Departments of Electrical Engineering (B.A.L., B.M.D.), Computer Engineering (B.A.L., B.M.D.), Computer Science and Biomedical Engineering (B.A.L., B.M.D.), and Neurology (D.O.C.), Vanderbilt University, Nashville, TN.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Konrad</LastName>
                    <ForeName>Peter E</ForeName>
                    <Initials>PE</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Radiology and Radiological Sciences (M.R.J., M.J.D.), Neurological Surgery (D.J.E., P.E.K.), Biostatistics (Y.-C.L., H.K.), Neurology (P.T., P.H., M.J.D.), and Psychiatry (M.J.D.), Vanderbilt University Medical Center, Nashville, TN; Department of Pathophysiology and Transplantation (G.F.) University of Milan, Italy; and Chemical and Physical Biology Program (K.J.P.) and Departments of Electrical Engineering (B.A.L., B.M.D.), Computer Engineering (B.A.L., B.M.D.), Computer Science and Biomedical Engineering (B.A.L., B.M.D.), and Neurology (D.O.C.), Vanderbilt University, Nashville, TN.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dawant</LastName>
                    <ForeName>Benoit M</ForeName>
                    <Initials>BM</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Radiology and Radiological Sciences (M.R.J., M.J.D.), Neurological Surgery (D.J.E., P.E.K.), Biostatistics (Y.-C.L., H.K.), Neurology (P.T., P.H., M.J.D.), and Psychiatry (M.J.D.), Vanderbilt University Medical Center, Nashville, TN; Department of Pathophysiology and Transplantation (G.F.) University of Milan, Italy; and Chemical and Physical Biology Program (K.J.P.) and Departments of Electrical Engineering (B.A.L., B.M.D.), Computer Engineering (B.A.L., B.M.D.), Computer Science and Biomedical Engineering (B.A.L., B.M.D.), and Neurology (D.O.C.), Vanderbilt University, Nashville, TN.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Claassen</LastName>
                    <ForeName>Daniel O</ForeName>
                    <Initials>DO</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Departments of Radiology and Radiological Sciences (M.R.J., M.J.D.), Neurological Surgery (D.J.E., P.E.K.), Biostatistics (Y.-C.L., H.K.), Neurology (P.T., P.H., M.J.D.), and Psychiatry (M.J.D.), Vanderbilt University Medical Center, Nashville, TN; Department of Pathophysiology and Transplantation (G.F.) University of Milan, Italy; and Chemical and Physical Biology Program (K.J.P.) and Departments of Electrical Engineering (B.A.L., B.M.D.), Computer Engineering (B.A.L., B.M.D.), Computer Science and Biomedical Engineering (B.A.L., B.M.D.), and Neurology (D.O.C.), Vanderbilt University, Nashville, TN. daniel.claassen@vumc.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R01 NS097783</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U54 HD083211</GrantID>
                    <Acronym>HD</Acronym>
                    <Agency>NICHD NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Neurology</MedlineTA>
            <NlmUniqueID>0401060</NlmUniqueID>
            <ISSNLinking>0028-3878</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016880" MajorTopicYN="N">Anisotropy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020329" MajorTopicYN="N">Essential Tremor</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D056784" MajorTopicYN="N">Leukoencephalopathies</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>05</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30504432</ArticleId>
            <ArticleId IdType="pii">WNL.0000000000006694</ArticleId>
            <ArticleId IdType="doi">10.1212/WNL.0000000000006694</ArticleId>
            <ArticleId IdType="pmc">PMC6336163</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Neuroimage. 2006 Feb 15;29(4):1092-105</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16236527</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Radiol. 2016 Oct;26(10):3327-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26780637</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroimage. 2002 Apr;15(4):870-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11906227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cereb Cortex. 2010 Sep;20(9):2055-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20032062</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2007 Jun 15;22(8):1182-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17469200</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroimage. 1999 Nov;10(5):489-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10547327</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Genet. 2009 Mar;41(3):277-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19182806</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Physiol Rev. 1992 Oct;72(4):967-1017</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1438583</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2015 Oct;30(12):1591-601</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26474316</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Image Comput Comput Assist Interv. 2006;9(Pt 2):58-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17354756</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Brain Res. 1973 Aug 31;18(1):69-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4746753</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroimage. 2007 Jul 1;36(3):630-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17481925</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2014 Nov;29(13):1637-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24531928</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol Sci. 2012 Jun 15;317(1-2):52-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22425540</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2010 Nov 15;25(15):2649-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21069833</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurotherapeutics. 2007 Jul;4(3):316-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17599699</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AJNR Am J Neuroradiol. 2014 Aug;35(8):1450-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23620075</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stereotact Funct Neurosurg. 2011;89(1):34-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21160241</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Stat Softw. 2010;33(1):1-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20808728</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2012 Aug 22;32(34):11586-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22915103</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroimage Clin. 2014 May 09;5:217-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25068111</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2015 Oct 15;24(20):5677-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26188006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsonism Relat Disord. 2016 Dec;33:12-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27765426</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsonism Relat Disord. 2012 Jun;18(5):477-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22297126</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World Neurosurg. 2016 Dec;96:613.e9-613.e16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27593719</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Brain Mapp. 2011 Jun;32(6):896-904</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20572209</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Magn Reson Med. 2003 Nov;50(5):1077-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14587019</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1564476</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroimage. 2007 Jan 1;34(1):144-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17070705</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Investig Med. 2009 Dec;57(8):830-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19574929</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 1998;13 Suppl 3:2-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9827589</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroscience. 1993 Jul;55(2):303-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8377927</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Brain Mapp. 2018 Jan;39(1):509-521</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29086460</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2007 Oct;13(10):1228-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17906634</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Integr Neurosci. 2012 Apr 24;6:15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22536176</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroimage. 2004;23 Suppl 1:S208-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15501092</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Neurol Neurosci Rep. 2013 Sep;13(9):378</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23893097</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AJNR Am J Neuroradiol. 2008 Jan;29(1):151-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17921227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2006 Dec;21(12):2052-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17078051</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2009 May 14;62(3):308-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19447086</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain. 2018 Feb 1;141(2):472-485</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29293948</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroepidemiology. 1997;16(3):124-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9159767</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Biol. 2017 Apr 13;15(4):e2001494</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28406906</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroimage. 2008 Jan 1;39(1):336-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17931890</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2010 Mar 23;74(12):988-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20308683</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30504429</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>14</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1526-632X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>92</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neurology</Title>
                <ISOAbbreviation>Neurology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>CSF β-amyloid<sub>42</sub> and risk of freezing of gait in early Parkinson disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e40-e47</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000006692</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE">To determine whether CSF biomarkers can be used as a predictor of freezing of gait (FOG) in Parkinson disease (PD) and to investigate the predictive value of clinical, dopamine transporter (DAT) imaging, and CSF parameters both separately and in combination.</AbstractText>
                <AbstractText Label="METHODS">This study using the PPMI data included 393 patients with newly diagnosed PD without FOG at baseline. We evaluated CSF for β-amyloid 1-42 (Aβ<sub>42</sub>), α-synuclein, total tau, phosphorylated tau<sub>181</sub>, and the calculated ratio of Aβ<sub>42</sub> to total tau at baseline. Demographic and clinical data and DAT imaging results were also investigated. Cox proportional-hazards regression analyses were performed to identify the factors predictive of FOG. From these results, we constructed a predictive model for the development of FOG.</AbstractText>
                <AbstractText Label="RESULTS">During a median follow-up of 4.0 years, only Aβ<sub>42</sub> among the CSF biomarkers was associated with the development of FOG (hazard ratio 0.997, 95% confidence interval [CI] 0.996-0.999, <i>p</i> = 0.009). Postural instability gait difficulty (PIGD) score, caudate DAT uptake, and, to a lesser extent, male sex, Movement Disorders Society Unified Parkinson's Disease Rating Scale motor score, and Montreal Cognitive Assessment score were also predictive of FOG. The combined model integrating the PIGD score, caudate DAT uptake, and CSF Aβ<sub>42</sub> achieved a better discriminative ability (area under the curve 0.755, 95% CI 0.700-0.810) than any factor alone.</AbstractText>
                <AbstractText Label="CONCLUSION">We found CSF Aβ<sub>42</sub> to be a predictor of FOG in patients with early PD. Furthermore, the development of FOG within 4 years after diagnosis of PD can be predicted with acceptable accuracy with our risk model.</AbstractText>
                <CopyrightInformation>© 2018 American Academy of Neurology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Ryul</ForeName>
                    <Initials>R</Initials>
                    <Identifier Source="ORCID">0000-0001-8219-9663</Identifier>
                    <AffiliationInfo>
                        <Affiliation>From the Department of Neurology (R.K., H.-J.K., A.K., B.J.), Seoul National University Hospital, College of Medicine; Department of Neurology (R.K.), Aerospace Medical Center, Republic of Korea Air Force, Cheongju; Medical Research Collaborating Center (J.L.), Seoul National University Hospital; Department of Neurology (M.J.), Presbyterian Medical Center, Jeonju, Republic of Korea; and Department of Neurology (U.J.K.), Columbia University Medical Center, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Joongyub</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Department of Neurology (R.K., H.-J.K., A.K., B.J.), Seoul National University Hospital, College of Medicine; Department of Neurology (R.K.), Aerospace Medical Center, Republic of Korea Air Force, Cheongju; Medical Research Collaborating Center (J.L.), Seoul National University Hospital; Department of Neurology (M.J.), Presbyterian Medical Center, Jeonju, Republic of Korea; and Department of Neurology (U.J.K.), Columbia University Medical Center, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Han-Joon</ForeName>
                    <Initials>HJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Department of Neurology (R.K., H.-J.K., A.K., B.J.), Seoul National University Hospital, College of Medicine; Department of Neurology (R.K.), Aerospace Medical Center, Republic of Korea Air Force, Cheongju; Medical Research Collaborating Center (J.L.), Seoul National University Hospital; Department of Neurology (M.J.), Presbyterian Medical Center, Jeonju, Republic of Korea; and Department of Neurology (U.J.K.), Columbia University Medical Center, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Aryun</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Department of Neurology (R.K., H.-J.K., A.K., B.J.), Seoul National University Hospital, College of Medicine; Department of Neurology (R.K.), Aerospace Medical Center, Republic of Korea Air Force, Cheongju; Medical Research Collaborating Center (J.L.), Seoul National University Hospital; Department of Neurology (M.J.), Presbyterian Medical Center, Jeonju, Republic of Korea; and Department of Neurology (U.J.K.), Columbia University Medical Center, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jang</LastName>
                    <ForeName>Mihee</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Department of Neurology (R.K., H.-J.K., A.K., B.J.), Seoul National University Hospital, College of Medicine; Department of Neurology (R.K.), Aerospace Medical Center, Republic of Korea Air Force, Cheongju; Medical Research Collaborating Center (J.L.), Seoul National University Hospital; Department of Neurology (M.J.), Presbyterian Medical Center, Jeonju, Republic of Korea; and Department of Neurology (U.J.K.), Columbia University Medical Center, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jeon</LastName>
                    <ForeName>Beomseok</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Department of Neurology (R.K., H.-J.K., A.K., B.J.), Seoul National University Hospital, College of Medicine; Department of Neurology (R.K.), Aerospace Medical Center, Republic of Korea Air Force, Cheongju; Medical Research Collaborating Center (J.L.), Seoul National University Hospital; Department of Neurology (M.J.), Presbyterian Medical Center, Jeonju, Republic of Korea; and Department of Neurology (U.J.K.), Columbia University Medical Center, New York, NY. brain@snu.ac.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kang</LastName>
                    <ForeName>Un Jung</ForeName>
                    <Initials>UJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Department of Neurology (R.K., H.-J.K., A.K., B.J.), Seoul National University Hospital, College of Medicine; Department of Neurology (R.K.), Aerospace Medical Center, Republic of Korea Air Force, Cheongju; Medical Research Collaborating Center (J.L.), Seoul National University Hospital; Department of Neurology (M.J.), Presbyterian Medical Center, Jeonju, Republic of Korea; and Department of Neurology (U.J.K.), Columbia University Medical Center, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Neurology</MedlineTA>
            <NlmUniqueID>0401060</NlmUniqueID>
            <ISSNLinking>0028-3878</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D050483">Dopamine Plasma Membrane Transport Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C075222">amyloid beta-protein (1-42)</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName>
                <QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004185" MajorTopicYN="N">Disability Evaluation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D050483" MajorTopicYN="N">Dopamine Plasma Membrane Transport Proteins</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020233" MajorTopicYN="N">Gait Disorders, Neurologic</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
                <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName>
                <QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName>
                <QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName>
                <QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>05</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30504429</ArticleId>
            <ArticleId IdType="pii">WNL.0000000000006692</ArticleId>
            <ArticleId IdType="doi">10.1212/WNL.0000000000006692</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30503143</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>03</Month>
            <Day>03</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1875-9777</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>24</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                        <Day>03</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell stem cell</Title>
                <ISOAbbreviation>Cell Stem Cell</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Single-Cell Sequencing of iPSC-Dopamine Neurons Reconstructs Disease Progression and Identifies HDAC4 as a Regulator of Parkinson Cell Phenotypes.</ArticleTitle>
            <Pagination>
                <MedlinePgn>93-106.e6</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1934-5909(18)30504-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.stem.2018.10.023</ELocationID>
            <Abstract>
                <AbstractText>Induced pluripotent stem cell (iPSC)-derived dopamine neurons provide an opportunity to model Parkinson's disease (PD), but neuronal cultures are confounded by asynchronous and heterogeneous appearance of disease phenotypes in vitro. Using high-resolution, single-cell transcriptomic analyses of iPSC-derived dopamine neurons carrying the GBA-N370S PD risk variant, we identified a progressive axis of gene expression variation leading to endoplasmic reticulum stress. Pseudotime analysis of genes differentially expressed (DE) along this axis identified the transcriptional repressor histone deacetylase 4 (HDAC4) as an upstream regulator of disease progression. HDAC4 was mislocalized to the nucleus in PD iPSC-derived dopamine neurons and repressed genes early in the disease axis, leading to late deficits in protein homeostasis. Treatment of iPSC-derived dopamine neurons with HDAC4-modulating compounds upregulated genes early in the DE axis and corrected PD-related cellular phenotypes. Our study demonstrates how single-cell transcriptomics can exploit cellular heterogeneity to reveal disease mechanisms and identify therapeutic targets.</AbstractText>
                <CopyrightInformation>Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lang</LastName>
                    <ForeName>Charmaine</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Parkinson's Disease Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Campbell</LastName>
                    <ForeName>Kieran R</ForeName>
                    <Initials>KR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Parkinson's Disease Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, UK; The Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ryan</LastName>
                    <ForeName>Brent J</ForeName>
                    <Initials>BJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Parkinson's Disease Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carling</LastName>
                    <ForeName>Phillippa</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Parkinson's Disease Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Attar</LastName>
                    <ForeName>Moustafa</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vowles</LastName>
                    <ForeName>Jane</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Perestenko</LastName>
                    <ForeName>Olga V</ForeName>
                    <Initials>OV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bowden</LastName>
                    <ForeName>Rory</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baig</LastName>
                    <ForeName>Fahd</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Parkinson's Disease Centre, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kasten</LastName>
                    <ForeName>Meike</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry and Psychotherapy and Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Michele T</ForeName>
                    <Initials>MT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Parkinson's Disease Centre, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cowley</LastName>
                    <ForeName>Sally A</ForeName>
                    <Initials>SA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Webber</LastName>
                    <ForeName>Caleb</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Parkinson's Disease Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, UK. Electronic address: webberc4@cardiff.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wade-Martins</LastName>
                    <ForeName>Richard</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oxford Parkinson's Disease Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, UK. Electronic address: richard.wade-martins@dpag.ox.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>MR/M00919X/1</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>G84/6443</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MC_UP_A320_1004</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MC_UU_00016/15</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <Acronym>DH_</Acronym>
                    <Agency>Department of Health</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MC_UU_12009/16</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MC_PC_16034</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>090532/Z/09/Z</GrantID>
                    <Acronym>WT_</Acronym>
                    <Agency>Wellcome Trust</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MC_EX_MR/N50192X/1</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MR/M024962/1</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MR/L023784/1</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MR/L006340/1</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>WTISSF121302</GrantID>
                    <Acronym>WT_</Acronym>
                    <Agency>Wellcome Trust</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>J-0901</GrantID>
                    <Acronym>PUK_</Acronym>
                    <Agency>Parkinson's UK</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MC_UU_12021/4</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MR/L023784/2</GrantID>
                    <Acronym>MRC_</Acronym>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>29</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Cell Stem Cell</MedlineTA>
            <NlmUniqueID>101311472</NlmUniqueID>
            <ISSNLinking>1875-9777</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D012097">Repressor Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.2.1.45</RegistryNumber>
                <NameOfSubstance UI="C000633564">GBA protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.2.1.45</RegistryNumber>
                <NameOfSubstance UI="D005962">Glucosylceramidase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.5.1.98</RegistryNumber>
                <NameOfSubstance UI="C400300">HDAC4 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.5.1.98</RegistryNumber>
                <NameOfSubstance UI="D006655">Histone Deacetylases</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>VTD58H1Z2X</RegistryNumber>
                <NameOfSubstance UI="D004298">Dopamine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059290" MajorTopicYN="N">Dopaminergic Neurons</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059865" MajorTopicYN="N">Endoplasmic Reticulum Stress</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005962" MajorTopicYN="N">Glucosylceramidase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006655" MajorTopicYN="N">Histone Deacetylases</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012097" MajorTopicYN="N">Repressor Proteins</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059010" MajorTopicYN="N">Single-Cell Analysis</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Parkinson’s disease</Keyword>
            <Keyword MajorTopicYN="Y">histone deacetylase 4</Keyword>
            <Keyword MajorTopicYN="Y">induced pluripotent stem cells</Keyword>
            <Keyword MajorTopicYN="Y">single-cell RNA sequencing</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>03</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>07</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>3</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30503143</ArticleId>
            <ArticleId IdType="pii">S1934-5909(18)30504-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.stem.2018.10.023</ArticleId>
            <ArticleId IdType="pmc">PMC6327112</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Genomics. 2019 Jul;111(4):819-830</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29852216</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2016 Oct 1;32(19):2973-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27318198</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cancer Ther. 2015 Jul;14(7):1540-1547</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25939762</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2014 Jun 06;5:4028</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24905578</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2017 Apr 15;33(8):1179-1186</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28088763</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO Mol Med. 2012 May;4(5):380-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22407749</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Epidemiol. 2013 Feb;42(1):128-128k</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23257687</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Biotechnol. 2013 Nov 20;13:104</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24256843</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2013 Dec 15;19(24):6891-901</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24255071</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2004 Sep 11;329(7466):611-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15361447</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013 Aug 12;8(8):e71098</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23951090</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Altern Complement Med. 1999 Feb;5(1):57-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10100031</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2017 Aug 21;7(1):9003</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28827786</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stem Cell Reports. 2017 Aug 8;9(2):587-599</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28689993</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Biol. 2014;15(12):550</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25516281</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Methods. 2017 May;14(5):483-486</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28346451</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 2016 May;34(5):525-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27043002</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurochem. 2003 Apr;85(1):151-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12641737</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2013 Feb 15;73(4):1386-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23149916</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Genet Metab. 2003 Jun;79(2):104-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12809640</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Methods. 2013 Nov;10(11):1096-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24056875</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Cell. 2016 Mar 14;29(3):311-323</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26977882</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Methods. 2013 Nov;10(11):1093-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24056876</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Aging. 2018 Sep;69:283-291</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29935433</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Biol. 2010;11(2):R14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20132535</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Biol. 2013 Nov;11(11):e1001717</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24302884</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain. 1991 Oct;114 ( Pt 5):2283-301</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1933245</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2011 Nov 06;480(7378):547-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22056989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>F1000Res. 2015 Dec 30;4:1521</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26925227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1564476</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2005 Oct 12;25(41):9544-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16221865</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2016 Jul 27;44(13):e117</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27179027</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Biol. 2015 Nov 02;16:241</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26527291</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2017 Jun 20;7(1):3902</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28634347</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Stem Cell. 2016 Dec 1;19(6):709-724</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27618216</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Cycle. 2008 Feb 1;7(3):304-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18235239</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>F1000Res. 2016 Aug 31;5:2122</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27909575</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Comput Biol. 2014 Aug 28;10(8):e1003815</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25166029</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Biol. 2016 Feb 17;17:29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26887813</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Methods. 2016 Oct;13(10):845-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27571553</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Med. 2013 Dec;45(8):511-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24219755</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2009 Jul 1;18(13):2370-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19351654</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2007 Nov 30;131(5):861-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18035408</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Methods. 2015 Apr;12(4):357-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25751142</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stem Cell Reports. 2016 Mar 8;6(3):342-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26905200</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Biol Cell. 2008 Feb;19(2):655-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18045992</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2016 Aug 1;34(22):2636-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27298414</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2017 Apr 15;33(8):1241-1242</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28011787</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsonism Relat Disord. 2014 Jan;20(1):99-105</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24183678</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2012 Nov 9;151(4):821-834</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23141539</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2014 Jun 1;23(11):2802-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24399444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2017 Feb 1;26(3):552-566</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28096185</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 1997 Nov;12(6):871-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9399209</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Neurobiol. 2017 Nov;54(9):7204-7211</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27796756</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mutat. 2008 May;29(5):567-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18338393</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30504066</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>07</Month>
            <Day>22</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>07</Month>
            <Day>22</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-5883</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>396</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of the neurological sciences</Title>
                <ISOAbbreviation>J Neurol Sci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Medication status and dual-tasking on turning strategies in Parkinson disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>206-212</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0022-510X(18)30481-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jns.2018.11.028</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND">Parkinson disease (PD) patients have turning impairments that may increase fall risk. Clinics lack specialized kinematic equipment used in gait and turn analysis and require a simple method to evaluate fall risk and advise patients in turning strategy selection.</AbstractText>
                <AbstractText Label="OBJECTIVES">To enhance understanding of PD turning strategies and determine if turning can be assessed using a video-recording and categorization method, we compared 180-degree and 90-degree turns as a function of medication status and dual-tasking (DT).</AbstractText>
                <AbstractText Label="METHODS">21 PD participants (H&amp;Y stage 1-3) in PD-ON and PD-OFF medication states and 16 controls completed 180-degree and 90-degree turn-tasks with and without DT. Video-recordings of tasks permitted classification of 180-degree turns into Few-Step turns (FST) vs. Multi-Step turns (MST) and 90-degree turns into Step vs. Spin-turns. FST were further sub-classified into Twisting vs. Sideways turns and MST into Backward, Festination, Forward or Wheeling turns. Percentages of subtypes were analyzed across groups by task.</AbstractText>
                <AbstractText Label="RESULTS">IN 180-degree tasks, there was an effect of group: FST vs. MST F(2,55) = 9.578, p &lt; .001. PD participants in the off-medication state (PD-OFF) produced significantly more MST with a larger number of different turning subtypes vs. controls or PD on medication (PD-ON). In 90-degree tasks, controls significantly increased their proportion of Step-turns while DT (p &lt; .001), an adaptation not observed in PD-ON or PD-OFF.</AbstractText>
                <AbstractText Label="CONCLUSIONS">PD turning impairments may stem from an inability to select a unified turning strategy and to adapt to the turning environment, which may be exacerbated in PD-OFF. Video-analysis may prove beneficial in predicting a clinical course for PD patients by revealing features of turning dysfunction.</AbstractText>
                <CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Adamson</LastName>
                    <ForeName>M B</ForeName>
                    <Initials>MB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physiology and Pharmacology, Western University, Canada; London Movement Disorder Centre, Canada. Electronic address: mitchell.adamson@mail.utoronto.ca.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gilmore</LastName>
                    <ForeName>G</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>London Movement Disorder Centre, Canada; Department of Biomedical Engineering, Western University, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stratton</LastName>
                    <ForeName>T W</ForeName>
                    <Initials>TW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physiology and Pharmacology, Western University, Canada; London Movement Disorder Centre, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baktash</LastName>
                    <ForeName>N</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>London Movement Disorder Centre, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jog</LastName>
                    <ForeName>M S</ForeName>
                    <Initials>MS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physiology and Pharmacology, Western University, Canada; London Movement Disorder Centre, Canada; NPF Centre of Excellence and London Movement Disorder Centre, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>J Neurol Sci</MedlineTA>
            <NlmUniqueID>0375403</NlmUniqueID>
            <ISSNLinking>0022-510X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>46627O600J</RegistryNumber>
                <NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000058" MajorTopicYN="N">Accidental Falls</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000978" MajorTopicYN="N">Antiparkinson Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001696" MajorTopicYN="N">Biomechanical Phenomena</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005239" MajorTopicYN="N">Fear</DescriptorName>
                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007980" MajorTopicYN="N">Levodopa</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009068" MajorTopicYN="N">Movement</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011597" MajorTopicYN="N">Psychomotor Performance</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013647" MajorTopicYN="Y">Task Performance and Analysis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014741" MajorTopicYN="N">Video Recording</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Dual-tasking</Keyword>
            <Keyword MajorTopicYN="Y">Gait</Keyword>
            <Keyword MajorTopicYN="Y">Medication state</Keyword>
            <Keyword MajorTopicYN="Y">Motor control</Keyword>
            <Keyword MajorTopicYN="Y">Movement disorders</Keyword>
            <Keyword MajorTopicYN="Y">Parkinson disease</Keyword>
            <Keyword MajorTopicYN="Y">Turning strategies</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>5</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>7</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30504066</ArticleId>
            <ArticleId IdType="pii">S0022-510X(18)30481-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jns.2018.11.028</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">30476908</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>02</Month>
            <Day>24</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>02</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1423-0208</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>52</Volume>
                    <Issue>1-2</Issue>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Neuroepidemiology</Title>
                <ISOAbbreviation>Neuroepidemiology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Therapies for Pain in Parkinson Disease: Concerns Related to a Meta-Analysis on Treating Different Types of Pain as if They Were the Same.</ArticleTitle>
            <Pagination>
                <MedlinePgn>74-75</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1159/000494686</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Raphael</LastName>
                    <ForeName>Karen Gail</ForeName>
                    <Initials>KG</Initials>
                    <AffiliationInfo>
                        <Affiliation>New York University College of Dentistry, New York, New York, USA, kgr234@nyu.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
                <PublicationType UI="D016420">Comment</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>26</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Neuroepidemiology</MedlineTA>
            <NlmUniqueID>8218700</NlmUniqueID>
            <ISSNLinking>0251-5350</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentOn">
                <RefSource>Neuroepidemiology. 2018;51(3-4):190-206</RefSource>
                <PMID Version="1">30153669</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>Neuroepidemiology. 2020;54(3):281-282</RefSource>
                <PMID Version="1">31812958</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059408" MajorTopicYN="N">Pain Management</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>2</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30476908</ArticleId>
            <ArticleId IdType="pii">000494686</ArticleId>
            <ArticleId IdType="doi">10.1159/000494686</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30468694</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>01</Month>
            <Day>02</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>01</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1531-8257</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>34</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Movement disorders : official journal of the Movement Disorder Society</Title>
                <ISOAbbreviation>Mov Disord</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa).</ArticleTitle>
            <Pagination>
                <MedlinePgn>67-77</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.27492</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVES">The objectives of this study were to investigate (1) the annual rate of progression of motor and cognitive symptoms and (2) baseline predictors of different modalities for this progression in early Parkinson's disease (PD) when compared with healthy controls.</AbstractText>
                <AbstractText Label="METHODS">A total of 135 de novo PD and 109 healthy controls (of the De Novo Parkinson cohort) were investigated at baseline and after 24 and 48 months. To delineate motor progression and cognitive decline, the Movement Disorder Society-Unified Parkinson's Disease Rating Scale part III (MDS-UPDRS III) and the Mini-Mental Status Examination (MMSE) were selected. Baseline variables used to predict progression included sociodemographic factors, comorbidities, motor/nonmotor symptoms, polysomnography, MRI, and laboratory biomarkers in serum and CSF.</AbstractText>
                <AbstractText Label="RESULTS">Symptoms worsened over 4 years in PD with an annual change of 1.8 points on the MDS-UPDRS III and 0.2 points on the MMSE. Baseline predictors of worse progression of motor symptoms in PD included male sex, orthostatic blood pressure drop, diagnosis of coronary artery disease, arterial hypertension, elevated serum uric acid, and CSF neurofilament light chain. Predictors of cognitive decline in PD included previous heavy alcohol abuse, current diagnoses of diabetes mellitus, arterial hypertension, elevated periodic limb movement index during sleep, decreased hippocampal volume by MRI, higher baseline levels of uric acid, C-reactive protein, high density lipoprotein (HDL) cholesterol, and glucose levels.</AbstractText>
                <AbstractText Label="CONCLUSION">Cardiovascular risk factors, deregulated blood glucose, uric acid metabolism, and inflammation were identified as risk markers for faster disease progression. Our panel of risk parameters needs validation during our continuing follow-up and also in independent patient cohorts. © 2018 International Parkinson and Movement Disorder Society.</AbstractText>
                <CopyrightInformation>© 2018 International Parkinson and Movement Disorder Society.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mollenhauer</LastName>
                    <ForeName>Brit</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Paracelsus-Elena-Klinik, Kassel, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, University Medical Centre Goettingen, Goettingen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zimmermann</LastName>
                    <ForeName>Johannes</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Psychologische Hochschule Berlin, Berlin, Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sixel-Döring</LastName>
                    <ForeName>Friederike</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Paracelsus-Elena-Klinik, Kassel, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Focke</LastName>
                    <ForeName>Niels K</ForeName>
                    <Initials>NK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Neurophysiology, University Medical Centre Goettingen, Goettingen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wicke</LastName>
                    <ForeName>Tamara</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Paracelsus-Elena-Klinik, Kassel, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ebentheuer</LastName>
                    <ForeName>Jens</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Paracelsus-Elena-Klinik, Kassel, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schaumburg</LastName>
                    <ForeName>Martina</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Paracelsus-Elena-Klinik, Kassel, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lang</LastName>
                    <ForeName>Elisabeth</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Paracelsus-Elena-Klinik, Kassel, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Friede</LastName>
                    <ForeName>Tim</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Statistics, University Medical Centre Goettingen, Goettingen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Trenkwalder</LastName>
                    <ForeName>Claudia</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Paracelsus-Elena-Klinik, Kassel, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, University Medical Centre GoettingenGoettingen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>DeNoPa Study Group</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <Agency>University Medical Centre Goettingen</Agency>
                    <Country>International</Country>
                </Grant>
                <Grant>
                    <Agency>Paracelsus-Elena-Klinik, Kassel, Germany</Agency>
                    <Country>International</Country>
                </Grant>
                <Grant>
                    <Agency>Michael J Fox Foundation for Parkinson's Research</Agency>
                    <Country>International</Country>
                </Grant>
                <Grant>
                    <Agency>ParkinsonFonds Deutschland</Agency>
                    <Country>International</Country>
                </Grant>
                <Grant>
                    <Agency>TEVA Pharma</Agency>
                    <Country>International</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mov Disord</MedlineTA>
            <NlmUniqueID>8610688</NlmUniqueID>
            <ISSNLinking>0885-3185</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>9007-41-4</RegistryNumber>
                <NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Parkinson's disease/parkinsonism</Keyword>
            <Keyword MajorTopicYN="Y">cohort studies</Keyword>
            <Keyword MajorTopicYN="Y">outcome research</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2017</Year>
                <Month>11</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>07</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>07</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>1</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30468694</ArticleId>
            <ArticleId IdType="doi">10.1002/mds.27492</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">30445622</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>14</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1524-4040</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>84</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neurosurgery</Title>
                <ISOAbbreviation>Neurosurgery</ISOAbbreviation>
            </Journal>
            <ArticleTitle>In Reply: Deep Brain Stimulation of the Pedunculopontine Nucleus Area in Parkinson Disease: Magnetic Resonance Imaging-Based Anatomoclinical Correlations and Optimal Target.</ArticleTitle>
            <Pagination>
                <MedlinePgn>E106-E107</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/neuros/nyy518</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Goetz</LastName>
                    <ForeName>Laurent</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Grenoble Institute of Neurosciences INSERM U1216 CEA-UJF-CHUGA Grenoble, France.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>University Grenoble Alpes Grenoble, France.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>CERVO Brain Research CenterInstitut Universitaire en Santé Mentale de QuébecDepartment of Psychiatry and NeuroscienceUniversité Laval Québec City, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chabardès</LastName>
                    <ForeName>Stéphan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Grenoble Institute of Neurosciences INSERM U1216 CEA-UJF-CHUGA Grenoble, France.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>University Grenoble Alpes Grenoble, France.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of NeurosurgeryCentre Hospitalier Universitaire Grenoble Alpes Grenoble, France.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Clinatec-CEA-LetiGrenoble, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
                <PublicationType UI="D016420">Comment</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Neurosurgery</MedlineTA>
            <NlmUniqueID>7802914</NlmUniqueID>
            <ISSNLinking>0148-396X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentOn">
                <RefSource>Neurosurgery. 2019 Feb 1;84(2):506-518</RefSource>
                <PMID Version="1">29846707</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="CommentOn">
                <RefSource>Neurosurgery. 2019 Jan 1;84(1):E103-E105</RefSource>
                <PMID Version="1">30395324</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D046690" MajorTopicYN="Y">Deep Brain Stimulation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D045042" MajorTopicYN="Y">Pedunculopontine Tegmental Nucleus</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30445622</ArticleId>
            <ArticleId IdType="pii">5184867</ArticleId>
            <ArticleId IdType="doi">10.1093/neuros/nyy518</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">30444088</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>20</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1840-2445</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>16</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Feb</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina</Title>
                <ISOAbbreviation>Med Glas (Zenica)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effects of kinesiotherapy on muscle strengthening in patients with Parkinson disease.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.17392/970-18</ELocationID>
            <Abstract>
                <AbstractText>Aim To investigate the effect of kinesiotherapy on muscle strengthening in patients with Parkinon's disease. Methods This clinical retrospective - prospective study was based on collected data from medical histories and included 40 patients, who, beside medicaments, had undergone kinesiotherapy. This study analysed age, gender, duration of the rehabilitation and estimation of the gross muscle strength at admittance and discharge using Manual Muscle Test (MMT). Results Females was slightly more represented in the total sample without significant statistical difference. After kinesiotherapy significant statistical difference in muscle strength was observed, average MMT of the upper extremities increased from 3.25±0.6 to 3.53±0.8 and on the lower extremities from 2.9±0.8 to 3.3±0.9. The analysis of the gender on the higher score of MMT showed that gender does not affect the score of MMT. Correlational analysis of the age and duration of hospitalization on the score of MMT showed that patients with longer hospitalization had better improvement. Conclusion Results of the study showed that kinesiotherapy has positive effect on muscle strength in patients with Parkinson's disease.</AbstractText>
                <CopyrightInformation>Copyright© by the Medical Assotiation of Zenica-Doboj Canton.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tanović</LastName>
                    <ForeName>Edina</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinic for Physical Medicine and Rehabilitation, University Clinical Centre Sarajevo, Sarajevo, Bosnia and Herzegovina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Talić-Tanović</LastName>
                    <ForeName>Adnana</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinic for Orthopaedics and Traumatology, University Clinical Centre in Sarajevo, Bosnia and Herzegovina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ðelilović-Vranić</LastName>
                    <ForeName>Jasminka</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinic for Neurology; University Clinical Centre Sarajevo, Sarajevo, Bosnia and Herzegovina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rekić</LastName>
                    <ForeName>Amir</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departement of Family Medicine and Emergency Medicine, Health Care Centre Cazin, Bosnia and Herzegovina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Papović</LastName>
                    <ForeName>Adnan</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinic for Orthopaedics and Traumatology, University Clinical Centre in Sarajevo, Bosnia and Herzegovina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tanović</LastName>
                    <ForeName>Emina</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmacy, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>02</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Bosnia and Herzegovina</Country>
            <MedlineTA>Med Glas (Zenica)</MedlineTA>
            <NlmUniqueID>101250177</NlmUniqueID>
            <ISSNLinking>1840-0132</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">hospitalization</Keyword>
            <Keyword MajorTopicYN="N">manual muscle test
(MMT)</Keyword>
            <Keyword MajorTopicYN="N">rehabilitation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>06</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>07</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>07</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30444088</ArticleId>
            <ArticleId IdType="doi">10.17392/970-18</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">30418543</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>06</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1460-2199</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>29</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>04</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cerebral cortex (New York, N.Y. : 1991)</Title>
                <ISOAbbreviation>Cereb Cortex</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Emergent Functional Network Effects in Parkinson Disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1701</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/cercor/bhy229</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gratton</LastName>
                    <ForeName>Caterina</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Koller</LastName>
                    <ForeName>Jonathan M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shannon</LastName>
                    <ForeName>William</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>BioRankings, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Greene</LastName>
                    <ForeName>Deanna J</ForeName>
                    <Initials>DJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maiti</LastName>
                    <ForeName>Baijayanta</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Snyder</LastName>
                    <ForeName>Abraham Z</ForeName>
                    <Initials>AZ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Petersen</LastName>
                    <ForeName>Steven E</ForeName>
                    <Initials>SE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychology, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroscience, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurological Surgery, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Perlmutter</LastName>
                    <ForeName>Joel S</ForeName>
                    <Initials>JS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroscience, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Occupational Therapy, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Physical Therapy, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Campbell</LastName>
                    <ForeName>Meghan C</ForeName>
                    <Initials>MC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016425">Published Erratum</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Cereb Cortex</MedlineTA>
            <NlmUniqueID>9110718</NlmUniqueID>
            <ISSNLinking>1047-3211</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="ErratumFor">
                <RefSource>Cereb Cortex. 2019 Jun 1;29(6):2509-2523</RefSource>
                <PMID Version="1">29878081</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>08</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30418543</ArticleId>
            <ArticleId IdType="pii">5174330</ArticleId>
            <ArticleId IdType="doi">10.1093/cercor/bhy229</ArticleId>
            <ArticleId IdType="pmc">PMC7302739</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30408497</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>02</Month>
            <Day>28</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>02</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1090-2139</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>76</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>02</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Brain, behavior, and immunity</Title>
                <ISOAbbreviation>Brain Behav Immun</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Histamine-4 receptor antagonist JNJ7777120 inhibits pro-inflammatory microglia and prevents the progression of Parkinson-like pathology and behaviour in a rat model.</ArticleTitle>
            <Pagination>
                <MedlinePgn>61-73</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0889-1591(18)30783-9</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbi.2018.11.006</ELocationID>
            <Abstract>
                <AbstractText>The activation of microglial cells is presumed to play a key role in the pathogenesis of Parkinson's disease (PD). The activity of microglia is regulated by the histamine-4 receptor (H<sub>4</sub>R), thus providing a novel target that may prevent the progression of PD. However, this putative mechanism has so far not been validated. In our previous study, we found that mRNA expression of H<sub>4</sub>R was upregulated in PD patients. In the present study, we validated this possible mechanism using the rotenone-induced PD rat model, in which mRNA expression levels of H<sub>4</sub>R-, and microglial markers were significantly increased in the ventral midbrain. Inhibition of H<sub>4</sub>R in rotenone-induced PD rat model by infusion of the specific H<sub>4</sub>R antagonist JNJ7777120 into the lateral ventricle resulted in blockade of microglial activation. In addition, pharmacological targeting of H<sub>4</sub>R in rotenone-lesioned rats resulted in reduced apomorphine-induced rotational behaviour, prevention of dopaminergic neuron degeneration and associated decreases in striatal dopamine levels. These changes were accompanied by a reduction of Lewy body-like neuropathology. Our results provide first proof of the efficacy of an H<sub>4</sub>R antagonist in a commonly used PD rat model, and proposes the H<sub>4</sub>R as a promising target to clinically tackle microglial activation and thereby the progression of PD.</AbstractText>
                <CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Pei</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Medical Laboratory, Dalian Medical University, Dalian, Liaoning 116044, China; Department of Clinical Laboratory, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei 443003, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Homberg</LastName>
                    <ForeName>Judith R</ForeName>
                    <Initials>JR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fang</LastName>
                    <ForeName>Qiuyuan</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Medical Laboratory, Dalian Medical University, Dalian, Liaoning 116044, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Jiaqi</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Medical Laboratory, Dalian Medical University, Dalian, Liaoning 116044, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Weizhuo</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Medical Laboratory, Dalian Medical University, Dalian, Liaoning 116044, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meng</LastName>
                    <ForeName>Xianzong</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Medical Laboratory, Dalian Medical University, Dalian, Liaoning 116044, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shen</LastName>
                    <ForeName>Junqing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Medical Laboratory, Dalian Medical University, Dalian, Liaoning 116044, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Luan</LastName>
                    <ForeName>Yi</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Medical Laboratory, Dalian Medical University, Dalian, Liaoning 116044, China; Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liao</LastName>
                    <ForeName>Peng</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Medical Laboratory, Dalian Medical University, Dalian, Liaoning 116044, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Swaab</LastName>
                    <ForeName>Dick F</ForeName>
                    <Initials>DF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Netherlands Institute for Neuroscience, an Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam, the Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shan</LastName>
                    <ForeName>Ling</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Netherlands Institute for Neuroscience, an Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam, the Netherlands. Electronic address: l.shan@nin.knaw.nl.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Chunqing</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Medical Laboratory, Dalian Medical University, Dalian, Liaoning 116044, China. Electronic address: liuchunqing@dlmedu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Brain Behav Immun</MedlineTA>
            <NlmUniqueID>8800478</NlmUniqueID>
            <ISSNLinking>0889-1591</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C498828">Hrh4 protein, rat</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007211">Indoles</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010879">Piperazines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000074040">Receptors, Histamine H4</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>03L9OT429T</RegistryNumber>
                <NameOfSubstance UI="D012402">Rotenone</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>4H1AU2V37X</RegistryNumber>
                <NameOfSubstance UI="C484309">1-((5-chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>820484N8I3</RegistryNumber>
                <NameOfSubstance UI="D006632">Histamine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003342" MajorTopicYN="N">Corpus Striatum</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059290" MajorTopicYN="N">Dopaminergic Neurons</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006632" MajorTopicYN="N">Histamine</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007211" MajorTopicYN="N">Indoles</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020734" MajorTopicYN="N">Parkinsonian Disorders</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010879" MajorTopicYN="N">Piperazines</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000074040" MajorTopicYN="N">Receptors, Histamine H4</DescriptorName>
                <QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012402" MajorTopicYN="N">Rotenone</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Histamine 4 receptor antagonist</Keyword>
            <Keyword MajorTopicYN="Y">Microglia</Keyword>
            <Keyword MajorTopicYN="Y">Parkinson’s disease</Keyword>
            <Keyword MajorTopicYN="Y">Rotenone</Keyword>
            <Keyword MajorTopicYN="Y">α-Synuclein</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>04</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>2</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30408497</ArticleId>
            <ArticleId IdType="pii">S0889-1591(18)30783-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbi.2018.11.006</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30408230</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>25</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>03</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1531-8249</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>85</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of neurology</Title>
                <ISOAbbreviation>Ann Neurol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>96-104</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/ana.25376</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE">Newer magnetic resonance imaging (MRI) techniques have shown promise in capturing early Parkinson disease (PD)-related changes in the substantia nigra pars compacta (SNc), the key pathological loci. Their translational value, however, is hindered by technical complexity and inconsistent results.</AbstractText>
                <AbstractText Label="METHODS">A novel yet simple MRI contrast, the T1w/T2w ratio, was used to study 76 PD patients and 70 controls. The T1w/T2w ratio maps were analyzed using both voxel-based and region-of-interest approaches in normalized space. The sensitivity and specificity of the SNc T1w/T2w ratio in discriminating between PD and controls also were assessed. In addition, its diagnostic performance was tested in a subgroup of PD patients with disease duration ≤2 years (PDE). A second independent cohort of 73 PD patients and 49 controls was used for validation.</AbstractText>
                <AbstractText Label="RESULTS">Compared to controls, PD patients showed a higher T1w/T2w ratio in both the right (cluster size = 164mm<sup>3</sup> , p &lt; 0.0001) and left (cluster size = 213mm<sup>3</sup> , p &lt; 0.0001) midbrain that was located ventrolateral to the red nucleus and corresponded to the SNc. The region-of-interest approach confirmed the group difference in the SNc T1w/T2w ratio between PD and controls (p &lt; 0.0001). The SNc T1w/T2w ratio had high sensitivity (0.908) and specificity (0.80) to separate PD and controls (area under the curve [AUC] = 0.926), even for PDE patients (AUC = 0.901, sensitivity = 0.857, specificity = 0.857). These results were validated in the second cohort.</AbstractText>
                <AbstractText Label="INTERPRETATION">The T1w/T2w ratio can detect PD-related changes in the SNc and may be used as a novel, parsimonious in vivo biomarker for the disease, particularly for early stage patients, with high translational value for clinical practice and research. ANN NEUROL 2019;85:96-104.</AbstractText>
                <CopyrightInformation>© 2018 American Neurological Association.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Du</LastName>
                    <ForeName>Guangwei</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Penn State Hershey Medical Center, Hershey, PA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lewis</LastName>
                    <ForeName>Mechelle M</ForeName>
                    <Initials>MM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Penn State Hershey Medical Center, Hershey, PA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Penn State Hershey Medical Center, Hershey, PA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sica</LastName>
                    <ForeName>Christopher</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Penn State Hershey Medical Center, Hershey, PA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kong</LastName>
                    <ForeName>Lan</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Public Health Sciences, Penn State Hershey Medical Center, Hershey, PA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Xuemei</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Penn State Hershey Medical Center, Hershey, PA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Penn State Hershey Medical Center, Hershey, PA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Penn State Hershey Medical Center, Hershey, PA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, Penn State Hershey Medical Center, Hershey, PA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Kinesiology, Penn State Hershey Medical Center, Hershey, PA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <Agency>Michael J. Fox Foundation for Parkinson's Research</Agency>
                    <Country>International</Country>
                </Grant>
                <Grant>
                    <GrantID>U01 NS082151</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <Agency>Pennsylvania Department of Health Tobacco CURE Funds</Agency>
                    <Country>International</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 NS060722</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>UL1 RR033184</GrantID>
                    <Acronym>RR</Acronym>
                    <Agency>NCRR NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <Agency>Weston Brain Institute</Agency>
                    <Country>International</Country>
                </Grant>
                <Grant>
                    <GrantID>UL1 TR002014</GrantID>
                    <Acronym>TR</Acronym>
                    <Agency>NCATS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <Agency>Hershey Medical Center General Clinical Research Center</Agency>
                    <Country>International</Country>
                </Grant>
                <Grant>
                    <Agency>Alzheimer's Research UK</Agency>
                    <Country>International</Country>
                </Grant>
                <Grant>
                    <Agency>Alzheimer's Association</Agency>
                    <Country>International</Country>
                </Grant>
                <Grant>
                    <GrantID>UL1 TR000127</GrantID>
                    <Acronym>TR</Acronym>
                    <Agency>NCATS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016430">Clinical Trial</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Ann Neurol</MedlineTA>
            <NlmUniqueID>7707449</NlmUniqueID>
            <ISSNLinking>0364-5134</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>Nat Rev Neurol. 2019 Jan;15(1):2-3</RefSource>
                <PMID Version="1">30467345</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>02</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30408230</ArticleId>
            <ArticleId IdType="doi">10.1002/ana.25376</ArticleId>
            <ArticleId IdType="pmc">PMC6342624</ArticleId>
            <ArticleId IdType="mid">NIHMS998841</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Brain. 2000 Dec;123 Pt 12:2423-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11099445</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2017 Oct;82(4):519-529</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28833433</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Aging. 2015 Feb;36(2):1097-104</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25467638</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain. 2013 Aug;136(Pt 8):2419-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23884810</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain. 2010 Nov;133(11):3423-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20736190</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2013 Mar 14;495(7440):187-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23486058</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2011 Aug 10;31(32):11597-616</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21832190</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1564476</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Neurol. 2014 Dec;10(12):708-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25385334</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Image Anal. 2008 Feb;12(1):26-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17659998</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain. 2016 Feb;139(Pt 2):495-508</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26705348</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroimage. 2009 Aug 15;47(2):435-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19447183</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroimage. 2014 Dec;103:323-333</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25271843</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2014 Jul 29;83(5):406-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24975862</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain. 2017 Aug 1;140(8):2183-2192</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28899020</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Magn Reson Med. 2009 Sep;62(3):717-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19623619</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2016 Mar;31(3):317-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26362242</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Aging Neurosci. 2016 Aug 22;8:196</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27597825</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2013 Nov 20;33(47):18618-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24259583</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2008 Apr 15;70(16 Pt 2):1411-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18172063</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Magn Reson Med. 2015 Jan;73(1):82-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25044035</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2017 Oct;82(4):635-639</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28833377</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2018 Sep;33(9):1432-1439</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29756231</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AJNR Am J Neuroradiol. 2017 May;38(5):966-972</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28364007</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Magn Reson Med. 2008 Dec;60(6):1372-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19025904</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2009 Apr 21;72(16):1378-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19129507</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2018 Sep;33(9):1423-1431</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29756399</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2012 Nov;27(13):1636-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23008179</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Brain Mapp. 2017 Apr;38(4):1780-1790</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28009069</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroimage. 2010 Jun;51(2):512-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20211271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain. 1991 Oct;114 ( Pt 5):2283-301</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1933245</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Magn Reson Imaging. 2015 Jan;33(1):1-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25267705</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroimage Clin. 2013 Oct 14;3:481-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24273730</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Neurol. 2015 Oct;14(10):1002-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26271532</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain. 2017 Jan;140(1):118-131</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27836833</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2016 Feb 9;86(6):566-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26764028</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroimage. 2011 Feb 1;54(3):2033-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20851191</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol Sci. 2006 Feb 15;241(1-2):19-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16386758</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Transl Neurodegener. 2017 Mar 28;6:8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28360997</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30397850</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>12</Month>
            <Day>20</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>03</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1559-1182</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>56</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular neurobiology</Title>
                <ISOAbbreviation>Mol Neurobiol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4799-4811</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-018-1419-8</ELocationID>
            <Abstract>
                <AbstractText>Parkinson's disease is a neurodegenerative disorder accompanied by depletion of dopamine and loss of dopaminergic neurons in the brain that is believed to be responsible for the motor and non-motor symptoms in this disease. The main drug prescribed for Parkinsonian patients is L-dopa, which can be converted to dopamine by passing through the blood-brain barrier. Although L-dopa is able to improve motor function and improve the quality of life in the patients, there is inter-individual variability and some patients do not achieve the therapeutic effect. Variations in treatment response and side effects of current drugs have convinced scientists to think of treating Parkinson's disease at the cellular and molecular level. Molecular and cellular therapy for Parkinson's disease include (i) cell transplantation therapy with human embryonic stem (ES) cells, human induced pluripotent stem (iPS) cells and human fetal mesencephalic tissue, (ii) immunological and inflammatory therapy which is done using antibodies, and (iii) gene therapy with AADC-TH-GCH gene therapy, viral vector-mediated gene delivery, RNA interference-based therapy, CRISPR-Cas9 gene editing system, and alternative methods such as optogenetics and chemogenetics. Although these methods currently have a series of challenges, they seem to be promising techniques for Parkinson's treatment in future. In this study, these prospective therapeutic approaches are reviewed.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jamebozorgi</LastName>
                    <ForeName>Khosro</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, Zabol University of Medical Sciences, Zabol, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Taghizadeh</LastName>
                    <ForeName>Eskandar</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Departments of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rostami</LastName>
                    <ForeName>Daryoush</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of School Allied, Zabol University of Medical Sciences, Zabol, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pormasoumi</LastName>
                    <ForeName>Hosein</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, Zabol University of Medical Sciences, Zabol, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barreto</LastName>
                    <ForeName>George E</ForeName>
                    <Initials>GE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá D.C., Colombia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Instituto de Ciencias Biomédicas, Universidad Autónoma de Chile, Santiago, Chile.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hayat</LastName>
                    <ForeName>Seyed Mohammad Gheibi</ForeName>
                    <Initials>SMG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sahebkar</LastName>
                    <ForeName>Amirhossein</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8656-1444</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, P.O. Box: 91779-48564, Mashhad, Iran. sahebkara@mums.ac.ir.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mol Neurobiol</MedlineTA>
            <NlmUniqueID>8900963</NlmUniqueID>
            <ISSNLinking>0893-7648</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D001688">Biological Products</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001688" MajorTopicYN="N">Biological Products</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017690" MajorTopicYN="N">Cell Transplantation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000072669" MajorTopicYN="N">Gene Editing</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015316" MajorTopicYN="N">Genetic Therapy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Gene therapy</Keyword>
            <Keyword MajorTopicYN="N">L-dopa</Keyword>
            <Keyword MajorTopicYN="N">Molecular mechanisms</Keyword>
            <Keyword MajorTopicYN="N">Parkinson’s disease</Keyword>
            <Keyword MajorTopicYN="N">Transplantation therapy</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>08</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>12</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30397850</ArticleId>
            <ArticleId IdType="doi">10.1007/s12035-018-1419-8</ArticleId>
            <ArticleId IdType="pii">10.1007/s12035-018-1419-8</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Neuroreport. 2009 Jan 28;20(2):150-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19151598</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Behav Brain Res. 2002 Oct 17;136(1):317-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12385818</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Neurosci. 2013 Jan;14(1):38-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23254192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Neurol. 2017 Jul 1;74(7):780-792</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28586827</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Surg Neurol Int. 2017 Apr 26;8:65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28540131</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Neurol. 2014 Mar;253:180-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24412491</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2014 Apr 23-30;311(16):1670-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24756517</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Res. 2008 Mar 10;1198:188-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18241847</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stem Cells. 2013 Aug;31(8):1548-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23666606</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsonism Relat Disord. 2017 May;38:1-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28202372</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Transl Med. 2009 Oct 14;1(2):2ra4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20368163</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Med Chem. 2017 Dec 1;141:257-272</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29031072</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Stem Cell. 2015 Mar 5;16(3):269-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25732245</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2015 Jun;30(7):919-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25737166</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Neurol. 2006 Jun;5(6):525-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16713924</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 1998;13 Suppl 1:24-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9613715</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2012 Jun 28;1(6):703-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22813745</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurochem Res. 2009 Feb;34(2):215-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18512151</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Drug Metab. 2017;18(1):50-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27396919</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2005 Jun;115(6):1449-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15931380</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prog Brain Res. 2008;172:465-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18772046</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Tissue Res. 2004 Oct;318(1):261-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15309619</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Stem Cell. 2013 Oct 3;13(4):382-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24094319</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Control Release. 2018 Sep 28;286:114-124</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30026082</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Neurosci. 1999 Dec;2(12):1137-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10570493</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Struct Funct. 2015 Jan;220(1):479-500</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24292256</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2014 Mar 29;383(9923):1138-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24412048</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Parkinsons Dis. 2011;1(4):395-412</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23933658</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 1987 Oct;22(4):457-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3435067</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CNS Neurosci Ther. 2014 Jan;20(1):76-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24279586</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1998 Nov 6;282(5391):1145-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9804556</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 2014 Apr;32(4):347-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24584096</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Transplant. 2013;22(7):1281-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22963760</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2841426</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurotherapeutics. 2011 Oct;8(4):549-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21997523</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2008 Jan 9;28(2):425-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18184785</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurochem. 2016 Oct;139 Suppl 1:325-337</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27577098</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2002 Jul 4;418(6893):50-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12077607</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2015 Aug;78(2):248-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26061140</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2017 Sep 13;549(7671):292</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28905919</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Planta Med. 2016 Jul;82(11-12):942-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27224274</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Springerplus. 2015 Oct 13;4:597</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26543732</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Ther. 2006 Oct;14(4):571-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16781894</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1998 May 26;95(11):6469-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9600990</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cold Spring Harb Perspect Med. 2012 Apr;2(4):a009431</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22474617</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Development. 2016 Jul 15;143(14):2494-510</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27436039</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2013 Mar;28(3):268-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23401015</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 1994 Feb;35(2):172-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8109898</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Stem Cell Res Ther. 2016;11(7):561-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26027681</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2009 Apr 17;324(5925):354-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19299587</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2017 Feb;32(2):211-218</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27886407</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO Mol Med. 2015 Mar 09;7(5):510-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25759364</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Neurosci. 2011 Mar;14(3):387-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21278729</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Glia. 2017 Nov;65(11):1833-1847</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28836295</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurogenetics. 2008 May;9(2):83-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18097693</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Dis Primers. 2017 Mar 23;3:17013</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28332488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2010 Nov 23;75(21):1920-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21098407</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Aging Neurosci. 2016 May 02;8:97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27199743</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Neurol Scand. 2016 Nov;134(5):314-326</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26869347</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Chem. 2016;12(3):204-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26477707</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2017 Aug 30;548(7669):592-596</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28858313</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Protoc. 2007;2(12):3081-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18079707</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain. 1994 Jun;117 ( Pt 3):487-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8032859</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2017 Sep;32(9):1264-1310</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28887905</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2402-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24510898</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Ther. 2013 May;138(2):155-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23348013</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Dis. 2016 Nov;95:225-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27452483</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CNS Neurol Disord Drug Targets. 2016;15(3):292-300</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26831259</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Stem Cell. 2014 Nov 6;15(5):653-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25517469</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biophys Chem. 2017 Jan;220:34-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27863716</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2001 Mar 8;344(10):710-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11236774</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nutr Neurosci. 2012 May;15(3):120-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22732354</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Stem Cell. 2012 Aug 3;11(2):147-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22862941</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosurg. 1985 Feb;62(2):169-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2578558</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2002 Dec 1;22(23):10302-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12451130</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Gene Ther. 2009 May;20(5):511-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19254173</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Embryol Exp Morphol. 1962 Dec;10:622-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">13951335</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Genet. 2017;98:43-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28942794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2011 Nov 06;480(7378):547-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22056989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Neurol. 2008 Aug;212(2):307-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18511044</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neural Transm (Vienna). 2016 Nov;123(11):1301-1307</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27250986</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stem Cell Reports. 2014 Mar 06;2(3):337-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24672756</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS J. 2008 Apr;275(7):1377-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18279377</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Cell Neurosci. 2014 Aug 04;8:211</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25136294</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Microbiol Mol Biol Rev. 2003 Dec;67(4):657-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14665679</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1972 Mar 3;175(4025):949-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5061866</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2003;53 Suppl 3:S16-23; discussion S23-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12666095</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Chem. 2018 Jul 20;6:276</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30175092</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neural Transm (Vienna). 2016 Jan;123(1):73-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26293352</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Philos Trans R Soc Lond B Biol Sci. 2015 Oct 19;370(1680):20140370</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26416681</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2018 Aug 1;27(R2):R79-R88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29659822</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Ther Nucleic Acids. 2017 Dec 15;9:57-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29246324</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochim Biophys Acta. 2002 May 3;1575(1-3):15-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12020814</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2005 May;20(5):523-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15818599</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Rep. 2014 Jun 26;7(6):1755-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24910427</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Neurol. 2017 Dec;30(6):630-638</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28906270</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br Med Bull. 2008;86:109-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18398010</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Neurosci. 2008 Jun;31(6):303-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18471904</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Neuroanat. 2015 Feb 13;9:10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25762899</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2008 May 20;70(21):1980-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18401019</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Ther. 2014 Mar;22(3):487-497</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24356252</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Dis. 2017 Jan;97(Pt B):179-188</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27616425</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Commun Signal. 2013 May 17;11(1):34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23683503</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10343-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21646515</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Ther. 2010 Aug;18(8):1458-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20531394</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Neurol. 2013 Jan;9(1):13-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23183883</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1992 Nov 26;327(22):1541-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1435880</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2017 Apr 04;8:45883</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28374838</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antioxid Redox Signal. 2009 Sep;11(9):2189-208</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19485712</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2015 Feb;30(2):229-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25449044</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Gene Ther. 2012 Apr;23(4):377-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22424171</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Neurol. 2014 Mar;71(3):291-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24395393</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Neurosci. 2007 May;30(5):194-202</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17408759</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1969 Jul 26;2(7613):165-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4183130</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Pharm Des. 2017;23(28):4180-4188</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28302024</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mov Disord. 2016 Jan;9(1):14-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26828212</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurochem. 2016 Oct;139 Suppl 1:318-324</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27401947</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Neuropathol Commun. 2017 Jan 13;5(1):7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28086964</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2016 Jun;31(6):882-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26926119</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Cell Neurosci. 2015 Apr 10;9:124</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25914621</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Life Sci. 1975 Jul 1;17(1):131-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1143006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2003 Sep 11;39(6):889-909</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12971891</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochim Biophys Acta. 2011 Jan;1812(1):1-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20713152</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Pathol. 2015 Mar;25(2):121-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24995389</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Protoc. 2013 Nov;8(11):2281-2308</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24157548</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Control Release. 2014 Dec 10;195:49-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25111131</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Neuropathol. 2014;127(6):861-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24525765</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurosci Res. 2012 Oct;74(2):80-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22902554</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Philos Trans R Soc Lond B Biol Sci. 2008 Jan 12;363(1489):87-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17322002</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuropsychologia. 2003;41(11):1431-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12849761</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Ther Targets. 2015;19(10):1351-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26135549</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Neurol. 2013 Jan;12(1):84-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23237903</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2009 Mar 15;24(4):564-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19086083</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2013 Mar 1;22(5):1039-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23223016</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Neurodegener. 2015 Sep 23;10:47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26394842</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurosci. 2010 Apr;17(2):92-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25205879</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2014 Jul 9;34(28):9441-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25009275</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurochem Res. 2010 Oct;35(10):1546-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20635141</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Neurol. 2015 Aug;14(8):855-866</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26050140</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Presse Med. 2017 Mar;46(2 Pt 1):175-181</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28189372</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Stem Cell. 2011 Oct 4;9(4):374-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21962918</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2013 Sep 12;154(6):1380-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23992846</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nutr Neurosci. 2012 Jan;15(1):1-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22305647</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Sci (Lond). 2005 Oct;109(4):355-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16171459</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Neurobiol. 2019 Apr;56(4):2339-2351</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29982985</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Neurosci. 2002 Jul;5(7):627-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12042822</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Transl Neurodegener. 2017 Oct 25;6:28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29090092</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Neurol. 2014 Dec 15;5:242</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25566170</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">30395324</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>14</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1524-4040</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>84</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neurosurgery</Title>
                <ISOAbbreviation>Neurosurgery</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Letter: Deep Brain Stimulation of the Pedunculopontine Nucleus Area in Parkinson Disease: Magnetic Resonance Imaging-Based Anatomoclinical Correlations and Optimal Target.</ArticleTitle>
            <Pagination>
                <MedlinePgn>E103-E105</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/neuros/nyy516</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tuleasca</LastName>
                    <ForeName>Constantin</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neurosurgery Service and Gamma Knife Center Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Medical Image Analysis Laboratory (MIAL) and Department of Radiology-Center of Biomedical Imaging (CIBM) Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Signal Processing Laboratory (LTS 5) Ecole Polytechnique Fédérale de Lausanne (EPFL) Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Biology and Medicine (FBM) University of Lausanne (Unil) Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculté de Médecine, Sorbonne Université Paris, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Régis</LastName>
                    <ForeName>Jean</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Stereotactic and Functional Neurosurgery Service and Gamma Knife Unit CHU Timone Marseille, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Najdenovska</LastName>
                    <ForeName>Elena</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Image Analysis Laboratory (MIAL) and Department of Radiology-Center of Biomedical Imaging (CIBM) Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Witjas</LastName>
                    <ForeName>Tatiana</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neurology Department CHU Timone Marseille, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Girard</LastName>
                    <ForeName>Nadine</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>AMU, CRMBM UMR CNRS 7339 Faculté de Médecine and APHM Hopital Timone Department of Diagnostic and Interventionnal Neuroradiology Marseille, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thiran</LastName>
                    <ForeName>Jean-Philippe</ForeName>
                    <Initials>JP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Signal Processing Laboratory (LTS 5) Ecole Polytechnique Fédérale de Lausanne (EPFL) Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Biology and Medicine (FBM) University of Lausanne (Unil) Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cuadra</LastName>
                    <ForeName>Meritxell Bach</ForeName>
                    <Initials>MB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Image Analysis Laboratory (MIAL) and Department of Radiology-Center of Biomedical Imaging (CIBM) Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Signal Processing Laboratory (LTS 5) Ecole Polytechnique Fédérale de Lausanne (EPFL) Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Levivier</LastName>
                    <ForeName>Marc</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neurosurgery Service and Gamma Knife Center Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Biology and Medicine (FBM) University of Lausanne (Unil) Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Van De Ville</LastName>
                    <ForeName>Dimitri</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine University of Geneva Geneva, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Medical Image Processing Laboratory Ecole Polytechnique Fédérale de Lausanne (EPFL) Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
                <PublicationType UI="D016420">Comment</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Neurosurgery</MedlineTA>
            <NlmUniqueID>7802914</NlmUniqueID>
            <ISSNLinking>0148-396X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentOn">
                <RefSource>Neurosurgery. 2019 Feb 1;84(2):506-518</RefSource>
                <PMID Version="1">29846707</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>Neurosurgery. 2019 Jan 1;84(1):E106-E107</RefSource>
                <PMID Version="1">30445622</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D046690" MajorTopicYN="Y">Deep Brain Stimulation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D045042" MajorTopicYN="Y">Pedunculopontine Tegmental Nucleus</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30395324</ArticleId>
            <ArticleId IdType="pii">5156885</ArticleId>
            <ArticleId IdType="doi">10.1093/neuros/nyy516</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30386933</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>03</Month>
            <Day>11</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>02</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1590-3478</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>40</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Feb</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title>
                <ISOAbbreviation>Neurol Sci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Association of olfaction dysfunction with brain microstructure in prodromal Parkinson disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>283-291</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-018-3629-2</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Although olfaction dysfunction is now considered as an established clinical marker of prodromal Parkinson disease (PD), little is known about the neural underpinnings of olfaction dysfunction in the prodromal phase of PD. The aim of this study was to examine the microstructural association of olfaction in prodromal PD compared to early stage drug-naïve PD patients.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Diffusion MRI connectometry was conducted on 18 early PD and 17 prodromal PD patients to investigate the differences in group in terms of altered connectivity, i.e., integrity of white matter tracts, and subsequently to study the correlation of University of Pennsylvania Smell Identification Test (UPSIT) score to white matter integrity in each group using a multiple regression model considering age, sex, RBD, and MoCA, as covariates.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Individuals with prodromal PD had significantly higher quantitative anisotropy (QA) comparing with PD patients in bilateral middle cerebellar peduncles and right arcuate fasciculus. Multiple regression analysis in prodromal PD demonstrated positive association between UPSIT score and connectivity in left and right subgenual cingulum, right inferior fronto-occipital fasciculus, left corticospinal tract, left parietopontine, left corticothalamic tract, and the body and the splenium of corpus callosum.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These results indicate that PD and prodromal PD patients, which were matched for sex, UPSIT, and MoCA scores, have different white matter fiber architecture. Thus, it is postulated that olfaction dysfunction in prodromal and early clinical phases of PD may involve distinct pathogenesis. Increased network connectivity in prodromal and early PD may suggest the neural compensation.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sanjari Moghaddam</LastName>
                    <ForeName>Hossein</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dolatshahi</LastName>
                    <ForeName>Mahsa</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Salardini</LastName>
                    <ForeName>Elaheh</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aarabi</LastName>
                    <ForeName>Mohammad Hadi</ForeName>
                    <Initials>MH</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5550-9782</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran. mohammadhadiarabi@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016448">Multicenter Study</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Italy</Country>
            <MedlineTA>Neurol Sci</MedlineTA>
            <NlmUniqueID>100959175</NlmUniqueID>
            <ISSNLinking>1590-1874</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D038524" MajorTopicYN="Y">Diffusion Magnetic Resonance Imaging</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009434" MajorTopicYN="N">Neural Pathways</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000857" MajorTopicYN="N">Olfaction Disorders</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D062706" MajorTopicYN="N">Prodromal Symptoms</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D066127" MajorTopicYN="N">White Matter</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Diffusion MRI</Keyword>
            <Keyword MajorTopicYN="N">Olfaction</Keyword>
            <Keyword MajorTopicYN="N">Parkinson disease</Keyword>
            <Keyword MajorTopicYN="N">Prodromal PD</Keyword>
            <Keyword MajorTopicYN="N">UPSIT</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>06</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>3</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30386933</ArticleId>
            <ArticleId IdType="doi">10.1007/s10072-018-3629-2</ArticleId>
            <ArticleId IdType="pii">10.1007/s10072-018-3629-2</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Chem Senses. 2000 Feb;25(1):111-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10668001</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2001 Jul;50(1):34-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11456307</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Aging. 2003 Mar-Apr;24(2):197-211</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12498954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2004 Aug;56(2):173-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15293269</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2005 May 24;64(10):1716-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15911797</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Res Brain Res Rev. 2005 Dec 15;50(2):287-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16213593</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2007 Apr 30;22(6):839-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17357143</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol. 2007 Jan;254(1):84-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17508142</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2008 Feb;63(2):167-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18067173</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurosci Lett. 2008 Dec 5;447(1):12-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18838108</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann N Y Acad Sci. 2008 Oct;1142:266-309</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18990132</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsonism Relat Disord. 2009 Aug;15(7):490-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19138875</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2009 May 15;24(7):1060-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19353591</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroscience. 2009 Aug 18;162(2):537-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19401224</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2009 Dec 9;29(49):15410-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20007465</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain. 2010 Jun;133(Pt 6):1747-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20413575</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2010 Sep 15;25(12):1888-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20669268</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2011 May;69(5):811-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21246603</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2011 Mar;26(4):621-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21284041</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2011 Feb;69(2):400-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21387382</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroimage. 2011 Sep 1;58(1):91-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21704171</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AJNR Am J Neuroradiol. 2011 Dec;32(11):2116-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21903908</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain. 2012 Jan;135(Pt 1):161-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22287381</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2012 Apr 15;27(5):617-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22508280</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2012 Apr 15;27(5):656-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22508284</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Neurol. 2012 May 15;8(6):329-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22584158</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroimage Clin. 2013 Jun 29;2:912-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24179842</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013 Oct 25;8(10):e78830</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24205327</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013 Nov 15;8(11):e80713</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24348913</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Brain Mapp. 2014 Aug;35(8):3932-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24453162</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2014 Aug;29(9):1205-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24482154</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2014 Apr;29(4):454-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24619848</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2014 Oct 03;9(10):e108124</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25279557</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2015 Feb 17;84(7):654-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25609758</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Brain Mapp. 2015 May;36(5):1716-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25640661</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsonism Relat Disord. 2015 Jul;21(7):698-703</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25937615</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2015 Oct;30(12):1600-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26474317</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurosci Biobehav Rev. 2016 Feb;61:26-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26645499</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Neurol. 2016 May;15(6):637-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26993435</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Brain Mapp. 2016 Dec;37(12):4500-4510</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27466157</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsonism Relat Disord. 2016 Dec;33:12-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27765426</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Neurol. 2016 Oct 27;12(11):622-634</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27786242</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sleep Breath. 2017 Mar;21(1):155-161</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27853964</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsonism Relat Disord. 2017 Dec;45:21-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28964628</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2017 Oct 2;7(1):12559</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28970540</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Imaging Behav. 2017 Nov 13;:null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29134611</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Neurol Belg. 2018 Mar 14;:null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29542093</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Psychogeriatr. 2018 Mar 21;:1-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29560834</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Neurol. 2018 Mar 20;9:163</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29662464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Neurol Belg. 2018 Dec;118(4):573-579</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29728904</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Neurol. 2018 Jun 26;9:441</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29997561</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PeerJ. 2018 Sep 13;6:e5539</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30225168</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Physiol Behav. 1984 Mar;32(3):489-502</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6463130</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 1994 Feb;44(2):266-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8309571</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 1998 Sep;44(3 Suppl 1):S10-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9749569</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30382389</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>05</Month>
            <Day>07</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2021</Year>
            <Month>01</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1432-1459</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>266</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neurology</Title>
                <ISOAbbreviation>J Neurol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>85-91</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-018-9104-4</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Falls represent one of the main complications of Parkinson's disease (PD), significantly lowering quality of life. Cardiovascular autonomic neuropathy (cAN) is one of the key contributing factors to PD-associated falls. However, a direct quantification of its impact on the risk of falling in PD is still lacking. In this 12-month prospective study, we sought to evaluate the association between cAN and falls.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Fifty consecutive patients were evaluated with a standardized battery of autonomic testing, Unified Parkinson's Disease Rating Scale, push and release (P&amp;R) test, timed up and go test, freezing of gait (FOG) questionnaire, Montreal cognitive assessment (MoCA). Dyskinesia severity and presence of REM sleep behavioral disorder (RBD) were additionally considered. Patients were followed-up for 12 months.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">We observed a 38% prevalence of cAN. At baseline, 36% of patients reported at least one fall in the previous 6 months. This figure increased to 56% over the follow-up. After adjusting for age, disease duration, axial symptoms, MoCA and dopaminergic treatment, cAN was significantly associated with a 15-fold (OR 15.194) higher probability of falls; orthostatic hypotension (OH), the most common expression of cAN, with a 10-fold probability (OR 10.702). In addition P&amp;R test (OR 14.021), RBD (OR 5.470) and FOG (OR 1.450) were independently associated with greater probability of falls.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">cAN, including but not limited to OH, is a strong independent predictor of falls in PD. Future research endeavors clarifying to what extent pharmacological and non-pharmacological treatments targeting autonomic dysfunctions might reduce the risk of falls are warranted.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Romagnolo</LastName>
                    <ForeName>Alberto</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1312-1843</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroscience Rita Levi Montalcini, University of Turin, via Cherasco 15, 10124, Torino, Italy. al.romagnolo@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zibetti</LastName>
                    <ForeName>Maurizio</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroscience Rita Levi Montalcini, University of Turin, via Cherasco 15, 10124, Torino, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Merola</LastName>
                    <ForeName>Aristide</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Canova</LastName>
                    <ForeName>Daniela</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroscience Rita Levi Montalcini, University of Turin, via Cherasco 15, 10124, Torino, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sarchioto</LastName>
                    <ForeName>Marianna</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences, University of Cagliari and Public Health, Cagliari, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Montanaro</LastName>
                    <ForeName>Elisa</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroscience Rita Levi Montalcini, University of Turin, via Cherasco 15, 10124, Torino, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Artusi</LastName>
                    <ForeName>Carlo Alberto</ForeName>
                    <Initials>CA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroscience Rita Levi Montalcini, University of Turin, via Cherasco 15, 10124, Torino, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vallelonga</LastName>
                    <ForeName>Fabrizio</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences, Autonomic Unit, University of Turin, Corso Bramante 88, 10126, Torino, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maule</LastName>
                    <ForeName>Simona</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences, Autonomic Unit, University of Turin, Corso Bramante 88, 10126, Torino, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lopiano</LastName>
                    <ForeName>Leonardo</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroscience Rita Levi Montalcini, University of Turin, via Cherasco 15, 10124, Torino, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>31</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>J Neurol</MedlineTA>
            <NlmUniqueID>0423161</NlmUniqueID>
            <ISSNLinking>0340-5354</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000058" MajorTopicYN="N">Accidental Falls</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001342" MajorTopicYN="N">Autonomic Nervous System Diseases</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020233" MajorTopicYN="N">Gait Disorders, Neurologic</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Autonomic neuropathy</Keyword>
            <Keyword MajorTopicYN="N">Falls</Keyword>
            <Keyword MajorTopicYN="N">Orthostatic hypotension</Keyword>
            <Keyword MajorTopicYN="N">Parkinson disease</Keyword>
            <Keyword MajorTopicYN="N">RBD</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>08</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>5</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>2</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30382389</ArticleId>
            <ArticleId IdType="doi">10.1007/s00415-018-9104-4</ArticleId>
            <ArticleId IdType="pii">10.1007/s00415-018-9104-4</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Mov Disord. 2010 Nov 15;25(15):2649-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21069833</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2007 Oct 15;22(13):1892-900</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17588236</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2011 Sep 13;77(11):1048-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21832215</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Geriatr Soc. 2005 Apr;53(4):695-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15817019</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsonism Relat Disord. 2016 Dec;33:65-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27641792</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Neurol. 2015 Aug;35(4):458-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26502768</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2015 Apr 15;30(5):639-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25678194</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):953-959</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28847794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol. 2010 Jul;257(7):1154-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20148335</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Neurol. 2016 Aug;15(9):954-966</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27478953</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2008 Jul 30;23(10):1453-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18512752</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Neurol. 2006 Sep;13(9):930-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16930356</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2003 Jul;18(7):738-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12815652</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2841426</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2015 Nov 3;85(18):1554-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26432848</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsonism Relat Disord. 2014 Apr;20(4):360-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24484618</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2017 Nov;32(11):1524-1536</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29067726</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsonism Relat Disord. 2000 Jul 1;6(3):165-170</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10817956</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Neurol. 2013 Jan;9(1):1-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23346153</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Geriatr Soc. 2011 May;59(5):887-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21410448</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2012 Jun;27(7):913-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22729987</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2009 Nov 17;73(20):1670-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19917989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol. 2016 Jan;263(1):133-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26530511</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Vestib Res. 1998 Jan-Feb;8(1):7-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9416584</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2008 Feb 5;70(6):473-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18250292</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Neurol. 2005 Mar;62(3):467-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15767513</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2012 Jul;27(8):996-1003</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22733427</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 2012 Sep 25;79(13):1323-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22972639</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsonism Relat Disord. 2006 May;12(4):195-204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16621660</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2012 Apr;71(4):560-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22522445</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vojnosanit Pregl. 2014 Apr;71(4):346-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24783414</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsonism Relat Disord. 2018 Feb;47:45-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29195729</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biometrics. 1980 Jun;36(2):343-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26625475</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2015 Feb;30(2):269-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25393613</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Neurol. 2015 Aug;72(8):863-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26076039</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mov Disord. 2017 May;32(5):796-797</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28256092</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol Sci. 2017 Jun 15;377:137-143</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28477684</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30373962</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>20</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>05</Month>
            <Day>20</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1877-718X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of Parkinson's disease</Title>
                <ISOAbbreviation>J Parkinsons Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Voice of the Parkinson Customer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>197-201</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3233/JPD-181431</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND AND OBJECTIVES">To improve the care for patients with chronic neurological conditions like Parkinson's disease, identifying the core needs of patients is crucial. In this article, we present the Voice of the Customer approach (originally developed in the field of industry to probe the clients' needs), a novel methodology to identify these needs.</AbstractText>
                <AbstractText Label="METHODS">A group of 12 discussants carried out in depth interviews to patients (n = 20), relatives (n = 12) and healthcare professionals (n = 11). The interviewers combined the most informative quotations into a comprehensive video, which was used as feedback to the interviewees. The interviewees then identified the most important needs in a consensus meeting.</AbstractText>
                <AbstractText Label="RESULTS AND CONCLUSIONS">The approach revealed that patients were more concerned about the impact of Parkinson's disease on their daily lives than about the bio-medical aspects of the disease. Their top unmet needs were: (1) more self management; (2) better interdisciplinary collaboration between different healthcare professionals; (3) more time to discuss the future and possible scenarios; and (4) a healthcare professional acting as a single point of access, acting as personal case manager, either to solve problems directly or to direct patients to the professional best equipped to address the problem at hand. These results can now be used to further optimize the care for patients with Parkinson's disease.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Vlaanderen</LastName>
                    <ForeName>Floris P</ForeName>
                    <Initials>FP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Scientific Institute for Quality of Healthcare, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rompen</LastName>
                    <ForeName>Lonneke</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Radboud university medical center, Nijmegen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Munneke</LastName>
                    <ForeName>Marten</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stoffer</LastName>
                    <ForeName>Marije</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Consultancy Group Process Improvement and Innovation, Radboud university medical center, Nijmegen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bloem</LastName>
                    <ForeName>Bastiaan R</ForeName>
                    <Initials>BR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Faber</LastName>
                    <ForeName>Marjan J</ForeName>
                    <Initials>MJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Scientific Institute for Quality of Healthcare, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>J Parkinsons Dis</MedlineTA>
            <NlmUniqueID>101567362</NlmUniqueID>
            <ISSNLinking>1877-7171</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020380" MajorTopicYN="Y">Needs Assessment</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010348" MajorTopicYN="N">Patient Care Team</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017060" MajorTopicYN="Y">Patient Satisfaction</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011369" MajorTopicYN="Y">Professional-Patient Relations</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000073278" MajorTopicYN="N">Self-Management</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Parkinson’s disease</Keyword>
            <Keyword MajorTopicYN="Y">Patient satisfaction</Keyword>
            <Keyword MajorTopicYN="Y">qualitative research</Keyword>
            <Keyword MajorTopicYN="Y">quality of health care</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>5</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30373962</ArticleId>
            <ArticleId IdType="pii">JPD181431</ArticleId>
            <ArticleId IdType="doi">10.3233/JPD-181431</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30340912</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>03</Month>
            <Day>02</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>03</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-5126</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>58</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Parkinsonism &amp; related disorders</Title>
                <ISOAbbreviation>Parkinsonism Relat Disord</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Submandibular gland is a suitable site for alpha synuclein pathology in Parkinson disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>35-39</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1353-8020(18)30207-4</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.parkreldis.2018.04.019</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE">To validate the role of α-synuclein (AS) pathology in submandibular gland (SMG) as a biomarker for Parkinson disease (PD).</AbstractText>
                <AbstractText Label="METHODS">We performed ultrasonography (USG) guided core needle biopsy of SMG in PD patients and procured SMG biopsy tissues or surgical excision specimens from non-PD patients as controls. Then, we compared AS deposition in the SMG tissues between the PD patients and the controls. We recruited 16 PD patients in this study. In each individual, two core needle biopsy tissues were obtained from the left submandibular gland under USG guidance. Fourteen sex and age-matched controls who did not have PD and dementia but received a core needle biopsy or surgical resection of the SMG due to SMG diseases were procured from the pathology archive. Biopsy tissues and surgical specimens were immuno-stained with serine 129 phosphorylated AS (pAS) antibody for microscopic examination. pAS deposition in neural structures such as ganglion cells and neurites was considered as positive.</AbstractText>
                <AbstractText Label="RESULTS">No serious complication occurred during and after the SMG biopsy. We found glandular parenchyma and neural structures in all biopsied SMG tissues from the patients and the controls. Nine out of 16 PD patients (56.2%) were positive for pAS staining, while none of the controls were positive (0%).</AbstractText>
                <AbstractText Label="CONCLUSIONS">SMG core needle biopsy can reliably and safely obtain sufficient glandular parenchyma and neural structures to evaluate the α-synuclein pathology. AS pathology in SMG has high specificity and good sensitivity as a biomarker for PD.</AbstractText>
                <CopyrightInformation>Copyright © 2018. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Shin</LastName>
                    <ForeName>Junghwan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Seoul National University Hospital, Seoul National University, Seoul, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Sung-Hye</ForeName>
                    <Initials>SH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Seoul National University Hospital, Seoul National University, Seoul, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shin</LastName>
                    <ForeName>Chaewon</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Kyung Hee University Hospital, Seoul, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Ji-Hoon</ForeName>
                    <Initials>JH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Seoul National University Hospital, Seoul National University, Seoul, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yun</LastName>
                    <ForeName>Tae Jin</ForeName>
                    <Initials>TJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Seoul National University Hospital, Seoul National University, Seoul, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Han-Joon</ForeName>
                    <Initials>HJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Seoul National University Hospital, Seoul National University, Seoul, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jeon</LastName>
                    <ForeName>Beomseok</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Seoul National University Hospital, Seoul National University, Seoul, South Korea. Electronic address: brain@snu.ac.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>04</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Parkinsonism Relat Disord</MedlineTA>
            <NlmUniqueID>9513583</NlmUniqueID>
            <ISSNLinking>1353-8020</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000074062">Environmental Biomarkers</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D062005" MajorTopicYN="N">Biopsy, Large-Core Needle</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000074062" MajorTopicYN="N">Environmental Biomarkers</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D061705" MajorTopicYN="N">Image-Guided Biopsy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013363" MajorTopicYN="N">Submandibular Gland</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Lewy body pathology</Keyword>
            <Keyword MajorTopicYN="Y">Parkinson disease</Keyword>
            <Keyword MajorTopicYN="Y">Submandibular gland biopsy</Keyword>
            <Keyword MajorTopicYN="Y">a-synuclein</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2017</Year>
                <Month>12</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>03</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>04</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>3</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30340912</ArticleId>
            <ArticleId IdType="pii">S1353-8020(18)30207-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.parkreldis.2018.04.019</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30336294</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>01</Month>
            <Day>17</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>01</Month>
            <Day>17</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-8769</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>121</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>World neurosurgery</Title>
                <ISOAbbreviation>World Neurosurg</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Pallidothalamic Tractotomy for Parkinson Disease with 1-Year Follow-Up: A Case Report.</ArticleTitle>
            <Pagination>
                <MedlinePgn>193-195</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1878-8750(18)32352-0</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.wneu.2018.10.055</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The pallidothalamic tract connects the globus pallidus internus and the ventrolateral portion of the thalamus, and ablation of the pallidothalamic tract (pallidothalamic tractotomy [PTT]) reportedly exerts antiparkinsonian effects. However, the detailed clinical course has not yet been elucidated. Here, we present the first single case report of PTT performed in a patient with Parkinson disease, with 1-year follow-up.</AbstractText>
                <AbstractText Label="CASE DESCRIPTION" NlmCategory="METHODS">The patient was a 68-year-old woman with Parkinson disease. After 14 years of receiving oral medication, she experienced the &quot;wearing-off&quot; phenomenon. Levodopa (300 mg/day) was required to maintain daily activities. Rigidity and peak-dose dyskinesia were predominantly observed in the right side of her body. In addition, she demonstrated right foot dystonia with pain. The preoperative Unified Parkinson Disease Rating Scale part 1, 2 (off medication/on medication), 3 (off medication/on medication), and 4 scores were 7, 26/4, 41/23, and 13, respectively. Further, the preoperative Unified Dyskinesia Rating Scale and Parkinson Disease Questionnaire-39 scores were 102 and 46, respectively. She underwent left-sided PTT, and no perioperative complications were observed. At 1 year postoperatively, daily administration of levodopa (200 mg) was maintained without an &quot;off&quot; condition all day. The 1-year Unified Parkinson Disease Rating Scale part 1, 2, 3, and 4 scores were 5, 9/1, 20/12, and 5, respectively. In addition, the 1-year Unified Dyskinesia Rating Scale and Parkinson Disease Questionnaire-39 scores were 20 and 20, respectively.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We present a rare case of PTT performed in a patient with Parkinson disease. PTT might be useful in patients who do not desire device implantation.</AbstractText>
                <CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Horisawa</LastName>
                    <ForeName>Shiro</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, Neurological Institute, Tokyo Women's Medical University, Tokyo, Japan. Electronic address: neurosurgery21@yahoo.co.jp.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nanke</LastName>
                    <ForeName>Magi</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kawamata</LastName>
                    <ForeName>Takakazu</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, Neurological Institute, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Taira</LastName>
                    <ForeName>Takaomi</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, Neurological Institute, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>World Neurosurg</MedlineTA>
            <NlmUniqueID>101528275</NlmUniqueID>
            <ISSNLinking>1878-8750</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005917" MajorTopicYN="N">Globus Pallidus</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009434" MajorTopicYN="N">Neural Pathways</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013788" MajorTopicYN="N">Thalamus</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Campotomy</Keyword>
            <Keyword MajorTopicYN="N">Pallidothalamic tract</Keyword>
            <Keyword MajorTopicYN="N">Parkinson disease</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>06</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>1</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30336294</ArticleId>
            <ArticleId IdType="pii">S1878-8750(18)32352-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.wneu.2018.10.055</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30315142</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>03</Month>
            <Day>30</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>03</Month>
            <Day>30</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1535-5667</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>60</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>05</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</Title>
                <ISOAbbreviation>J Nucl Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Cerebral Metabolic Changes Related to Freezing of Gait in Parkinson Disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>671-676</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.2967/jnumed.118.218248</ELocationID>
            <Abstract>
                <AbstractText>Freezing of gait (FOG) in Parkinson disease (PD) often occurs during steering of gait (i.e., complex gait), which is thought to arise from executive dysfunction. Our aim was to test whether cognitive corticobasal ganglia-thalamocortical circuitry is impaired and whether alternate neural circuits are used for complex gait in PD with FOG. <b>Methods:</b> Eighteen individuals with idiopathic PD in the off-medication state, 9 with FOG (aged 68 ± 6 y) and 9 without FOG (aged 65 ± 5 y), were included. PET was used to measure cerebral glucose metabolism during 2 gait tasks, steering and straight walking, performed during the radiotracer uptake period. <b>Results:</b> During steering, there was a reduced change in cerebral glucose metabolism within the cognitive corticothalamic circuit. More specifically, those with FOG had less activation of the posterior parietal cortex, less deactivation of the dorsolateral prefrontal cortex and thalamus, and increased activation in the supplementary motor area. Interestingly, activity in the dorsolateral prefrontal cortex correlated with gait impairment (i.e., reduced stride length) in the FOG group. <b>Conclusion:</b> These results demonstrate decreased parietal control and an alternate control mechanism mediated by prefrontal and supplementary motor areas in PD with FOG.</AbstractText>
                <CopyrightInformation>© 2019 by the Society of Nuclear Medicine and Molecular Imaging.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mitchell</LastName>
                    <ForeName>Trina</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Kinesiology and Physical Education, McGill University, Montréal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Interdisciplinary Research in Rehabilitation, Montréal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Potvin-Desrochers</LastName>
                    <ForeName>Alexandra</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Kinesiology and Physical Education, McGill University, Montréal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Interdisciplinary Research in Rehabilitation, Montréal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lafontaine</LastName>
                    <ForeName>Anne-Louise</ForeName>
                    <Initials>AL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Montreal Neurological Institute and Hospital, McGill University, Montréal, Quebec, Canada; Movement Disorders Unit, McGill University Health Centre, Montréal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Monchi</LastName>
                    <ForeName>Oury</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Neurosciences and Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thiel</LastName>
                    <ForeName>Alexander</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada; and.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jewish General Hospital, Lady Davis Institute for Medical Research, Montréal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paquette</LastName>
                    <ForeName>Caroline</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Kinesiology and Physical Education, McGill University, Montréal, Quebec, Canada caroline.paquette@mcgill.ca.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Interdisciplinary Research in Rehabilitation, Montréal, Quebec, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Nucl Med</MedlineTA>
            <NlmUniqueID>0217410</NlmUniqueID>
            <ISSNLinking>0161-5505</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0Z5B2CJX4D</RegistryNumber>
                <NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019788" MajorTopicYN="N">Fluorodeoxyglucose F18</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020233" MajorTopicYN="N">Gait Disorders, Neurologic</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Parkinson disease</Keyword>
            <Keyword MajorTopicYN="Y">cerebral glucose metabolism</Keyword>
            <Keyword MajorTopicYN="Y">complex gait</Keyword>
            <Keyword MajorTopicYN="Y">freezing of gait</Keyword>
            <Keyword MajorTopicYN="Y">humans</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>07</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>3</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30315142</ArticleId>
            <ArticleId IdType="pii">jnumed.118.218248</ArticleId>
            <ArticleId IdType="doi">10.2967/jnumed.118.218248</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30314846</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>03</Month>
            <Day>26</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>03</Month>
            <Day>26</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-5126</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>59</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>02</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Parkinsonism &amp; related disorders</Title>
                <ISOAbbreviation>Parkinsonism Relat Disord</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Progress in the treatment of Parkinson-Plus syndromes.</ArticleTitle>
            <Pagination>
                <MedlinePgn>101-110</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1353-8020(18)30432-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.parkreldis.2018.10.006</ELocationID>
            <Abstract>
                <AbstractText>Progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB) are the four major proteinopathic neurodegenerative disorders. Currently, there are no disease modifying therapies for these disorders. However, better understanding of the etiopathogenic mechanisms of these disorders has allowed the development of novel therapeutic approaches. These mainly include strategies directed to the pathologic conformational shift, seeding and aggregation, as well as transcellular spread of the proteins that aggregate in the brain which are α-synuclein and tau. Modulation of inflammatory responses and neuroprotection are also targets of interest. A number of clinical trials have been performed and others are ongoing or are planned to address the authentic need for disease modifying treatments. However, challenges exist in terms of accurate early clinical diagnostic criteria and robust outcome measures, and preclinical animal models that would best recapitulate human disease.</AbstractText>
                <CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Olfati</LastName>
                    <ForeName>Nahid</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Qaem Medical Center, Ahmad-Abad st., 91766-99199, Mashhad, Iran. Electronic address: olfatin921@mums.ac.ir.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shoeibi</LastName>
                    <ForeName>Ali</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Qaem Medical Center, Ahmad-Abad st., 91766-99199, Mashhad, Iran. Electronic address: ashoeybi@ucsd.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Litvan</LastName>
                    <ForeName>Irene</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>UC San Diego Department of Neurosciences, Parkinson and Other Movement Disorder Center, La Jolla, CA, USA. Electronic address: ilitvan@ucsd.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Parkinsonism Relat Disord</MedlineTA>
            <NlmUniqueID>9513583</NlmUniqueID>
            <ISSNLinking>1353-8020</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015259">Dopamine Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015259" MajorTopicYN="N">Dopamine Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020961" MajorTopicYN="N">Lewy Body Disease</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019578" MajorTopicYN="N">Multiple System Atrophy</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013494" MajorTopicYN="N">Supranuclear Palsy, Progressive</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000080874" MajorTopicYN="N">Synucleinopathies</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Corticobasal degeneration</Keyword>
            <Keyword MajorTopicYN="Y">Dementia with Lewy bodies</Keyword>
            <Keyword MajorTopicYN="Y">Multiple system atrophy</Keyword>
            <Keyword MajorTopicYN="Y">Parkinson-plus syndrome</Keyword>
            <Keyword MajorTopicYN="Y">Progressive supranuclear palsy</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>08</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>3</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30314846</ArticleId>
            <ArticleId IdType="pii">S1353-8020(18)30432-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.parkreldis.2018.10.006</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
